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Abstract
The fission yeast DSCl (DNA synthesis control) tianscription factor complex regulates cell 
cycle-specific periodic transcription of a gi'oup of genes at the G l-S phase transition during the 
mitotic cell cycle, by binding to MCB {Mini cell cycle box) sequence elements common to 
their promoters. Included in this group are several genes whose functions are required for the 
onset and progression o f S phase, such as cdc22^ (the large subunit of ribonucleotide 
reductase), cig2^ (the major S phase cyclin) and the DNA replication licensing factors cdcl8^ 
and cd tP . In concert with cyclin-dependent kinase activity, DSCl function is required for 
passage of START and entry into the mitotic cell division cycle. Similar gene expression 
programmes exist in both budding yeast and humans controlled by the SBF/MBF and E2F 
transcription factors, respectively.
Fission yeast DSCl comprises two related DNA-binding subunits, Res Ip and Res2p, 
each bound to a single molecule o f the regulatory CdclOp protein. In addition, the Rep2p 
protein has a transcriptional activator function (replaced by Rep Ip in the meiotic cycle). 
Knowledge about functional aspects of each of the DSCl components has been greatly 
enhanced by genetic and biochemical studies. However, to date, these proteins remain poorly 
characterised at the atomic level, with little known about structure beyond their amino acid 
sequence. The aim of this study was to clone and bacterially express the individual DSCl 
genes, to provide sufficient protein to carry out more detailed biophysical and ftmctional 
studies.
The cdclO^, resl^, res2^' and rep2^ genes, together with the putative meiotic subunit 
r e p t ,  were cloned and overexpressed in E. coli as N-terminal histidine-tagged fusion proteins. 
Inclusion of the His-tag facilitated purification of the proteins by affinity chi omatography.
Each recombinant protein (with the exception of His-CdclOp) was shown to function in vivo', 
ectopic expression of His-resD, His-res2^, H is-rep t  or His-rep2* rescued the cold-sensitive 
lethality of the fission yeast Ares I  mutant strain. Bacterially expressed His-Reslp, FIis-Res2p 
and His-Rep2p were recovered in soluble form, whilst His-Replp and His-CdclOp were 
detergent-solubilised from inclusion bodies. His-Res2p was expressed and purified in yields 
sufficient to undertake biophysical analyses. Both His-Replp and His-CdclOp were solubilised 
and purified fiom inclusion bodies in yields sufficient for structural studies, although initial 
biophysical data suggests that re-folding strategies will be required to obtain active preparations 
of these proteins.
In electrophoretic mobility shift assay experiments, neither His-Reslp nor His-Res2p 
displayed detectable MCB-specific DNA-binding in vitro. Intriguingly, replacement of the His- 
tag with an N-terminal GST-tag conferred detectable MCB-specific DNA-binding upon both 
proteins. These results suggest that efficient DNA-binding requires dimérisation, a property
IV
that, at least in vitro, is apparently not naturally intrinsic to either Resp protein. Taken together, 
the results presented in this study provide a significant basis with which to undertake future 
structural analyses o f these proteins. The implications of these results for further in vitro studies 
are discussed.
V
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Chapter 1
Introduction
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1.1 Introduction
The aim of cell division is to distribute a single, complete and accurate copy of the genome to 
each of two daughter cells. The most prominent events in this process are chromosomal 
replication and segregation, hi eukaryotes, the mitotic cell division cycle comprises a highly 
complex series of events, which are precisely regulated and co-ordinated. The entire process is 
typically divided into four phases of the order: G l, S and G2 (collectively knovm as 
interphase), followed by M phase and cellular division. The chromosomes aie replicated during 
S (synthesis) phase and a single copy o f each is then segregated into two identical daughter 
nuclei during M (mitotic) phase, followed by cytokinesis. Two gap phases, G l and G2, 
intercede between these two main processes, allowing time for growth and repair (Alberts et 
al., 1994). During G l, the cell monitors its environment before making the decision to enter 
into S phase. Entry into S phase marks an irreversible decision point, committing the cell to a 
new round of mitotic cell division. Prior to entry into S phase, the cell can undergo alternative 
developmental fates. The G2 phase provides a safety gap, ensuring that DNA replication is 
complete (and any DNA damage has been repaired) and the cell has grown to a sufficient size 
prior to division. Mitosis can be further sub-divided into prophase, metaphase, anaphase and 
telophase. The chromosomes condense during prophase, align in metaphase, separate during 
anaphase, décondense in telophase and are segregated into separate cells following cytokinesis. 
This is the basic pattern of cell division followed by all eukaryotic cells (Alberts et al., 1994).
The molecular mechanisms that are responsible for contiolling the major events o f the 
mitotic cell cycle are widely conserved in evolution, from yeast to man. This has facilitated the 
use o f several diverse organisms, each with their own particular experimental advantages, as 
model systems in cell cycle research. The conservation of many of the salient features has led 
to a unified theory o f eukaryotic cell cycle control (Nurse et al., 1998; Nurse, 2000). This has 
allowed the application o f knowledge gained from more basic systems to higher eukaryotes and 
humans in particular. This is especially relevant with respect to humans, where aberrant control 
of the cell cycle can manifest in potentially letlial conditions such as cancer (Ford and Pardee, 
1999).
Prominent in these investigations have been the budding yeast Saccharomyces 
cerevisiae and the fission yeast Schizosaccharomyces pombe, which have pioneered the 
elucidation of many o f the major cell cycle controls (Haitwell, 1991 ; Nurse et al., 1998).
1.2 Life cycles and genetics of the budding and fission yeasts
Studies in both budding yeast and the distantly related fission yeast have been particularly 
valuable in cell cycle research. Despite being unicellular, both yeasts have most o f the basic 
features that are typical o f more complex eukaryotes, making them excellent model systems for 
studying the eukaiyotic cell cycle (Lew et a l, 1997; Forsburg and Nurse, 1991). Significantly, 
budding and fission yeasts are widely divergent in evolutionaiy tenns and so cell cycle controls 
conserved between these two organisms most likely reflect mechanisms conseiwed throughout 
all eukaryotes (Sipiczki, 2000).
The haploid genomes o f both budding and fission yeasts have been sequenced and are 
similar in size; 12 Mb and 14 Mb, respectively (Goffeau et a l, 1996; Wood et a l ,  2002). The 
budding yeast genome is distributed amongst 16 chromosomes, whereas fission yeast contains 
only 3 chromosomes that are 5.7, 4.7 and 3.5 Mb in size. In budding yeast, cells can grow 
stably in either the haploid or diploid state. The mitotic cell division cycle begins with 
formation o f a growing bud on the parent cell, increasing in size as the cycle progresses. 
Eventually, the bud pinches off producing an initially smaller, though genetically identical, 
daughter cell (Forsburg and Nurse, 1991; Lew et a l, 1997). In contrast, fission yeast cells are 
stable only as haploids, although the transient diploid state can be maintained under appropriate 
conditions. Fission yeast cells grow by increasing length, dividing by septation and medial 
fission. The life cycles o f these two yeast species are summarised in Figures 1.1 and 1.2.
Important advances in cell cycle research have been primarily due to the isolation of 
mutants in both yeasts, which block at specific points or exliibit altered regulation of the cell 
cycle. Cells that have arrested in cell cycle progress, due to mutation o f a gene whose product 
is required for cell cycle progress, are called cell division cycle mutants (Nurse et a l, 1976), 
Mutants with cell cycle defects can be easily distinguished microscopically in both yeasts. In 
fission yeast, cdc mutants continue to grow without dividing, forming elongated cells at the 
non-permissive temperature. Similarly, CDC mutants o f budding yeast are recognised by their 
bud morphology, which is broadly indicative o f the point o f arrest (Hartwell et a l, 1974).
The fission yeast cell cycle has distinct G l, S, G2 and M phases similar to that o f higher 
eukaryotes. In budding yeast, however, many of the common cytological markers of the G2 and 
M phases (i.e. spindle pole body duplication, mitotic spindle formation) appear early in the 
eycle, to allow formation o f the bud and migration o f the nucleus to the bud neck. Budding 
yeast therefore lacks clear definition between the S, G2 and M phases of its mitotic cycle 
(Forsburg and Nurse, 1991).
There are two major control points in both yeasts mitotic cell cycle, one in late Gl called 
‘START’ and the other in late G2 regulating mitotic entry. Similar to higher eukaryotes, 
budding yeast chiefly regulates its cell cycle at the Gl-S transition (Hartwell, 1974). In rapidly
growing fission yeast S phase is normally initiated before the completion of cytokinesis and 
thus the G1 phase is very short. Under these conditions, fission yeast chiefly regulates its cell 
cycle at the G2-M transition where information on cell size and nutrition is monitored 
(MacNeill and Nurse, 1997). This situation is advantageous to a haploid organism as the 
majority of the cycle is spent in possession of two full copies of the genome, which may 
facilitate protection against DNA damage (Forsburg & Nurse, 1991; Humphrey, 2000). Indeed, 
the size control operating at G1 is normally cryptic, only becoming apparent under nutritional 
limitation or in certain cell cycle mutants. In the so-called wee mutants, cells divide before the 
parent has grown to its normal size, thus forming daughter cells that are smaller than normal. 
Consequently, the G1 phase is lengthened to allow cells to reach a critical size before entry into 
S phase (Nurse, 1975; Nurse, 1990).
In both organisms, passage of START and entry into S phase requires prior completion 
of mitosis in the previous cycle and a minimal cell size, in addition to propitious environmental 
conditions. When nutrients are in plentiful supply, cells grow and enter the mitotic cell cycle 
leading to DNA replication, chromosome segregation and the production of two genetically 
identical daughter cells. In the absence of nutrients the cell can undergo either of two 
alternative fates. Cells can exit from the mitotic cycle and accumulate in stationary phase (a 
metabolically dormant state where cells await the return of propitious conditions before 
returning to the mitotic cycle). Alternatively, in the presence o f cells of the opposite mating 
type, conjugation can occur, producing a diploid zygote. In budding yeast, diploid cells are 
stable and can undergo mitotic as well as meiotic division. In contrast, the diploid state in 
fission yeast is short-lived, almost immediately entering meiosis and sporulation.
A control point similar to START exists in mammalian cells, known as the ‘Restriction 
poinf (R), which also corresponds to an irreversible commitment to mitotic division (Pardee, 
1974; Blagosklonny and Pardee, 2002). Similarly, mammalian cells can also exit the cell cycle 
prior to the Restriction point, entering into a quiescent state known as GO. This state is often 
confused with the stationary phase of the two yeasts, which results from nutrient limitation that 
causes cells to accumulate before the size control that operates at START (Bartlett and Nurse, 
1990). Withdrawal from the cell cycle in higher eukaryotes results from the absence of 
mitogenic growth factors (or indeed the presence o f negative regulatory growth factors). 
Consequently, as the cell is not starved of nutrients, it remains metabolically active, albeit at a 
reduced level (Lodish et al., 1995).
In all cells, once START/R is passed the cell is committed to the mitotic cell cycle, until 
it returns to G1 (Forsburg and Nurse, 1991). Passage of the G2 control point and entry into 
mitosis is also dependent on the cell reaching a certain minimum size, as well as prior 
completion o f S phase and repair o f any DNA damage.
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Figure 1.1 The life cycle of the fission yeast Schizosaccharomyces pombe 
Fission yeast cells grow stably as haploids and propagate by mitotic division. In the absence 
of sufficient nutrients cells can exit from mitotic growth and enter into stationary phase. 
Alternatively, in the presence o f cells o f opposite mating type (h and h ) conjugation occurs 
forming a diploid zygote. The diploid state is unstable in fission yeast and proceeds directly 
into the meiotic cycle, producing a zygotic ascus containing four haploid ascospores. In 
favourable conditions the four haploid spores can again re-enter the mitotic cycle. The 
transient diploid state can be maintained if nutrients are re-supplied immediately following 
conjugation. In this case, the diploid cell can undergo diploid mitotic growth until nutrients 
become limiting. Starved diploid cells proceed into the meiotic cycle producing an azygotic 
ascus.
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Figure 1.2 The life cycle of the budding yeast Saccharomyces cerevisiae 
Budding yeast cells are capable of growth both as stable haploids and diploids.
In the absence of sufficient nutrients cells can exit from mitotic growth and enter into 
stationary phase. Alternatively, in the presence o f cells o f opposite mating type (a and a) 
conjugation occurs forming a diploid zygote. If nutrients are re-supplied, the diploid cell 
enters into the diploid mitotic cycle. However, if starved, diploids cells proceed into meiosis 
and sporulation forming four haploid cells, which can re-enter the mitotic cell cycle under 
favourable conditions.
1.2.1 A note on nomenclature
Throughout this thesis, reference will be made primarily to proteins involved in fission yeast 
cell cycle control. However, in the course o f the discussion, proteins with analogous functions 
in both budding yeast and humans will be referred to. Therefore, in the interest of clarity, 
proteins from different organisms will be distinguished by the following prefixes: Sp 
{Schizosaccharomyces pombe). Sc {Saccharomyces cerevisiae) and Hs {Homo sapiens).
1.3 The molecular mechanisms of the mitotic cell cycle
As described in Section 1.2, in both budding and fission yeasts and mammalian cells, the 
decision to enter a new round of chromosome duplication and cellular division is made at a 
control point in late G1 phase known as START/R. There are two main molecular mechanisms 
responsible for controlling passage through START/R and entiy into S phase, cyclin-dependent 
kinase (CDK) activity and the cell cycle-regulated periodic transcription of genes that are 
essential for S phase onset and progression.
The latter of these two mechanisms, which is centi al to this thesis, is discussed in more 
detail later (Section 1.6). The temporal association of distinct cyclin-CDK complexes, whose 
activities regulate the phase-specific events, primarily control the orderly progression o f the 
cell cycle. In budding yeast a single CDK, ScCdc28p, is the major regulator of the cell cycle. In 
G1 phase ScCdc28p associates with the G1 cyclins ScClnlp, ScCln2p and ScClnSp driving 
passage of START and entiy into S phase, in tandem with the MBF and SBF factors 
responsible for G l-S phase-specific transcription (Section 1.5.1). ScCdc28p then controls the 
onset of S phase and DNA replication in association with the ScClb5p and ScClb6p cyclins, 
whilst the ScClbl-4p cyclins govern the onset and progression o f mitosis (Nasmyth, 1996).
In mammalian cells there is more than one major CDK controlling the cell cycle, with 
HsCdklp, HsCdk2p, HsCdk4p and HsCdk6p the most prominent. Passage of the Restriction 
point and entry into S phase requires HsCdk4p/HsCdk6p-cyclin D and HsCdk2p-cyclin E 
kinase activities and the expression o f several genes under control o f the E2F family of 
transcription factors (Section 1.7). HsCdk2p then associates with cyclin A during S phase and 
G2 whilst HsCdklp-cyclin B drives mitosis (Sherr, 1996).
Similarly to budding yeast, a single CDK, SpCdc2p, drives the cell cycle in fission 
yeast and requires the expression o f several genes under control o f the DSCl complex, the 
focus o f this thesis (Section 1.6). The molecular control mechanisms of the fission yeast mitotic 
cell cycle are described in more detail below. Many of the main regulatory processes are 
conserved throughout evolution and consequently, several of the molecules and mechanisms 
are similar in both budding yeast and higher eukaryotes, and are alluded to where appropriate.
1.3.1 The molecular mechanisms of the mitotic cell cycle in fission yeast
1.3.2 The Gl-S transition
In fission yeast both the SpCdc2p kinase and DSCl-dependent transcription activities are 
required for passage of START and entry into S phase, (Nurse and Bissett, 1981; MacNeill and 
Nurse, 1997). In early G1 phase the mitotic form of SpCdc2p (associated with the SpCdcl3p 
cyclin) predominates, enduring from the previous M-phase (Booher et al., 1989; Moreno et al., 
1989). However, SpCdc2p-SpCdcl3p kinase activity is prohibited at this stage by CDK 
inhibition and cyclin proteolysis (Moser and Russell, 2000). The CDK inhibitor SpRumlp 
plays a major role in cell cycle regulation during G1 phase by binding to and inhibiting 
SpCdclSp. In addition, SpRumlp targets SpCdcl3p for ubiquitin-mediated proteolysis by the 
26S proteasome (Correa-Bordes et al., 1997; Benito et al., 1998).
Ubiquitin-mediated proteolysis plays an important role in the cell cycle, targeting 
proteins for degradation by the 26S proteasome in Gl-S phases and also during mitosis (Stone 
and Gordon, 2003). In mitosis, proteolysis is required for sister chromatid separation (at the 
metaphase to anaphase transition) and the degradation of mitotic cyclins, essential for the exit 
from mitosis (Section 1.3.6). The anaphase-promoting complex/cyclosome (APC/C) is a cell 
cycle-regulated multimeric complex that catalyses the transfer of ubiquitin to target proteins 
(Morgan, 1999; Harper et al., 2002). The APC/C is regulated by the reversible binding of 
activator proteins, which provide substrate specificity. In fission yeast, the SpSlplp and 
SpSte9p proteins are important for APC/C function. SpSte9p only interacts with APC in G l, 
where it targets the mitotic cyclins, SpCdclSp and SpCiglp, leftover fi’om the previous M 
phase. SpSte9p itself is negatively regulated by SpCdc2p-dependent phosphorylation, causing 
dissociation from the APC/C and subsequent degradation (Blanco et ah, 2000).
The combined effects of SpRumlp and APC/C-SpSte9p ensure that any SpCdc2p- 
SpCdcl3p kinase activity remaining from the previous M phase cannot act in G l. This is 
crucial, since inappropriate triggering of mitotic events at this point could induce cells to divide 
with unreplicated chromosomes, leading to aneuploidy.
Meanwhile, during G l, the DSCl complex activates transcription of the major S-phase 
cyclin, SpCig2p (Connolly and Beach, 1994; Obara-lshihara and Okayama, 1994). Initially, 
SpRumlp inhibits SpCdc2p-SpCig2p kinase activity (Benito et ah, 1998). However, the 
SpPuclp and SpCiglp cyclins (both of which are insensitive to SpRumlp) associate with 
SpCdc2p, leading to the phosphorylation and inactivation o f SpRumlp (Martin-Castellanos et 
ah, 2000; Moser and Russell, 2000). Consequently, SpRumlp is degraded allowing SpCdc2p- 
SpCig2p activity to increase, thereby promoting entry into S-phase (Martin-Castellanos et ah, 
1996; Mondesert et ah, 1996; Benito et al., 1998).
1.3.3 Onset of S phase
The molecular mechanisms that regulate DNA replication in eukaryotes are only partly 
understood. However, many of the factors involved are largely conserved, with the result that a 
general picture of the regulation of DNA replication initiation has emerged from genetic and 
biochemical studies in both yeasts and higher eukaryotes (Kelly and Brown, 2000; Lei and Tye, 
2001).
1.3.3.1 Origins of replication
At the onset of S phase, DNA replication is initiated at multiple specific sites throughout the 
genome known as origins of replication (Kelly and Brown, 2000). These cA-acting DNA 
elements have been particularly well characterised in budding yeast, and are known as 
autonomous replicating sequences (ARS) based on their ability to promote the autonomous 
replication of plasmids (Marahens and Stillman, 1992). Budding yeast ARSs are defined by an 
11 bp AT-rich consensus sequence that is distributed over sequence blocks of 100-200 bp 
(Marahens and Stillman, 1992). The sequences defining replication origins in fission yeast and 
higher eukaiyotes are less well defined, although AT-rich regions also appear to be important 
(Okuno et al., 1999; Masukata et al., 2003).
1.3.3.2 The origin recognition complex
In all eukaryotes examined, replication origins are bound by a hetero-hexameric origin 
recognition complex (ORC), which in fission yeast comprises the SpOrplp-SpOrp6p proteins 
(Moon et al., 1999; Chaung et al., 2002). The ORC was originally identified in budding yeast 
based on its ability to bind the well-defined ARS and is widely conserved; analogous 
complexes are found in higher eukaryotes (Bell and Stillman, 1992; Kelly and Brown, 2000). 
Studies in fission yeast have shown that ORC remains bound to chromatin, via SpOrp4p, 
throughout the cell cycle (Lygerou and Nurse, 1999; Chuang and Kelly, 1999). ORC appears to 
function as a scaffold, upon which occurs the ordered assembly of several proteins, culminating 
in the recruitment and activation o f the DNA replication machinery (Brown and Kelly, 2000; 
Lei and Tye, 2001).
1.3.3.3 The mini-chromosome maintenance complex
Tight control over the initiation of DNA replication is crucial to ensure that it occurs only once, 
and at the appropriate time, in each cell cycle. O f particular importance, in this context, is the 
recruitment of the mini-chromosome maintenance complex (MCM) to origins, in a process 
known as DNA licensing. Similarly to ORC, the M CM  genes were originally identified in 
budding yeast, as mutants unable to support the maintenance of mini-chromosomes (i.e. 
replication of plasmids; Tye, 1999). The MCM complex is a hetero-hexamer composed o f the
SpMcm2p-SpMcm7p proteins, all of which share conserved nucleotide binding domains, and is 
widely conserved throughout eukaryotes (Forsburg, 2004). Accessory proteins, which 
themselves are precisely regulated, tightly control the loading o f the MCM complex onto 
origins.
1.3.3.4 SpCdclSp, SpCdtlp and the control of DNA licensing
The critical factors for DNA licensing in fission yeast are the SpCdclSp and SpCdtlp proteins, 
homologues o f which exist in budding yeast and higher eukaryotes, ScCdc6p/HsCdc6p and 
ScTahllp/HsCdtlp, respectively (Kelly et al., 1993; Hofmann and Beach, 1994; Lygerou and 
Nurse, 2000; Tanaka and Diffley, 2002). Their presence is essential for loading the SpMcm2p- 
SpMcm7p complex onto origins associated with ORC, thereby licensing DNA for replication 
(Nishitani et al., 2000; Lygerou and Nurse, 2000). SpCdclSp and SpCdtlp associate with 
chromatin independently o f each other, yet act co-operatively to bring about the construction of 
the pre-replicative complex (pre-RC) on origins (Figure 1.3; Lygerou and Nurse, 2000). Both 
proteins are transcribed in late M phase, under the control of the DSCl complex (Baum et al, 
1998; Nishitani et al., 2000). At this point, SpCdclSp levels are kept low by SpCdc2p- 
SpCdc 13p-dependent phosphoiylation and subsequent degiadation (Jallepalli et al, 1997; 
Lopez-Girona et al, 1998). However, as cells exit mitosis and enter G l, the mitotic SpCdc2p- 
SpCdcl3p kinase activity decreases (Section 1.3.2) and accumulation of SpCdclSp ensues 
(Baum et al, 1998; Jallepalli et al, 1997; Lopez-Girona et al, 1998). The combination of 
transcriptional and post-translational controls ensures a sharp increase in SpCdcl8p as cells exit 
mitosis and enter G l, with the presence o f both SpCdcl 8p and SpCdtlp proteins bound to ORC 
facilitating recruitment o f the SpMcm2p-SpMcm7p complex (Nishitani et al, 2000).
1.3.3.5 Activation of DNA replication: CDK and DDK
Following assembly o f the pre-RC, DNA replication is activated by the actions o f two sets o f 
protein kinases, the CDK SpCdc2p-SpCig2p and the DDK (Dip 1-dependent kinase) SpHsklp- 
SpDfplp. The SpCdc2p-SpCig2p kinase is the major S phase promoting CDK in fission yeast 
(Section 1.3.2). The SpHsklp protein is a member of the Cdc7p family o f protein kinases that 
are essential in all eukaryotes for the initiation of DNA replication (Brown and Kelly, 1998). 
Although SpHsklp alone has kinase activity, association with SpDfplp provides substrate 
specificity (Brown and Kelly, 1998; Brown and Kelly, 1999). The abundance o f SpDfplp is 
regulated throughout the cell cycle both transcriptionally and post-transcriptionally (Brown and 
Kelly, 1999).
Although the specific targets of SpCdc2p-SpCig2p are unclear, with respect to 
replication initiation, SpHsklp-SpDfplp can phosphorylate the SpMcm2p-SpMcm7p complex 
in vitro, on SpMcm2p and SpMcm4p (Brown and Kelly, 1998; Lee et al., 2003). In fission
yeast, a sub-complex of the SpMcm-4p -6p and -7p proteins has been shown to possess helicase 
activity in vitro, and it has been proposed that phosphorylation o f the SpMcm2p-SpMcm7p 
complex could activate intrinsic DNA helicase activity, which may be important for DNA 
unwinding at replication forks (Lee and Hurwitz, 2001). SpHsklp-SpDfplp-mediated 
phosphorylation of SpMcm2p is dependent on the association of the DDK with the SpCdc23p 
protein, suggesting an accessory role for this protein in recruiting SpHsklp-SpDfplp to origins 
(Lee et al, 2003). Recent experiments have revealed a further role for SpCdc23p in recruiting 
the ScCdc45p homologue SpSna41p to origins (Gregan et al., 2003).
The recruitment of SpSna41p is likely to be important for loading of DNA polymerase 
a  onto the SpMcm2p-7p complex (Uchiyama et al., 2001). Activation o f DNA replication then 
begins following recruitment o f other components of the replication machineiy (Diffley and 
Labib, 2002). Despite the lack o f clarity regarding specific phosphorylation targets, the CDK 
and DDK activities initiate a chain of events that ultimately leads to establishment of functional 
replication forks (Diffley and Labib, 2002). Following replication, the two daughter DNA 
molecules remain tightly associated in a process called sister chromatid cohesion. This requires 
a number o f factors and can only occur during DNA replication (Section 1.3.6). Cohesion 
occurs at specific sites, including centromeres, and is crucial for mitosis and also important for 
DNA repair. Termination occurs when two replication forks meet and the nascent DNA from 
the two forks is ligated together (Diffley and Labib, 2002).
1.3.3.6 Prevention of re-replication
In addition to functioning as an activator of DNA replication, SpCdc2p-SpCig2p also has a 
negative role in preventing re-initiation from origins following activation (Jallepalli et al., 
1997; Lopez-Girona et al., 1998). This apparently contradictory behaviour is crucial, both to 
ensure proper initiation o f DNA replication and the prevention o f re-replication. Whilst 
SpCdcl 8p accumulates (in late mitosis) as a result of declining SpCdc2p-SpCdcl3p activity, it 
is phosphorylated and targeted for degradation by the rising SpCdc2p-SpCig2p kinase activity, 
in late Gl (Jallepalli et al., 1997; Lopez-Girona et al., 1998). Furthermore, cdclS^ expression 
declines during S phase (Kelly et al., 1993). As a consequence o f this dual control, SpCdclSp 
dissociates from origins, thereby preventing re-initiation at origins that have already fired. 
Consistent with c d t t  transcription being under DSCl control, the expression pattern is similar 
to cdcIS^ (Hofmann and Beach, 1994; Nishitani et al., 2000). The protein levels also fluctuate 
in parallel with SpCdclSp, suggesting that SpCdtlp may also be degraded in a CDK-dependent 
process (Nishitani et al., 2000). Thus, both CDK-dependent proteolysis and cell cycle-regulated 
periodic transcription conspire to ensure that re-initiation is prevented until the following M 
phase has passed. It has recently been shown that the SpCdc2p-SpCdcl3p kinase also plays a
1 0
crucial role in preventing re-initiation by binding to replication origins (via ORC), presumably 
by phosphorylating and inactivating components of the pre-RC (Wuarin et al., 2002).
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Figure 1.3 Model for fission yeast DNA licensing and replication
(A) ORC is bound to origins throughout the cell cycle. At the end of M phase, Cdc 18p and 
Cdtl p are recruited independently to ORC at origins to which Cdc23p binds. (B) Cdcl 8p and 
Cdtlp then recruit the MCM complex, thereby forming the pre-RC. This is known as DNA 
licensing. (C) The SpCig2p-SpCdc2p and SpHsklp-SpDfplp protein kinases then play 
essential roles in triggering the initiation o f DNA replication. SpCdcl 8p and SpCdtlp are 
removed for degradation and SpHsklp-SpDfplp phosphorylates the SpMcm2p-SpMcm7p 
complex, thereby promoting its helicase activity. (D) After activation of these protein kinases, 
additional factors such as SpSna41p are recruited, and origins are unwound. (E) Finally, DNA 
polymerase a, single strand DNA-binding protein (RFA) and primase are recruited and semi­
conservative replication ensues (Adapted from Lei and Tye, 2001).
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1.3.4 The G2-M transition
At the end of G2 phase, when cells reach a critical size, M phase is induced due to increasing 
SpCdc2p-SpCdcl3p kinase activity (Nurse, 1990; Moser and Russell, 2000). Activation of 
SpCdc2p-SpCdcl3p is essential for entiy into mitosis and represents the rate-limiting step 
(Nurse, 1990). After passing START, SpCdc2p is associated with SpCdcl 3p in S phase, 
staying associated throughout the entire length of G2, but activity is kept low by inhibitory 
phosphoiylation on Tyrosine-15 (Y-15), carried out by the SpWeelp and SpMiklp kinases 
(MacNeill and Nurse, 1997). To induce mitosis, SpCdc25p de-phosphoiylates SpCdc2p at Y- 
15. Activation of SpCdc2p-SpCdcl3p is promoted by the activation o f SpCdc25p and the 
SpW eelp inhibitory kinases, SpCdrlp and SpCdr2p (MacNeill and Nurse, 1997).
The mikJ^ gene is under ti’anscriptional contiol of the DSCl complex (Ng et al., 2001). 
Consequently, mikl* mRNA and protein levels increase in S-phase (Baber-Furnari et al., 2000; 
Christensen et al., 2000). This suggests that the presence of SpMiklp in S phase is important 
for maintaining the low SpCdc2p-SpCdcl3p activity during G2 phase (Baber-Furnari et al., 
2000; Christensen et al., 2000). In contrast, SpWeelp levels are constant throughout the cell 
cycle (Moser and Russell, 2000). SpCdc25p appears to be regulated at a translational level, 
since SpCdc25p synthesis is particularly sensitive to reduced translation initiation activity 
(Daga and Jimenez, 1999). This suggests that control of SpCdc25p translation initiation may 
form part o f the mechanism coupling cell growth with cell division (Daga and Jimenez, 1999; 
Kellogg, 2003). Co-ordination of these mitotic inliibitors and activators ultimately leads to an 
increase in SpCdc2p-SpCdc 13p kinase activity, which facilitates the subsequent mitotic events 
(Nurse, 1990; Su and Yanagida, 1997).
1.3.5 Checkpoint controls: DNA integrity
Before a cell can exit G2 phase and enter into mitosis, it must ensure that the genome has been 
fully and faithfully replicated. Two signal transduction cascades (known as checkpoints) 
operate in eukaryotes to ensure that when DNA is damaged or replication peiturbed, normal 
cell cycle progression is delayed (Hartwell and Weinert, 1989). Delayed mitotic entry permits 
completion o f either the replication or repair processes. These control mechanisms are crucial 
to prevent the propagation of potentially genotoxic mutations and cell division with an 
incomplete genome.
The main effectors of the checkpoint pathways are the SpChklp and SpCdslp protein 
kinases, which function in response to DNA-damage and stalled DNA replication signals, 
respectively (Rhind and Russell, 2000; Boddy and Russell, 2001). These signals are sensed and 
relayed by the checkpoint SpRadp proteins, which in turn contiol the kinase activity of 
SpChklp and SpCdslp. Several o f the gene products involved in checkpoint control in fission 
yeast are widely conseived in evolution (Carr and Caspari, 2003).
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In fission yeast, the checkpoint kinases indirectly maintain the inhibitory Y-15 
phosphorylation of SpCdc2p, thereby preventing mitotic entry (Section 1.3.4; Rliind et al., 
2000). Accordingly, the targets of SpChklp and SpCdslp are the SpCdc25p and SpMiklp 
proteins, although the exact mechanisms are unclear (Rliind et al., 2000). Regulation of 
SpWeelp does not seem to be important for checkpoint function (Rhind and Russell, 2001). It 
has been proposed that, in response to DNA damage, SpChklp negatively regulates SpCdc25p 
phosphatase activity (Rhind et al., 2000). Consistent with its role during S phase, SpMiklp 
levels are increased following DNA damage, and therefore may also contribute to the 
checkpoint response by increasing its SpCdc2p Y-15 directed kinase activity (Baber-Furnari, et 
al., 2000). Checkpoint-mediated inhibition o f SpCdc25p and activation of SpMiklp ensures 
that SpCdc2p Y-15 phosphoiylation is maintained, thereby preventing entry into mitosis.
1.3.6 Mitosis and cytokinesis
The major processes that occur during M phase, required to divide the replicated genome 
equally into two cells, are essentially similar in all eukaryotes examined (Alberts et al, 1994).
Mitosis is characterised by a highly complex series o f cytoskeletal and nuclear re­
arrangements, which together achieve chromosome condensation, segregation and cytokinesis 
(Alberts et al, 1994). These events are triggered by the M phase CDK-dependent 
phosphorylation of numerous substi ates. When M phase CDK activity reaches a critical level, 
cells proceed from G2 into mitosis. Conversely, mitotic exit relies on inactivation of this CDK 
activity via ubiquitin-mediated proteolysis o f the mitotic cyclins (Morgan, 1999). Loss of 
mitotic CDK activity is controlled by the actions of the highly regulated APC/C (Section 1.3.2; 
Morgan, 1999; Harper et al., 2002).
In fission yeast, the numerous events of mitosis are brought about by the rise in 
SpCdc2p-SpCdcl3p kinase activity, controlled at the G2-M transition by the action of 
SpCdc25p (Section 1.3.4; MacNeill and Nurse, 1997). SpCdc2p-SpCdcl3p is the major mitotic 
kinase in fission yeast, although more recently additional roles for the Polo, Aurora and NIMA 
kinases have been described (Nigg, 2001).
Preparation for mitosis begins during S phase, when newly replicated sister chromatids 
are joined together by a complex of proteins collectively known as cohesins, and the spindle 
pole body is duplicated (Nasmyth et al., 2000). In fission yeast, the cohesin complex is 
composed o f four proteins, SpPsmlp, SpPsm3p, SpRad21p and SpPsc3p (Hagstrom and 
Meyer, 2003). Cohesion between sister chromatids is required to prevent premature separation 
prior to the onset of anaphase, important in preventing aneuploidy.
Prophase: The onset o f M phase is then initiated by compaction of chromosomes, in a 
process known as condensation. Chromosome condensation is required to re-organize the 
loosely packed interphase assortment into highly compact structures. This is necessary to
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permit attachment of the mitotic spindle to centromeres and allow separation without 
entanglement. A multi-protein complex, known as condensin, effects the necessary changes in 
chromosome structure. In fission yeast, condensin is composed o f an SpCutl4p-SpCut3p 
hetero-dimer associated with SpCndlp, SpCnd2p and SpCnd3p (Hagstrom and Meyer, 2003).
Metaphase: The opposing forces of the mitotic spindles, pulling sister chromatids 
toward opposite poles o f the cell, are counteracted by the maintenance of chromosome 
cohesion. As a result, the sister chromatids align along the metaphase plate. At this point, a 
spindle checkpoint mechanism monitors the attachment of the mitotic spindle to chromosomes, 
delaying anaphase until all chromosomes are properly attached and under tension.
Anaphase: Following bipolar attachment o f the chromosomes to the spindle, anaphase 
begins. During anaphase, cohesion between sister chromatids is dissolved and chromosomes 
are separated. Anaphase onset is induced by the activating phosphorylation of the APC/C, at 
this point associated with SpSlplp. APC/C-SpSlplp facilitates separation of sister chromatids 
by ubiquitylating a protein commonly known as securin. The securin protein is normally 
complexed with a protease separin, which is held inactive in this heterodimeric state (Yanagida, 
2000). It is thought that ubiquitin-mediated proteolysis of securin liberates the separin subunit, 
thereby releasing its proteolytic potential. In fission yeast, SpCut2p and SpCutlp are the 
putative securin and separin proteins, respectively (Yanagida, 2000). The liberated separin 
protease then degrades the cohesins responsible for sister chromatid attachment. Loss of 
cohesion releases the physical tension at the metaphase plate, thereby allowing mitotic spindles 
to elongate, segregating the sister chromatids to opposite poles of the cell.
Mitotic exit (telophase and cytokinesis): Exit from mitosis requires the inactivation 
of mitotic CDK activity. Loss of CDK activity is mediated by the destruction of the mitotic 
cyclins, by ubiquitin-mediated proteolysis (Morgan, 1999). A conserved signalling cascade 
governs the co-ordination o f late mitotic events in both budding and fission yeasts, known as 
the mitotic exit network (MEN) and septation initiation network (SIN), respectively 
(McCollum and Gould, 2001; Bardin and Amon, 2001). The SIN is a GTPase-regulated protein 
kinase cascade, which functions to regulate the initiation o f cytokinesis at the end o f anaphase.
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1.4 Cell cycle-regulated transcription
One of the key mechanisms deployed in controlling the cell cycle is the phase-specific 
regulation o f transcription. Typically, several groups o f genes are co-ordinately expressed at a 
particular period in the cell cycle, commonly corresponding to the phase during which their 
function is required (Breeden, 2003; Mclnerny, 2004). Co-ordinated transcription progiammes 
are dependent on the recognition o f specific c/s-acting DNA sequences in gene promoters, by 
trans-acting proteins. These sequence-specific transcription factors in turn recruit chromatin re­
modelling machines and components o f the general transcriptional apparatus, thereby 
conti'olling tianscriptional initiation (Levine and Tjian, 2003).
It has been proposed that phase-specific transcription programmes may serve to limit 
the functions of particular gene products to a particular point in the cycle at which they are 
required (Breeden, 2003; Mclnerny, 2004). In some cases this may be important for cell cycle 
progression per se. For example, inappropriate expression of a cyclin (or another key cell cycle 
regulator) outwith its normal period o f activity may be deleterious to the cell. However, in the 
majority of cases, a gene may be periodically expressed simply as a means of conserving 
resources. Nevertheless, the fact that phase-specific transcription programmes are a universal 
feature of the eukaryotic cell cycle (being widely conserved from yeast to humans) is indicative 
o f its importance. Recent microarray studies have revealed the extent of this regulatoiy 
mechanism during the cell cycle. In budding yeast, ~800 genes have been identified whose 
transcripts are cell cycle-regulated (Spellman et al, 1998). Similarly, in fission yeast -400 
genes display a cell cycle-periodic increase in their transcription (Rustic! et al., 2004) and in 
human cells approximately 700 genes display a cell cycle-periodic increase in their 
transcription (Cho et al., 2001).
1.5 Cell-cycle regulated transcription at the G l-S  transition
As described previously, START/R marks the point of irreversible commitment to the mitotic 
cell division cycle, requiring propitious conditions and CDK activity (Section 1.2). A key 
function of the CDK at this stage is to activate transcription o f several genes, whose functions 
are required for progression into S phase. Of these genes, perhaps the most salient are the G 1 
and S phase cyclins, which associate with the CDK to allow passage o f START/R and drive 
downstream events. Correct temporal expression o f these genes is, therefore, crucial for correct 
cell cycle progression.
Cell cycle-regulated tianscription at the G l-S phase boundary has been particularly 
well studied in the budding and fission yeast systems. In budding yeast, two DNA-binding 
factors, known as SBF and MBF, are responsible for initiating this co-ordinated programme of 
gene expression (Merrill et al., 1992). In fission yeast, a single MBF-like complex, referred to
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here as DSCT, performs an analogous function (Whitehall et al., 1999). The remarkable 
structural and functional homology shared by the MBF/SBF and DSC 1 systems, suggests that a 
co-ordinated programme of G l-S phase-specific transcription is widely conserved in 
eukaryotes. Regulation of transcription at the Gl-S phase transition has been well documented 
in mammalian cells, under the control of the E2F complex (Dyson, 1998). Although not related 
to either o f the yeast DNA-binding factors at the primary structure level, E2F shares some 
striking similarities and therefore appears to be responsible for regulating the equivalent 
process in humans (Section 1.7).
* DSCl is the traditional name for the Gl-S-regulatory transcription factor complex in fission yeast; however, it is 
now commonly referred to as MBF. Therefore, in this thesis, to avoid confusion during the discussion o f both MBF 
complexes in the fission and budding yeasts, the former is referred to as DSCl whilst the latter MBF,
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1.5.1 Gl-S phase-specific transcription in budding yeast
In budding yeast passage of START and entry into S phase requires the activity o f the 
ScCde28p kinase in assoeiation with the Gl cyclins, ScClnlp, ScCln2p and ScCln3p 
(Nasmyth, 1996; Lew et a l, 1997). The ScClnp-ScCdc28p kinase activities are required for 
passage of START and the early events of the cell cycle: initiation of DNA replication, spindle 
pole body duplication and bud formation (Nasmyth, 1996; Lew et a l ,  1997). Transcription of 
CLNl and CLN2 is phase-specific, peaking in late G l, whereas CLN3 is transcribed earlier, 
peaking at the M-Gl boundary (Ogas et a l, 1991; Mclnerny et a l, 1997; MacKay et a l ,  2001). 
In addition, transcription of the PC Ll and PCL2 cyclins, which may also have a role at 
START, is regulated similarly to CLNl and CLN2 (Espinoza et a l , 1994; Measday et a l,
1994). A large number of genes (>200), in addition to the Gl cyclins (excluding CLN3), have 
been identified, including the CLB5 and CLB6 cyclins required for entiy into S phase, that are 
periodically transcribed in late Gl phase (Epstein and Cross, 1992; Schwob and Nasmyth, 
1993; Spellman et a l, 1998). These genes can be sub-divided into two gioups based on the e x ­
acting regulatory sequence element present in their promoter and their eognate DNA-binding 
factors. Activation o f both o f these transcription factors requires the ScCin3p-ScCdc28p kinase 
activity (Wijnen et a l, 2002).
1.5.2 The SBF complex
The first group of genes, which include the CLNl, CLN2, PC Ll and PCL2 cyclins, contain a 
common 5’ CACGAAA 3’ sequence element in their promoter, known as the ScSwi4p- 
ScSwi6p cell cycle-box (SCB). Transcription of these genes is activated in late G l, dependent 
on the heterodimeric SCB-binding factor (SBF), composed o f the ScSwi6p and ScSwi4p 
proteins (Koch and Nasmyth, 1994; Iyer et a l, 2001).
The first evidence o f a role for the SWI4 and SWI6 gene products in tianscriptional 
regulation was the discoveiy that both were required, together with a repeated promoter 
element (now known as the SCB), for the cell cycle-regulated and START-dependent 
transcription of the HO  endonuclease gene, involved in the mating type switch (Breeden and 
Nasmyth, 1987a). Furthermore, the pleiotropic effects displayed in either swi4 or swi6 mutants 
(which are not seen in ho mutants) and the lethality of the swi4 swi6 double mutant indicated 
that these gene products must function in some other essential cellular process (Breeden and 
Nasmyth, 1987a). The role o f these proteins as transcription factors was confirmed 
subsequently, when they were biochemically identified (in band-shift assays), as components of 
an SCB-specific DNA-binding factor (Andrews and Herskowitz, 1989a; Andrews and 
Herskowitz, 1989b; Taba et a l, 1991).
Both proteins display a modular architecture typical of ti anscription factors (Figure 1.4). 
In the SBF complex, sequence-specific DNA-binding is mediated by an N-terminal domain in
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the 123 kDa ScSwi4p subunit. ScSwi4p also contains centrally located ankyrin-repeat motifs, 
thought to be involved in protein-protein interactions, and a C-terminal heterodimerization 
domain (Andrews and Herskowitz 1989b; Primig et al., 1992; Bork et al., 1993; Sedgwick and 
Smerdon, 1999).
The 92 kDa ScSwi6p protein has no intrinsic DNA-binding capability, instead playing a 
regulatory role, containing distinct N and C-terminal transcriptional activation domains 
(Sedgwick et a l, 1998). ScSwiôp also contains the centrally located ankyrin-repeat motifs and 
heterodimerises with ScSwi4p via their C-termini (Breeden and Nasmyth 1987b; Primig et al, 
1992; Andrews and Moore, 1992; Foord et a l, 1999). Mutational analyses of ScSwi6p indicate 
that the ankyrin-repeat motifs and a leucine zipper region (located in the C-terminal third of the 
protein) are required for DNA-binding by the ScSwi4p/ScSwi6p complex (Sidorova and 
Breeden, 1993). The ankyrin-repeat motifs are dispensable for the association o f ScSwi4p and 
ScSwiôp (Andrews and Moore, 1992).
1.5.3 The MBF complex
A second group of genes are also periodically expressed in late G l, and encode a wide range of 
factors required for S phase, including several proteins necessary for DNA synthesis (Johnston 
and Lowndes, 1992; Koch and Nasmyth, 1994). Although many of these gene products are 
stable throughout the cell cycle, and therefore not rate-limiting, others such as the CLB5 and 
CLB6 cyclins are important for cell cycle progression per se (Epstein and Cross, 1992; Schwob 
and Nasmyth, 1993). Similarly to SBF-regulated genes, this second group are also defined by a 
cx-acting regulatory element common to their promoters. This element has the consensus 
sequence 5’ ACGCGT 3 \  whieh coineidentally conesponds to the Miul restriction enzyme 
recognition site. Thus it is known as the Mlul cell cycle box (MCB), and is both necessary and 
sufficient for the cell cycle-regulated late Gl expression of these genes (McIntosh et al, 1991; 
Lowndes et al, 1991). The MCB motif is bound by the heterodimerie MCB-binding factor 
(MBF), which is composed o f ScSwiôp and ScMbplp (Lowndes et a l, 1991; Lowndes et a l, 
1992b; Dirick et a l, 1992; Koch et a l, 1993; Iyer et a l , 2001). Analogous to SBF, the 
regulatory function is provided by ScSwiôp, whilst the 120 kDa ScMbplp protein provides the 
sequence-specific DNA-binding capability (Dirick et a l, 1992; Koch et a l, 1993). The 
ScMbplp protein resembles ScSwi4p in structure as well as function, consisting of N-terminal 
DNA-binding and C-terminal heterodimerization domains, separated by the centrally located 
ankyrin-repeat motifs (Figure 1.4; Koch et a l, 1993).
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1.5.4 Functional redundancy in SBF and MBF-dependent gene expression
The molecular mechanisms by which SBF and MBF-dependent transcription are regulated are 
complex and not fully understood (Section 1.5.8). The situation is further complicated by the 
apparent functional redundancy between the two systems, as suggested by phenotypic analyses, 
most notably the lethality of mbpl swi4 double mutants, due to inadequate expression of the 
CLNl and CLN2 cyclins (Koch et al., 1993). In contrast, single mutants o f either gene are 
viable, indicating a requirement for the function of at least one complex for cell cycle 
progression (Koch et al., 1993). That some functional overlap should exist is perhaps not 
surprising, given that both systems share several common features. The SCB and MCB 
elements are related in sequence and when present at high eoncentration in vitro, each element 
can cross-compete with the other for complex binding, although SBF and MBF bind 
preferentially to the SCB and MCB elements, respectively (Taylor et al., 2000). In at least one 
case in vivo, Gl-S-regulated transcription is apparently controlled by SBF binding to MCB-like 
motifs, thus indicating an overlap in binding specificity (Partridge et al., 1997).
1.5.5 A family of transcription factors
The ScSwi4p/ScMbplp/ScSwi6p proteins o f SBF/MBF and the SpRes 1 p/SpRes2p/SpCdc 1 Op 
proteins o f the fission yeast MBF-homologue DSCl (Section 1.6) constitute a family of 
transcription factors that share a eommon function and architectural design. The sequence 
homology shared amongst these six proteins locates to three main regions. The N-termini show 
significant similarity at the primaiy structure level, particularly between the ScSwi4p/ScMbplp 
and SpRes lp/SpRes2p proteins, which each harbour DNA-binding domains within this region 
(Figure 1.5). The centrally located ankyrin-repeat motifs are common to all six members, and 
the C-terminal domains required for heterodimerization also show similarity (Figure 1.7). X- 
ray crystailogiaphic analysis of a 36 kDa domain from ScSwiôp, containing the ankyrin 
domain, suggests that intramolecular interactions within this region may allow the N and C 
termini to come into contact (Foord et al., 1999). This may be important for ScSwi4p since it 
has been proposed that C-terminally mediated auto-inhibition o f the N-terminal DNA-binding 
domain is important for its regulation (Baetz and Andrews, 1999).
The 3-dimensional (3-D) structuie o f the N-terminal DNA-binding domain of 
ScMbplp has also been solved by X-ray crystallographic analysis (Xu et al., 1997; Taylor et 
al., 1997). In addition, characterisation o f this same N-terminal fragment o f ScMbplp at the 
atomic level has been enhaneed by NMR studies (McIntosh et al., 2000; Nair et al., 2003).
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1.5.6 The N-terminal DNA-binding domain
The ciystal structure o f the DNA-binding domain of ScMbplp has been solved at 2.1 Â 
resolution, and is shown in Figure 1.5B (Xu et al., 1997; Taylor et al., 1997). This fragment 
corresponds to amino acids 1-124 and reveals a globular molecule consisting of a twisted six- 
stranded anti-parallel P-sheet (pi-p6) with two pairs of a-helices (aA- aB and aC- aD), which 
fold into a motif similar to the winged-helix-turn-helix (wHTH) family o f proteins, including 
HNF3y and the bacterial eatabolite activator protein, CAP (Schultz et al., 1991; Clarke et al., 
1993; Xu et al., 1997; Taylor et al., 1997). Helices aA and aB form the helix-turn-helix motif 
with the hairpin between the p5-p6 strands forming the putative ‘wing’. The pi-p4 and P5-P6 
p-sheets are at right angles to one another, forming a barrel with a hydrophobic core. Several of 
the most highly conserved non-polar residues within the ScMbplp/ScSwi4p/SpResp proteins, 
particularly the aromatic amino acids, are situated within this hydrophobic core (Figure 1.5A). 
The greatest amino acid sequence conservation amongst these proteins is situated within the 
wHTH region (from P3 to p6) whilst C-terminal to this the sequences diverge (Xu et al., 1997; 
Taylor et al., 1997).
1.5.7 Model for DNA-binding
The eonseiwed charged and polar residues of the wHTH all lie on one face of the molecule, 
most notably within the aB helix, thereby forming a positively charged surface and suggesting 
an involvement in DNA-binding. The aB helix has been proposed to be responsible for the 
major sequence interactions, within the major groove of the DNA double helix (Xu et al., 1997; 
Taylor et al., 1997;Taylor et al., 2000; Nair et al., 2003). The P-hairpin (‘wing’) may also make 
contact with the DNA (Figure 1.6). Surprisingly, the non-conserved residues C-terminal to the 
core are required for efficient DNA binding, suggesting that two distinct domains are involved 
in DNA-binding (Taylor et al., 2000; Nair et al., 2003). The sequence homology between the 
ScMbplp/ScSwi4p/SpResp proteins within the DNA-binding domains suggests they all adopt a 
similar fold and thus share a common mode o f DNA-binding. However, the SpResp proteins 
are believed to bind to DNA as dimers, whereas both ScMbplp and ScSwl4p bind to their 
respective recognition sequences as monomers (Section 1.6.6; Taylor et al., 2000). In this 
respect the SpRes lp/SpRes2p proteins might resemble the CAP and E2F/DP proteins, which 
also utilise a similar wHTH fold for DNA-binding (Schultz et al., 1991; Zheng et al., 1999).
2 1
DNA-BD ANK H-DMZ
N C ScSwi4p 123 kDA
N ScM bplp 93 kDA
N i
TA TA
LZ
ScSwiôp 91 kDA
Figure 1.4 Domain architecture of ScSwi4p, ScMbplp and ScSwiôp
A schematic representation of the major domains in ScSwi4p, ScMbplp and ScSwiôp: 
DNA-BD = DNA-binding domain, ANK = Ankyrin repeat domain, H-DMZ = 
Heterodimerization domain, TA -  Transcriptional activation domain, LZ = Leucine 
zipper (note that the N-terminal domain of ScSwiôp does not bind to DNA).
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Figure 1.5
A. Alignment of ScM bplp, ScSwi4p, SpRes Ip and SpRes2p DNA-binding 
domains
Sequence alignment of the N-terminal DNA-binding domains of ScMbp 1 p, 
ScSwi4p, SpRes Ip and SpRes2p. The residue numbers and secondary 
structure elements are annotated for ScMbplp. Identical residues are shown as 
white characters boxed in red with similarity denoted by red characters boxed 
in white. P strands (arrows), a  helices (squiggle) and P turns (TT) are also 
shown. The position of the Glu 56 —» Lys mutation of SpRes Ip is indicated
( ^  - Section 1.6.6). This figure was generated using the ESPript program 
(Gouet et al., 1999).
B. ScM bplp DNA-binding domain
Ribbon diagram of the X-ray crystal structure of the ScMbplp DNA-binding 
domain (Taylor et al., 2000).
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Figure 1.7 Alignment of the ScSwi6p/SpCdcl0p ankyrin domains
Sequence alignment between the members o f the ScSwi6p/SpCdc 1 Op family within 
the ankyrin-repeat region. The residue numbers and secondary structure elements are 
annotated for ScSwiôp. Identical residues are shown as white characters boxed in red 
with similarity denoted by red characters boxed in white. P strands (arrows), a  helices 
(squiggle) and P turns (TT) are also shown. This figure was generated using the 
ESPript program (Gouet et al., 1999).
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1.5.8 Regulation of SBF and MBF-dependent gene expression
Despite the structural and functional similarities displayed by the SBF and MBF systems, it 
appears that distinct mechanisms exist to regulate their shared aim of Gl-S phase-specific 
transcription.
Activation of both SBF and MBF-dependent tianscription at START is dependent on 
the ScCln3p-ScCdc28p kinase activity. Although the precise mechanism by which this occurs 
is unknown, it appears that neither complex is a direct target of the CDK (Wijnen et al., 2002). 
A recent study suggests that the ScCln3p-ScCdc28p kinase may activate SBF-dependent 
transcription indirectly by antagonising an SBF-associated repressor (De Bruin et al., 2004). 
ScCln3p-ScCdc28p-dependent phosphoiylation of the ScWhi5p protein promotes its 
dissociation from SBF, thereby allowing recruitment of the RNA pol II holoenzyme, leading to 
transcriptional activation (De Bruin et al., 2004; Cosma et al., 1999).
Paradoxically, in addition to a positive role in MBF/SBF-dependent transcription, the 
ScCln3p-ScCdc28p kinase seemingly also negatively regulates MBF activity. The ScStblp 
protein has recently been identified as an MBF-associated activator protein (via its interaction 
with ScSwiôp). However, ScCln3p-ScCdc28p-dependent phosphorylation leads to dissociation 
of ScStblp and the consequent down-regulation of MBF-dependent transcription (Costanzo et 
al., 2003). In contrast, repression o f SBF-regulated genes during G2 and M is dependent on the 
ScCIbp-ScCdc28p kinases, which have no apparent effect on MBF-regulation genes (Amon et 
al, 1993). Consistent with this SBF-specific function, it has been proposed that down-regulation 
of SBF activity may occur through the direct interaction of ScSwi4p with the ScClb2p- 
ScCdc28p kinase during G2 and M (Siegmund and Nasmyth, 1996).
The subcellular localisation of ScSwiôp is cell cycle-regulated by phosphorylation. 
Predominantly nuclear during late M and early Gl phases, ScSwiôp becomes largely 
cytoplasmic in S, G2 and early M phases, only re-appearing in the nucleus following 
completion of mitosis (Taba et al., 1991; Sidorova et al., 1995). It has been proposed that 
phosphoiylation of ScSwiôp (on Serine lôO) by the ScClbôp-ScCdc28p kinase, facilitates 
nuclear export, by the kaiyopherin ScMsn5p, thereby resulting in down-regulation o f MBF and 
SBF-dependent transcription (Queralt and Igual, 2003; Gaymonet et ah, 2004). Intriguingly, 
however, the ScMsn5p-mediated export o f ScSwiôp is specifically required for SBF function, 
but not MBF, again highlighting different regulatory properties (Queralt and Igual, 2003).
Nevertheless, the recruitment o f ScSwiôp to the nucleus cannot be solely responsible 
for activating transcription. The SBF complex is bound to target gene promoters in early Gl 
phase, yet transcription occurs only in late Gl (Harrington and Andrews, 1996; Koch et al., 
199Ô). This suggests a subsequent activation event must occur, presumably related to the 
functions of the ScWhi5p and ScStblp proteins mentioned above.
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MBF SBF
ScMbplp ScSwi4p
Figure 1.8 The MBF and SBF DNA-binding complexes
Schematic representations o f the MBF and SBF DNA-binding complexes bound to the 
MCB and SCB sequence elements, respectively. The N and C-termini o f each protein are 
indicated in yellow.
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The SWI4 gene is itself transcribed in a cell cycle-regulated manner, peaking in late M-Gl 
phase, thereby contributing to the temporal activation of SBF in late G1 (McKay et ah, 2001). 
An additional level of control over the SBF complex has also been proposed through regulation 
of ScSwi4p DNA-binding by C-terminally mediated auto-inhibition (Baetz and Andrews, 
1999).
1.6 G l-S phase-specific transcription in fission yeast
In fission yeast, passage o f START and entry into S phase requires the activity of the SpCdc2p 
kinase in association with the G1 cyclins, SpPuclp, SpCiglp and SpCig2p (Fisher and Nurse, 
1995). Transcription of several genes that are essential for S phase onset and progression is cell 
cycle-regulated, peaking in late G1 (e.g. cdclS^ and m ik t) .
In contrast to the situation in budding yeast, where the Gl-S phase-specific transcription 
programme is controlled by two distinct transcription factors (SBF and MBF), fission yeast 
contains only one such factor. The DSCl complex is responsible for controlling the late Gl-S 
phase-specific transcription programme during mitotic cell division. Following isolation o f a 
MCB-specific DNA-binding activity in budding yeast (MBF - Section 1.5.3) a similar DNA- 
binding activity was identified in fission yeast, bound specifically to the MCB elements present 
in the promoter of the cdc22^ gene (Lowndes et ah, 1992a; Maqbool et ah, 2003). The cdc22^ 
gene, which encodes the large subunit o f ribonucleotide reductase, is periodically expressed in 
late Gl-S and contains seven copies of the MCB element in its promoter (Gordon and Fantes, 
1986; Fernandez-Sarabia et ah, 1993; Maqbool et ah, 2003). In addition, the cdclO^ gene 
product was shown to be a component of this factor, shortly followed by the discovery that 
ScSwi6p was also a component of the budding yeast MBF complex (Lowndes et ah, 1992a; 
Lowndes et ah, 1992b). The ammo acid sequence homology between the ScSwi4/6p and 
SpCdclOp proteins, allied to their roles as START-specific transcription factors, indicates that 
the mechanisms governing late G 1-specific hanscriptional control might be conserved in these 
distantly related yeasts (Merrill et ah, 1992).
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1.6.1 The DSCl complex
Similar to the MBF system o f budding yeast, the DSCl complex regulates transcription of 
several genes required for entry into, and onset of, S phase by binding to the MCB elements 
common to their promoters (MacNeill and Nurse, 1997). The transcription o f at least 10 genes 
{cdc22^, cdclS^, cig2^, e d i t ,  ra d 2 l\  suc22^, r a d l f ,  ste9^, m ik f  and cdt2^) required for S 
phase and DNA replication are under the control o f DSCl during the mitotic cell cycle 
(Lowndes et ah, 1992; Fernandez-Sarabia et ah, 1993; Kelly et ah, 1993; Connolly and Beach, 
1994; Hofmann and Beach, 1994; Birkenbihl and Subramani, 1995; Harris et ah, 1996; Parker 
et ah, 1997; Tournier and Millar, 2000; Ayte et ah, 2001; Ng et ah, 2001; Yoshida et ah, 2003; 
Maqbool et ah, 2003). DSCl is composed of at least four gene products: SpCdclOp, SpReslp, 
SpRes2p and SpRep2p and has been widely studied during the mitotic cell cycle (Lowndes et 
ah, 1992; Caligiuri & Beach, 1993; Tanaka et ah, 1992; Zhu et ah, 1994; Miyamoto et ah, 
1994; Nakashima et ah, 1995). In DSCl, the SpReslp and SpRes2p proteins confer sequence- 
specific DNA-binding activity and interact with the regulatoiy SpCdclOp and co-activating 
SpRep2p subunits.
1.6.2 A *DSCl-like’ complex in meiosis
A ‘DSCl-like’ complex has been recently identified, which regulates transcription in the 
meiotic cycle and is composed of at least SpRes2p, SpCdclOp and SpReplp (Cunliffe et ah, 
2004). In addition, microarray analysis has identified -100 genes that aie transcribed 
specifically during late G l-S phase in the meiotic cycle, which also have promoter regions 
enriched for the MCB motif (Mata et ah, 2002).
In this specialised cell cycle, the chromosomes o f a diploid cell aie replicated forming 
homologous pairs (as opposed to sister chromatids in mitosis). During the first cellular division, 
cohesion is maintained between homologous chromosome pairs, allowing the exchange of 
genetic material -  known as homologous recombination (Alberts et ah, 1994). Consequently, 
the first nuclear and cellular division is equationah Each cell, now with diploid genomic 
content, subsequently undergoes a second meiotic division, without intervening DNA 
replication. Four haploid cells (spores in yeast, gametes in mammals) are ultimately produced 
from a single diploid cell (Alberts et ah, 1994). In fission yeast, meiosis is initiated after two 
haploid cells (of opposite mating type) aiTest in Gl phase (pre-START), as a result of nutrient 
depletion (Figure 1.1). These cells then conjugate, forming a transient diploid, which undergoes 
meiotic division to produce a four-spored ascus. This specialised form o f  cell division requires 
re-programming of the mitotic cell, such that it retains many of the factors required for DNA 
replication, whilst additionally producing many specialised meiotic gene products (Lee and 
Amon, 2001). The ‘DSCl-like’ complex regulates transcription of several genes during 
meiosis, some o f which also function in mitotic S phase (e.g. cdc22* and cdcl8*\ whilst others
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(e.g. the rec^ gene products involved in homologous recombination) have roles that are 
exclusively meiotic (Cunliffe et al., 2004). The genes encoding the SpReslp, SpRes2p, 
SpReplp and SpRep2p proteins were originally identified by genetic suppressor analyses, 
designed to isolate components o f the regulatory pathway required for the ct/c/O-dependent 
passage of START.
1.6.3 SpCdclOp
The cdclO^ gene was first identified as one of two essential genes, whose functions were 
required for passage o f START and commitment to the mitotic cell cycle in fission yeast 
(Nurse et al., 1976; Nurse and Bisset, 1981). Mutants in cdclO^ arrest in Gl and retain the 
ability to conjugate, indicating they cannot traverse START until after the execution of 
SpCdclOp function (Nurse and Bisset, 1981). The cdclO* gene was subsequently cloned by 
rescue of mutant function, and encodes a protein of 85 kDa (Aves et al., 1985). SpCdclOp 
shares striking sequence similarity with the ScSwi6p protein o f budding yeast, specifically 
within the centrally located ankyrin motifs, which are characteristic o f the SpCdclOp/ScSwip 
family of proteins (Aves et al., 1985; Breeden and Nasmyth, 1987b - Figures 1.7 and 1.9).
Similar to the role of ScSwi6p in SBF/MBF, SpCdclOp has no intrinsic DNA-binding 
activity, instead functioning as a regulatory subunit (Zhu et al., 1994; Mcinerny et al., 1995). 
Mutational analyses of SpCdclOp indicate that the C-temiinal region and the ankyrin motifs are 
important for normal function (Reymond and Simanis, 1993). The majority o f cdclO ts 
mutations locate within the ankyrin-repeat region indicating it has an important, although as yet 
undefined, role (Reymond et al., 1992). The C-terminus of SpCdclOp most likely mediates the 
regulatory function, demonstrated by the properties of the cdclO-C4 mutant (Mcinerny et al.,
1995). The SpCdclO-C4p protein product is truncated at the C-terminus, which results in loss 
of the final 61 amino acids. In cdclO-C4 mutant cells, genes that are under DSC l control show 
a loss in periodicity, becoming constitutively transcribed throughout the cell cycle (Mcinerny et 
al., 1995). By analogy with ScSwi6p, the C-terminus o f SpCdclOp may be responsible for 
heterodimerization with the MCB-specific Resp DNA-binding proteins.
1.6.4 SpReslp and SpRes2p
Three different groups cloned the resl'^ gene independently, as a multi-copy suppressor of the 
temperature sensitive cdclO-129 mutant (Tanaka et al., 1992; Marks et al., 1992; Caligiuri and 
Beach, 1993). Concomitantly, SpReslp was biochemically identified as a component o f the 
DSCl band-shift activity present in crude fission yeast protein extracts (Caligiuri and Beach,
1993). The res2^ gene was then cloned, as a multi-copy suppressor of the Isj'esl mutant and 
independently in a genetic screen designed to identity DNA-binding partners of SpCdclOp 
(Miyamoto et al., 1994; Zhu et al., 1994). The demonstration that SpRes2p, together with
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SpCdclOp, bound specifically to MCB elements both in vitro and in vivo, confirmed that, like 
SpReslp, it was a DNA-binding partner o f SpCdclOp (Zhu et ah, 1994),
1.6.5 Functional redundancy between SpReslp and SpReslp
The molecular mechanisms by which DSCl-dependent transcription is regulated, either in the 
mitotic or meiotic cycles, is not fully understood (Section 1.6.8). The situation is further 
complicated by the apparently distinct yet overlapping functions of the two DNA-binding 
proteins, SpReslp and SpReslp. Both SpReslp and SpReslp function during the mitotic cycle 
and display some overlap with respect to these roles. However, SpReslp has an additional 
function in the meiotic cycle, which cannot be assumed by SpReslp.
Cells simultaneously deleted for both resl^  and res2^ are inviable, and overexpression 
o f either gene can rescue the conditional lethality of the cdc l0-129 mutant (Miyamoto et al.,
1994). Furthermore, overexpression o f res2'^ rescues the lethality of cells deleted for r e s t ,  
demonstrating that SpReslp can compensate for the loss of SpReslp mitotic function 
(Miyamoto et al., 1994). Despite a shared mitotic role, the phenotypes o f the âvresl and Aresl 
mutants indicate that only SpReslp functions during meiosis and, moreover, that SpReslp and 
SpReslp act predominantly in the mitotic and meiotic cycles, respectively (Tanaka et al., 1992; 
Caligiuri and Beach, 1993; Miyamoto et al., 1994; Zhu et al., 1994).
Cells deleted for res2^' are viable and display no obvious growth defects during mitotic 
division, yet they are defective in pre-meiotic DNA synthesis and undergo an abnormal meiosis 
(Miyamoto et al., 1994; Zhu et al, 1994). In contiast, cells deleted for r e s t  show no obvious 
defects in the meiotic cycle, yet when dividing mitotically they display severe heat and cold 
sensitivities, arresting pre-START at the restrictive temperature (Tanaka et al., 1992). 
Furthermore, I 'c s t  cannot suppress the meiotic defect of 2sres2 cells (Miyamoto et al., 1994; 
Sturm and Okayama, 1996). In fact, SpReslp levels decrease during meiosis and SpReslp is 
thought to be a repressor o f the sexual pathway (Caligiuri and Beach, 1993; Ayte et al., 1997). 
SpReslp levels increase during conjugation, consistent with its additional meiotic function 
(Miyamoto et al., 1994; Zhu et al., 1994; Ayte et al., 1997).
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1.6.6 Structure of SpReslp and SpReslp
The apparent contradiction that SpReslp and SpReslp have distinct roles yet are functionally 
overlapping, has been explained by analysis of their functional domains.
The r e s t  and r e s t  genes encode 72 kDa and 73 kDa proteins, respectively, which 
display the modular architecture typical of transcription factors. Consistent with an overlapping 
function, SpReslp and SpReslp share striking sequence similarity with each other in their N- 
termini, which include their DNA-binding domains, and the centrally located ankyrin-repeat 
motifs that are characteristic o f the SpCdcl0p/ScSwi6p family o f proteins (Tanaka et al., 1992; 
Caligiuri and Beach, 1993; Miyamoto et al., 1994; Zhu et al., 1994; Ayte et al., 1995; Zhu et 
al., 1997). This sequence similarity extends to include the ScSwi4p/ScMbplp proteins, which 
share a common architectural design, affirming their place as members o f this family of 
transcription factors (Section 1.5.5 and Figure 1.5). As described in Section 1.5.6, the X-ray 
structure of the ScMbp 1DNA-binding domain has been solved (Xu et al., 1997; Taylor et al., 
1997). In contrast, no structural data beyond the amino acid sequence is available for any o f the 
fission yeast members o f this family. The DNA-binding domain of ScMbp Ip, folds into a 
wHTFI motif, which makes sequence specific contacts in the major groove of the DNA 
(Section 1.5.6). Based on the significant sequence homology displayed witliin this region 
between family members, it has been proposed that SpReslp and SpRes2p will also bind DNA 
using this structural motif (Xu et al., 1997; Taylor et al., 1997). In agreement with this, a 
mutation within the SpReslp DNA-binding domain (Glu 56 —> Lys), within the putative 
recognition helix, results in enhanced DNA-binding and, moreover, renders SpReslp 
independent of SpCdclOp (Caligiuri and Beach, 1993; Figure 1.5).
Unlike ScMbp Ip and ScSwi4p, the SpReslp and SpRes2p proteins are believed to bind to 
DNA as dimers (Ayte et al., 1997; Zhu et al., 1997). This resembles the situation for the 
E2F/DP family of proteins, which are responsible for regulating tlie analogous program o f G l- 
S phase-specific transcription in mammalian cells (Zheng et al., 1999). Although not conserved 
in primary structure with any o f the ScSwip/SpResp family proteins, the E2F family of 
transcription factors also adopt a wHTH fold to bind DNA (Zheng et al,, 1999; Section 1.7).
Similarly to the ScSwi6p-ScSwi4p/ScMbplp interaction in budding yeast SBF/MBF, 
SpReslp and SpRes2p interact with SpCdclOp via their C-termini (Ayte et al., 1995; Zhu et al., 
1997). The distinct ftinctional specificities o f SpReslp and SpRes2p, however, are determined 
by their C-termini, m which they display greatest heterogeneity (Figure 1.9; Stunn and 
Okayama, 1996; Zhu et al., 1997; Whitehall et al., 1999). A domain within the C-terminus o f 
SpRes2p confers an as yet undefined meiotic-specific function (Sturm and Okayama, 1996; 
Zhu et al., 1997; Whitehall et al., 1999), In addition, two discrete domains in SpRes2p confer a 
requirement for the transcriptional co-activator subunit, SpRep2p (Sturm and Okayama, 1996; 
Tahara et al., 1998).
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Figure 1.9 Domain architecture of SpRes2p, SpReslp and SpCdclOp
A schematic representation o f the major domains in A SpRes2p - 73 kDa, B SpReslp - 
72 kDa and C SpCdclOp - 85 kDa. DNA-BD = DNA-binding domain, ANK = Ankyrin 
repeat domain, H-DMZ = Heterodimerization domain (note that the N-terminal domain 
of SpCdclOp does not bind to DNA - adapted from Sturm and Okayama, 1996).
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1.6.7 SpReplp and SpRep2p
The r e p t  gene encodes a 53 kDa protein containing a C terminal zinc finger motif, that is 
essential for its function (Sugiyama et ak, 1994). Considerably smaller than SpReplp, the 25 
kDa SpRep2p protein also contains a C terminal zinc finger motif, sharing significant 
homology with SpReplp in this region (Sugiyama et al., 1994; Nakashima et al., 1995; Figure 
1.10). In contrast to SpReslp and SpRes2p, which are both functional during mitosis, SpReslp 
and SpRes2p have distinct meiotic and mitotic functions, respectively (Sugiyama et al., 1994; 
Nakashima et al., 1995). However, resembling the scenario for SpReslp and SpRes2p, genetic 
suppressor analyses indicate that the r e p t  and rep2^ gene products also display some 
functional overlap.
Overexpression of either r e p t  or rep2'^ can rescue the conditional lethality o f the 
cdc l0-129 mutant, the property by which they were cloned (Sugiyama et al., 1994; Nakashima 
et al., 1995). Overexpression of r e p t  rescues the cold sensitive lethality o f cells deleted for 
rep2^, demonstrating that SpReplp can compensate for loss o f SpRep2p mitotic function 
(Sugiyama et al., 1994). The r e p t  gene is not expressed in the mitotic cycle; consequently, 
deletion o f r e p t  has no effect on mitotically dividing cells (Sugiyama et al., 1994). In the 
mitotic cycle lSj'ep2 cells (though viable at 30°C) are cold sensitive and arrest at START at < 
18°C. Conversely, tsrep2 cells show only slight meiotic defects, with the majority o f cells 
successfully completing meiosis. In contrast, hrep l mutants are unable to initiate pre-meiotic 
DNA synthesis and, moreover, are deficient in induction of the cdc22^ transcript (Sugiyama et 
al., 1994; Ding and Smith, 1998; Cunliffe et al., 2004). This behaviour is consistent with a 
suggested role for SpReplp as an activator of DSCl-dependent transcription in the meiotic 
cycle. In agreement with this proposal is the demonstration that SpRep2p acts as a 
transcriptional activator subunit for SpRes2p (Nakashima et al., 1995; Tahara et al., 1998). In 
tsrep2 cells, DSCl-regulated genes are transcribed at lower levels compared to wild type, 
although the periodicity is maintained (Baum et al., 1997). Furthermore, SpRep2p contains 
centrally located SpRes2p binding and C-terminal activation domains, both o f which are 
essential for its function (Nakashima et al., 1995; Taliara et al., 1998). Thus, SpReplp and 
SpRep2p are likely to be activators o f DSCl in the meiotic and mitotic cycles, respectively.
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Figure 1.10
A. Domain architecture of SpReplp and SpRep2p
Schematic representation of the major domains of SpReplp and SpReplp (adapted 
from Nakashima et al., 1995). TA = Transcriptional activation domain, ZF = Zinc 
finger motif. B. Alignment of SpReplp and SpReplp 
Sequence alignment between the SpReplp and SpReslp proteins. The residue 
numbers are annotated for SpReplp. Identical residues are shown as white characters 
boxed in red with similarity denoted by red characters boxed in white. This figure was 
generated using the ESPript program (Gouet et al., 1999).
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1.6.8 Regulation of DSC 1-dependent gene expression
Based largely on genetic evidence (Section 1.6.5), original models proposed that fission yeast 
contained two distinct yet functionally overlapping SpCdcl Op-containing transcription factors, 
analogous to the situation in budding yeast (Miyamoto et al., 1994; Zhu et al., 1994). 
According to this model, a SpReslp-SpCdclOp complex functioned during mitosis, whilst a 
SpRes2p-SpCdcl0p complex acted in meiosis. However, substantial evidence accumulated 
arguing that both SpReslp and SpRes2p functioned together with SpCdclOp in a single mitotic 
DSCl complex.
Analysis of the DSCl band-shift activity produced from fission yeast mitotic cell 
extracts showed it to contain at least SpReslp, SpRes2p and SpCdclOp (Ayte et al., 1997; Zhu 
et al., 1997). Furthermore, SpReslp and SpRes2p can heterodimerize in vitro, dependent on 
SpCdclOp (Zhu et al., 1997) and the DSCl band-shift activity is lost in cells deleted for either 
r e s t  or res2^, suggesting both subunits are required for the complex to form (Ayte et al., 1997; 
Zhu et al., 1997).
The existence of a SpResl p-SpRes2p-SpCdc 1 Op containing complex was confirmed by 
the demonstration that all three proteins were present in the in vivo DSCl complex throughout 
the mitotic cycle (Whitehall et al., 1999). Therefore, a DSCl complex composed o f at least 
SpReslp, SpRes2p and SpCdclOp, controls the mitotic Gl-S phase-specific transcription 
programme in fission yeast (Wliitehall et al., 1999). The stoichiometiy of the complex is 
unknown, although it is most likely heterotetrameric consisting o f one molecule each of 
SpReslp and SpRes2p, each of which bind an SpCdclOp molecule (Ayte et al., 1997; Reymond 
et al., 1993; Figure 1.11).
The levels o f SpCdclOp, SpReslp and SpRes2p remain constant throughout the cell 
cycle and thus it is likely that DSCl is regulated through post-translational modifications 
(Whitehall et al., 1999). In contrast to ScSwi6 p (Section 1.5.8), SpCdclOp is predominantly 
nuclear throughout the cell cycle, and so regulation of sub-cellular localisation is unlikely to 
contribute to DSCl regulation (Reymond et al., 1993; Wuarin et al., 2002). In budding yeast, 
ScCdc28p kinase activity has been shown to play a role in activating SBF/MBF-regulated 
transcription (Section 1.5.8; Wijnen et al., 2002). Similarly, in fission yeast the SpCdc2p kinase 
is required for passage o f START (Nurse and Bisset, 1981). However, to date, there is no 
evidence for the direct involvement o f SpCdc2p in activating DSCl-dependent tianscription 
(Baum et al., 1997; Whitehall et al., 1999). The SpPaslp-SpPeflp kinase apparently plays a 
role in the activation o f SpRes2p, by an unknown mechanism, although the SpPas 1 p-SpPefl p 
kinase may directly phosphoiylate SpRes2p (Tanaka and Okayama, 2000).
Repression o f DSCl-dependent tianscription is mediated, at least in part, by SpCig2p- 
SpCdc2p kinase activity (Ayte et al., 2001). The SpCig2p-SpCdc2p kinase complex binds to 
SpRes2p and phosphorylates SpReslp, causing repression of DSCl-dependent transcription.
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although the mechanics of this are unknown (Ayte et al., 2001). Inti iguingly, SpCig2p itself is a 
transcriptional target of DSCl. Thus a negative feedback loop appears to operate, whereby 
transcription o f SpCig2p leads to increasing SpCig2p-SpCdc2p kinase activity that in turn 
down-regulates DSCl-dependent transcription (Ayte et al., 2001). This model of SpRes2p 
mediated repression is consistent with the expression pattern o f MCB-regulated genes in ceils 
either deleted for or overexpressLng res2^. Overexpression of SpRes2p leads to repression o f 
DSC!-dependent hanscription, whilst A/'cs2 cells show increased levels o f transcription (Baum 
et al., 1997). In contrast, overexpression of SpReslp leads to increased levels o f DSCI- 
dependent transcription, whilst transcription is reduced in cells deleted for r e s t  (Baum et al., 
1997).
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SpCdclOp I SpCdclOp
SpRep2pSpReszp
Figure 1.11 The DSCl DNA-binding complex
A schematic representation of the fission yeast mitotic DSCl DNA-binding complex 
bound to the MCB sequence element. The N and C-termini of each protein are indicated in 
yellow.
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1.7 G l-S phase-specific transcription in mammalian cells
The conservation in both structure and function between the MBF/SBF and DSC 1 systems of 
budding and fission yeasts, suggested that a homologous Gl-S transcriptional control system 
also operates in higher eukaryotes.
In mammalian cells a Gl-S phase-specific transcription programme is also required for 
passage of the Restriction point and entry into S phase, conti’olled by the E2F family of 
transcription factors (Dyson, 1998). Similar to yeasts, several o f the genes that are activated by 
the E2F system encode functions required for DNA synthesis and replication (e.g. 
dihydrofolate reductase, thymidine kinase and the HsCdcbp, HsOrclp and HsMcmp proteins) 
and key cell cycle regulators such as cyclin A, cyclin E and HsCdklp (Ren et al., 2002). 
Furthermore, the TTTCGCGC consensus sequence element that is common to their promoters 
(and bound by the E2F proteins) resembles the MCB and SCB elements (Dyson, 1998). 
Moreover, the E2F proteins utilise a  similar wHTH structural fold for DNA-binding (Zheng et 
al., 1999). Despite these tantalizing parallels, the E2F proteins display no significant amino 
acid sequence homology with any o f the yeast proteins and so although they are responsible for 
regulating an analogous process in higher eukaryotes they are not true structural and functional 
homologues o f the yeast factors.
1.7.1 The E2F and DP proteins
The functional E2F complex acts as a heterodimer comprising one subunit derived from the 
E2F family and one derived from the DP family. In mammalian cells, seven E2F (E2F-1 to 
E2F-7) and two DP (DP-1 and DP-2) proteins have been discovered to date (Trimarclii and 
Lees, 2001; DeBruin et al., 2003). The proteins they encode contain highly conserved DNA- 
binding and dimérisation domains. In addition, the C-termini o f E2Fs 1-5 contain 
transactivation and pocket protein binding domains that are absent in E2F-6/7 and the DP 
proteins (Trimarchi and Lees, 2002; DeBrain et al., 2003). It is thought that the DP subunits 
activate transcription indirectly by enhancing the activity o f the E2F subunit. Little is known 
about the specific properties o f the individual E2Fs, although they have been categorised into 
tliree different subtypes based on both structural and functional properties (Dyson, 1998).
E2Fs 1-3: the activating E2Fs, these proteins activate transcription from E2F responsive genes, 
thereby driving proliferation. These proteins are under cell cycle control with levels peaking at 
G l-S boundary.
E2Fs-4 and -5: In contrast these proteins are constitutively expressed and are particularly 
prevalent in GO cells. They appear to bind to promoters in an inactive conformation, associated
39
with pocket proteins and thus are believed to be responsible for transcriptional repression. 
Release of the pocket proteins resumes their ti anscriptional activation potential.
E2Fs-6 and -7: Both of these proteins act as hanscriptional repressors. They each lack the C- 
terminal transactivation and pocket-binding domains and are therefore insensitive to the pRB 
family proteins. However, in contrast to E2F-6 (and all the other E2F and DP family members) 
E2F-7 contains two DNA-binding domains arranged in tandem and lacks the dimérisation 
domain, suggesting it can bind DNA in the absence of a DP partner (DeBruin et al., 2003; 
Logan et al., 2004). E2F-6 is proposed to act as a transcriptional repressor by binding to 
promoters, thereby preventing access by other ‘active’ E2F complexes and can recruit members 
o f the polycomb chromatin re-modelling family to repress chromatin (Stevens and LaThangue, 
2003).
1.7.2 Regulation of E2F-dependent gene expression
The molecular mechanisms by which E2F-dependent hanscription is regulated are complex and 
not fully understood. The most prominent regulator o f E2F-dependent transcription is the pRB 
pocket protein, which binds to and negatively regulates E2F. RB  was the first tumour 
suppressor gene to be cloned and disruption in pRB function is involved in the majority o f all 
human cancers (Weinberg, 1995).
The ability o f pRB to bind E2F is dependent on its phosphorylation state, which is 
controlled by the actions of the Cdks, thereby linking E2F activity to the cell cycle. Each 
member o f the pRB family contains multiple Cdk phosphorylation sites and the 
hyperphosphorylated forms have very low affinity for E2F. pRBs are thought to inactivate E2F 
by physically blocking the C-terminal transactivation domain. pRB can also recruit chromatin- 
remodelling machineiy to promoters (e.g. SWI/SNF proteins, histone deacetylases, histone 
methyltransferases), thereby repressing transcription through changes in chromatin stincture 
(Stevens and LaThangue, 2003).
During GO and early G l phases, pRB is hypophosphorylated and binds to E2F. In 
mammalian cells both positive and negative regulatory growth signals can act during G l, prior 
to the Restriction point (Sherr, 1996). Mitogenic growth factors initiate a signalling cascade, 
which ultimately leads to activation o f the HsCdk4p/6p-cycIin D activities. The activated 
HsCdk4p/6p-cyclin D kinase complexes then phosphorylate pRB, causing its release from E2F. 
Consequently, E2F activates the expression o f several genes whose functions are required for 
passage of the Restriction point and entry into S phase (Dyson, 1998).
Paradoxically, as a result o f its temporal association with pRB family proteins, E2F 
bound to promoters can mediate both transcriptional activation and repression. Attempts to 
explain these conflicting roles have led to classification of E2F complexes in three distinct
40
groups (Dyson, 1998). Firstly, activator complexes correspond to those in which the activation 
domain o f promoter bound E2F is free to stimulate transcription. Secondly, inhibited 
complexes represent those in which the activation domain of promoter bound E2F is blocked 
by pRB family proteins. Finally, an additional category corresponds to the repressor complexes 
in which pRB family proteins recruit and assemble chromatin-remodelling machinery, which 
represses chromatin.
Precisely how E2F activates transcription is unknown, although it can also interact with 
chromatin-remodelling machinery, presumably to reverse the effects o f tlie pRB-mediated 
repression highlighted above (e.g. CBP, recruitment o f HAT activity to promoter) and may also 
directly contact the general RNA polymerase 11 transcription machinery (Stevens and 
LaThangue, 2003).
In addition to pRB-mediated negative regulation, the decrease in E2F activity that is 
required for cells to exit S phase appears to be distinct from pRB-mediated phosphorylation. 
HsCdJk2p-cyclin A can both bind to E2F-1 and phosphorylate DP-1, thereby inhibiting DNA- 
binding activity. As cyclin A is a transcriptional target of the E2F complex, this negative 
feedback is reminiscent o f the action o f SpCig2p upon DSCl activity (Stevens and LaThangue, 
2003; Section 1.6.8).
1.8 Aims of this study
The aims of this study were to produce a stable, reproducible and active source of recombinant 
protein of the components o f the fission yeast DSCl complex, in yields that would allow more 
extensive biophysical, biochemical and functional analyses to be undertaken.
The cloning o f DSCl component genes and their subsequent overexpression in E. coli 
has the potential to produce a reproducible source of protein in yields sufficient (5-10 mg 1^  
culture) for this purpose, in contrast to their naturally low abundance in fission yeast. Chapter 3 
describes the cloning and expression of DSCl components as His-tagged fusion proteins in E. 
coli. Chapter 4 describes assaying the effects o f His-tags on the activity^ o f each component in 
fission yeast. In Chapter 5 DNA-binding activities are also assayed in vitro, following 
solubilisation of the recombinant proteins. In addition, GST-fusions o f Res Ip and Res2p are 
produced to further investigate the DNA-binding properties in vitro. Finally, in Chapter 6 , 
attempts to purify the individual recombinant components o f DSCl and obtain preliminary 
structural data are described.
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Chapter 2
Materials and methods
2.1 Molecular biology materials
2.1.1 Chemicals
All chemicals used were o f the highest grade available commercially and distilled water was of 
Millipore-Q quality.
Specialised chemicals such as ampicillin, kanamycin, chloramphenicol, protease 
inhibitors (phenylmethanesulfonylfluoride -  PMSF, chymostatin, pepstatin, antipain, leupeptin, 
aprotonin) and NZ amine, were from Sigma. Sephadex G-50, dATP (lOp Ci p f ')  and dldC (1 
mg ml ') were supplied by Amersham Pharmacia Biotech. Ditliiothreitol (DTT) was obtained 
from Melford laboratories Ltd, Suffolk.
2.1.2 Enzymes and kits
All restiiction enzymes, T4 DNA ligase, calf intestinal alkaline phosphatase, dNTPs, Taq DNA 
polymerase and T4 polynucleotide kinase were obtained from Promega. VentR DNA 
polymerase and Mung Bean Nuclease were obtained from New England Biolabs. The 
QIAprep® Spin Miniprep Kit and the QIAquick® Gel Extraction Kit were supplied by 
QIAGEN.
2.1.3 Molecular weight markers
DNA molecular weight marker X (0.07-12.2 kbp) was supplied by Roehe.
2.1.4 Oligonucleotides
Oligonucleotides were designed in the laboratory as required and synthesised by MWG-AG 
Biotech or DNA Technology A/S. All oligonucleotides used in this thesis are listed in 
Appendix II. The aimotation GO refers to the Glasgow lab oligo collection number.
2.1.5 Bacterial media
All strains o f Escherichia coli were grown in Luria Broth (LB; 10 g Bacto-tryptone, 5 g Bacto 
yeast extract and 10 g NaCl per litre, pH 7.5) or NZY^ broth (5 g NaCl, 2 g MgS0 4 .7 H2 0 , 5 g 
yeast extract, 10 g NZ amine per litre, pH 7.5). LB plates were made by adding 7.5 g bacto agar 
to 500 ml LB. All media were autoclaved before use and supplemented with ampicillin (50 pg 
ml''), kanamycin (30 pg ml"') or chloramphenicol (34 pg ml"') where appropriate.
2.1.6 Bacterial strains
All bacterial strains used in this thesis are listed in Appendix I. The annotation GB refers to the 
Glasgow lab bacteria collection number.
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E. coli DH5a: a recombination deficient strain used for the propagation and storage of plasmid 
DNA. Genotype; supEAA A/acU169 (^80/acZAM15) hsdRXl recAX endh l byrA96 thil relKX, 
E. coli BL21 CodonPliis(DE3)“RIL (Stratagene): an all-purpose strain for high-level protein 
expression and easy induction. Genotype: F ompT hsdSiyy mB') doin' T ef gal A,(DE3) endA 
Hte[argU HeY leuW  Cam*^ ].
2.1.7 Bacterial plasmid vectors
The pET vectors were purchased from Novagen, pCR2.1 was supplied by Invitrogen and 
pGEX-KG was obtained from a laboratoiy stock (Appendix III).
pET“28c: for expression of His-tagged recombinant proteins; the six histidine residues are 
linked to the N-terminus of the cloned gene (kanamycin resistant).
pET-14b: for expression o f His-tagged recombinant proteins; the six histidine residues are 
linked to the N-terminus of the cloned gene (ampicillin resistant).
pCR2.1: for one-step cloning of a polymerase chain reaction product with polydeoxyadenosine 
3’ overhangs (ampicillin resistant).
pGEX-KG: for expression of GST-tagged recombinant proteins; the GST tag is linked to the 
N-terminus of the cloned gene (ampicillin resistant; Guan and Dixon, 1991).
2.2 Molecular biology methods
2.2.1 Polymerase chain reaction (PGR)
P o l y m e r a s e  c h a i n  r e a c t i o n s  w e r e  p e r f o r m e d  u s i n g  e i t h e r  Taq DNA p o l y m e r a s e  o r  V e n t R  DNA 
p o l y m e r a s e .
2.2.2 PCR using Taq DNA polymerase
Standard PCR reactions were carried out in an MWG-Biotech Primus Thermal Cycler in 
0.5ml thin walled PCR tubes with Taq DNA polymerase. A typical 100 pi reaction volume 
contained 10 x Taq buffer at a final concentration of 1 x, 200 pM each of dNTPs, 100 ng 
each of the appropriate primers, 50 ng of DNA template and 2 U of Taq DNA polymerase. 
Annealing temperatures for each reaction were determined empirically.
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Typical cycle parameters were as follows:
30 cycles
Dénaturation: 95“C for 2 min 
Dénaturation: 95°C for 15 sec
Annealing; 50°C for 30 sec (temperature adapted as appropriate for 
primers)
Extension: 72°C for 1 min (time adapted as appropriate-1 min per 
kb of product)
Extension: 72°C for 5 min
2.2.3 PCR using VentR DNA polymerase
PCR was performed as above with the following modifications. A typical 100 pi reaction 
volume contained 10 x reaction buffer (100 inM KCl, 100 mM (NH4)2S0 4 , 200 mM Tris-HCl 
(pH 8 .8 ), 20 mM MgS0 4 , 1% Triton X-100) at a final concentration of 1 x, 200 pM of each 
dNTP, 100 ng each of the appropriate primers, 50 ng of DNA template and 2 U of VentR DNA 
polymerase. Typical cycle parameters were as follows:
 ^ 95 °C for 1 min
95°C for 30 sec
20 cycles ^ 58°C for 30 sec (temperature adapted as appropriate for primers)
6 8 °C for 2 min (time adapted as appropriate-1 min per kb of product)
, 6 8  °C for 3 min
The yield and purity of the PCR product obtained was analysed by agarose gel electrophoresis 
(2% (w/v) agarose) and stored at -20°C before and after agarose gel purification.
2.2.4 Agarose gel electrophoresis
The appropriate amount (1 g 100 ml ') o f agarose was dissolved in 1 x TBE (45 mM Tris- 
borate, 1 mM EDTA) and 2-3 pi ethidium bromide added to give slab agarose gels of the 
required percentage, routinely 1-2%. Samples for analysis were diluted 5 fold by the addition of 
6  X loading buffer (0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanol FF, 0.15% 
(w/v) Ficoll) before being loaded on the agarose gel. These were run at 100 V in 1 x TBE for 
between 40 min - 1 h until the dye front was about 1 cm from the bottom of the gel. Gels were 
then viewed using a UV transilluminator and photographed using E. A. S. Y imaging software.
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2.2.5 Purification of DNA from bacterial cultures
DNA was purified fiom bacterial cultures using the QIAprep® Spin Miniprep Kit supplied by 
QIAGEN. The kit was used as per the manufacturer’s instructions. Briefly, a 5 ml culture 
containing the appropriate antibiotic was inoculated with a single colony from an LB antibiotic 
plate. This was incubated with shaking at 37“C for not more than 16 h. Cells were pelleted at 
10,000 rpm for 5 min and resuspended in 250 pi Buffer PI. Cells were lysed by the addition of 
250 pi Buffer P2 and incubated for 5 min. 350 pi of Buffer N3 was added and the mixture 
centrifuged at 1 0 ,0 0 0  rpm for 1 0  min in a benchtop centrifuge to pellet the cell debris. 
Supernatant was applied to a QIAprep® column and centi'ifuged briefly to allow the DNA to 
bind to the membrane o f the spin column. The column was washed twice, firstly with 0.5 ml 
Buffer PB and then 0.75 ml Buffer PE, before the DNA was eluted in 50 pi nuclease-free 
water. The yield and purity o f DNA obtained was analysed by agarose gel electrophoresis.
2.2.6 Extraction of DNA from an agarose gel
DNA was purified from agarose gels using the QIAquick® gel exfraction kit (QIAGEN) as 
described in the manufacturer’s instructions.
Briefly, DNA was excised from an agarose gel using a sterile sealpel blade. The agarose 
slice was solubilized at 50“C in the appropriate volume of Buffer QG (as supplied). This 
mixture was applied to a spin column and centi'ifuged for 1 min to allow the DNA to bind the 
column. The column was washed with 750 pi of Buffer PE containing 80% (v/v) ethanol. 
Residual ethanol was removed by centrifuging the column for a further 1 min, before eluting 
the DNA in 50 pi Buffer EB (1 mM Tris-HCl, pH 8.5) or nuclease-free water.
The yield and purity o f DNA obtained was analysed by agarose gel electrophoresis.
2.2.7 Restriction digestion
Plasmid DNA and PCR products were routinely digested, prior to ligation, as follows: 5 pi 
DNA was digested with 1 pi enzyme for a single digest (or 1 pi of each enzyme in double 
digests), together with 2 pi o f the appropriate enzyme buffer in a final volume of 20 pi. This 
was incubated at 37”C for 30 min or as otherwise instructed for the enzyme (exceptions were 
Sma\, which required incubation at 25°C for 30 min and Ncoi in which a second aliquot of 
enzyme was added after 15 min due to the short half life of the enzyme).
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2.2.8 Dephosphoi-ylation of digested plasmid
Digested vector was dephosphorylated by the addition of 1 U of calf intestinal alkaline 
phosphatase and incubated at 37°C for a further 30 min. This was routinely carried out to 
prevent self-ligation of digested vector.
2.2.9 Ligations
Purified plasmid DNA was ligated with purified insert DNA at various ratios (1:3, 1:5, 1:7). A 
typical ligation reaction was set up as follows; 1 pi of digested, dephosphorylated and gel 
purified vector was mixed with 5 pi of digested and gel purified insert, 10 x T4 DNA ligase 
buffer (at a final concentration o f 1 x) and 1 U of T4 DNA ligase. Routinely, ligations were 
incubated overnight at 4°C before being transformed into E.coli DH5a competent cells 
following the standard protocol (Section 2.2.13). The resulting colonies were then screened by 
restriction digestion analysis (Section 2.2.7) to confirm the presence of insert DNA.
2.2.10 Cloning of blunt ended PCR products
The TA Cloning® Kit (Invitrogen) was used to clone blunt-ended PCR products as described in 
the manufacturer’s instructions.
2.2.11 Site-directed mutagenesis by overlap extension
The plasmid GB 130 (Appendix I), containing a -2,300 bp fragment representing the 
recombinant cdclO^ gene, was used as a template in the PCR reactions, which were adapted 
fiom a method described in Sambrook and Russell (2001). Four primers (GO 546, GO 459, GO 
547 and GO 548 - Appendix II) were used to introduce a site-specific mutation by overlap 
extension. The primers GO 546 and GO 459 were complementaiy to either end of the cdclO^ 
gene and allowed introduction of Ndel and BamHl sites, respectively, to the 5’ and 3’ ends of 
the PCR fragment. The primers GO 547 and GO 548 were complementary to the cdclO^ gene 
and were designed to introduce a single base pair G to C substitution at position 426 relative to 
the ATG. This introduces a silent mutation Tyrosine (TAG) to Tyrosine (TAG) and removes 
the artificial internal stop codon. The primer pairs GO 547 and GO 548 were necessarily 
complementary to each other and could not be used in the same PCR reaction. Therefore, 
mutation had to be carried out in two stages.
Stage 1 : Primer pairs GO 546/GO 548 and GO 459/GO 547 were used in separate PCR 
reactions to produce 2 different sized fragments. The PCR reaction in this step was carried out 
as described in Section 2.2.3.
46
Stage 2: The 2 fragments, each containing the G to C substitution at 426, were gel 
purified and joined together to generate the full-length cDNA in a fusion PCR reaction using 
primers GO 546 and GO 459.
The parameters of the fusion PCR reaction were as follows:
94“C for 1 min
10  cycles
10  cycles
2 0  cycles
94“C for 1 0  sec
50°C for 1 min
6 8 °C for 3.5 min
94"C for 10  sec
58°C for 1 min
6 8 °C for 3.5 min
94°C for 1 min
58°C for 1 min
6 8 °C for 3.5 min
6 8 "C for 7 min
2.2.12 Production of competent bacterial cells
Competent cells were made using the rubidium chloride method.
The appropriate bacterial E. coli strain was streaked onto a minimal LB plate and grown 
overnight at 37°C. A single colony was used to inoculate an overnight 5 ml LB culture. This 
was subcultured into 100 ml LB and giown at 37°C with shaking until the culture reached an 
optical density (OD) of 0.48 at 550 nm. The culture was then chilled on ice for 5 min, before 
centrifugation at 3000 rpm for 10 min at 4°C. The pellet was resuspended in 40 ml Buffer 1 
(100 mM rubidium chloride, 10 mM calcium chloride, 50 mM manganese chloride, 15% (v/v) 
glycerol in 30 mM potassium acetate, pH 5.8). Cells were centrifuged as before and the pellet 
resuspended in 4 ml Buffer 2 (10 mM rubidium chloride, 75 mM calcium chloride, 15% (v/v) 
glycerol in 10 mM 3-[N-morpholino] propanesulfonic acid (MOPS), pH 6.5). The cells were 
divided into 100 pi aliquots and stored at -70°C.
2.2.13 Transformation of competent bacteria
In electro-transformation a BIORAD E. coli puiser was used with a method adapted from the 
BIORAD manual.
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E, coli DH5a cells were routinely used for the propagation and harvesting of 
reeombinant plasmid DNA, and were transformed using the following method. To 50 pi of 
competent bacteria 1-2 pi of the appropriate plasmid DNA was added. The cell-DNA 
suspension was transferred to a pre-chilled 0.2 cm electroporation cuvette and pulsed at 2,5 kV. 
1 ml of SOC (2% Bacto tryptone, 0.5% Bacto yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM 
MgCb, 10 mM MgSO/t, 20 mM glucose) was added to the cells, which were then transferred to 
microfuge tubes and incubated at 37°C with shaking for 45 min. This mix was plated on an LB- 
agar plate containing the appropriate antibiotic and incubated overnight at 37°C.
E. coli BL21 CodonPlus(DE3)-RIL cells were routinely used for the expression of the 
desired recombinant proteins and transformed using the following method. To 50 pi of 
competent bacteria, 1-10 ng of DNA was added in a pre-chilled microfuge tube. The mixture 
was chilled for 15 min before heat shocking at 42°C for 90 sec and returned to ice. After 2 min 
450 pi of SOC was added and this was incubated at 37°C with shaking for 45 min. This mix 
was plated on an LB-agar plate containing the appropriate antibiotic and incubated overnight at 
37“C.
2.2.14 Electophoretic mobility shift assay (EMSA)
Electophoretic mobility shift assay (EMSA) was as described by Ng et al (2001). This 
technique is also commonly known as the band-shift assay and is referred to using both names 
in this thesis.
2.2.15 Probe preparation
DNA fragments were 5’ end-labelled using T4 polynucleotide kinase (PNK). To 5-10 pg of 
DNA in 5 pi of dH2 0  on ice was added 10 U of T4 PNK in I x T4 PNK buffer, followed by the 
addition of 10 pCi o f [y-^^P] dATP (lOp Ci p f ')  to give a total volume of 8 pi. The reaction 
was incubated at 37°C for 1 h, and the DNA was purified using a Sephadex G-50 column. 
Sephadex G-50 was prepared by adding two volumes of TE and autoclaving. The plunger was 
removed from a 1 ml syringe (Plastipak) and a small wad of siliconized glass wool was used to 
plug the end before the end was placed inside a microfuge tube. Sephadex G-50 was added to 
the syringe; the syringe and microfuge tube were placed inside a 50 ml centrifuge tube and then 
centrifuged at 3000 rpm for 5 min to remove the TE. This was repeated until -0.8 ml Sephadex 
G-50 remained in the syringe. A fresh microfuge tube was then placed at the bottom of the 
syringe and the radiolabelled probe added to the Sephadex G-50 column. This was spun again 
at 3000 rpm for 5 min and the syringe was monitored with a Geiger counter to confirm that 
unincorporated nucleotides had been removed fiom the probe. The purified probe was 
transferred to a fresh screw-top microfuge tube and stored at -70°C.
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2.2.16 EMSA assay
Each mobility shift assay was performed by adding 10 pi of sample buffer (1 M Tris-HCl pH 
7.5, 1 M KCl, 50% glycerol, 100 mM DTT, 100 mM protease inhibitors: chymostatin, 
pepstatin, antipain, leupeptin, aprotonin, 100 mM PMSF, 1 M M gCf) to 20 pg of protein (or as 
otherwise indicated), 1 pg of dldC (1 mg ml ') and 1-2 pi of labelled probe. If required, non­
specific or specific competitor DNA was also added. The samples were incubated for 5 min on 
ice before the addition of each reagent. Analysis of the formation of protein-DNA complexes 
was achieved by electrophoresis o f samples on a 10% acrylamide gel in 1 x TBE buffer (40 
mM Tris-borate, 1 mM EDTA pH 8 ) for 1.5-2 h at 180V. The gel was dried for 1.5 h at 80°C 
and exposed to autoradiography film at -70°C.
2.3 Protein biochemistry materials
2.3.1 Chemicals
Ultra pure imidazole and zinc chloride were purchased from MERCK, BDH. Triton X-100 was 
bought from Fisons, Loughborough. Isopropyl P-thiogalactopyranoside (IPTG) was obtained 
from Melford Laboratories Ltd, Suffolk. Glutathione Sepharose 4B was supplied from 
Amersham Pharmacia Biotech. Glutathione (reduced), NaF and acrylamide:bisacrylamide 
solution were supplied by Sigma. Bradfords Reagent (BIO-RAD protein assay reagent) was 
purchased from BIO-RAD.
2.3.2 Molecular weight markers
The relative molecular mass (subunit M J of proteins separated by SDS-PAGE was determined 
by comparison with low Mr markers (Amersham Pharmacia Biotech, Low molecular weight 
calibration kit for electrophoresis).
2.3.3 Phototgraphic materials
Nitrocellulose and Hyperfilm were purchased from Amersham Pharmacia Biotech. The X- 
Omat 100 processor was supplied by Kodak.
2.4 Protein biochemistry methods
2.4.1 Growth of bacterial cultures for protein induction
A single colony o f transformed BL21 CodonPliis(DE3)-RIL cells was picked from an LB-agar 
antibiotic plate and grown at 37°C with shaking in 5 ml growth media plus the appropriate
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antibiotic for 16 h. A 1 ml aliquot was subcultured into 50 ml growth media plus antibiotic and 
incubated at 37°C with shaking until the ODôoo was between 0.5-1.0. IPTG, at a final 
concentration o f 0.2 mM-1 mM (0.2 mM for 22“C and 15°C inductions or 1 mM for 30°C and 
37°C inductions), was then added and the cultures induced at the required temperature for 
either 3 h (30“C and 37°C inductions) or 16 h (22°C and 15°C inductions). During 3 h 
inductions samples were taken at zero time and then at 1 h intervals to check for 
overexpression. During 16 h inductions samples were taken at zero time and at 16 h. All 
samples were pelleted by centrifugation at 13,000 rpm for 1 rain and the pellets resuspended in 
Laemmli sample buffer (2% (w/v) SDS, 10% (w/v) sucrose, 62.5 mM Tris-HCl, pH 6 .8 , 
Pyronin Y dye) using 10 pi per 0.1 ODeoo units. Cells were harvested by centrifugation at 3,000 
rpm for 15 min and the supernatant discarded. The pellet was then resuspended in 3 ml o f the 
appropriate buffer for purification and stored at -20°C.
2.4.2 Large-scale protein induction
A single colony was picked fiom an LB-agar antibiotic plate and grown at 37°C with shaking in 
10 ml growth media plus antibiotic for 16 h. This was then subcultured into 500 ml growth 
media plus antibiotic and grown at 37°C with shaking until the ODeoo was between 0.5-1.0. 
Protein expression was induced by the addition of 0.2-1 mM IPTG (Section 2.4.1). Induction 
was again carried out for either 3 h or 16 h depending on the temperature used. Samples at zero 
time and at the end of induction were kept for analysis on SDS-PAGE to check that expression 
had occurred as before. Cells were harvested by centrifugation at 8,250 rpm for 15 min in a 
Beckman J2-21 centrifuge using a JA-14 rotor and the supernatant discarded. The pellet was 
then resuspended in 20 ml o f the appropriate buffer for purification and stored at -20°C.
2.4.3 Dialysis of protein samples
Visking tubing was prepared by boiling in 10 mM sodium bicarbonate, pH 8.0, 1 mM EDTA 
for 10 min. This was then rinsed in distilled water before being stored in 100% (v/v) ethanol. 
Tubing was thoroughly rinsed in distilled water before use.
Dialysis of protein took place at 4°C for several hours using multiple changes o f dialysis
buffer.
2.4.4 Concentration of protein samples
After dialysis, protein samples were concentrated by centrifugation in a Ceiitricon Plus-20 
centrifugal concentrator filter (Amicon), with cut off 30,000 Da, according to the 
manufacturer’s instructions.
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2.4.5 Determination of protein concentration
The method of Bradford (1976) was routinely employed. A standard curve was produced using 
known concentrations of BSA. The absorbance of the unknown samples were taken then 
measured at 5 9 5  nm and their concentiation extr apolated from the standard curve.
2.4.6 SDS-poIyacrylamide gel electrophoresis (SDS-PAGE)
The solutions required for SDS-PAGE were as follows:
Acrylamide solution
29.2% (w/v) acrylamide/0 .8 % (w/v) bis-acrylamide.
Resolving gel buffer
10% (w/v) acrylamide, 0.5 M Tris-HCl, pH 8 .8 , 0.1% (w/v) sodium dodecyl sulphate (SDS), 
0.1% (w/v) ammonium persulphate, 0.1% (v/v) N, N, N ', N'-tetramethlethylene diamine 
(TEMED).
Stacking gel buffer
4.5% (w/v) acrylamide, 0.06 M Tris-HCl, pH 6 .8 , 0.1% (w/v) SDS, 0.1% (w/v) ammonium 
persulphate, 0.1% (v/v) TEMED.
Running buffer
25 mM Tris-HCl, pH 8.3, 0.25 M glycine, 1% (w/v) SDS.
Proteins were resolved under denaturing conditions using the method of Laemmli (1970). 
Samples for analysis on SDS-PAGE were resuspended in Laemmli sample buffer to which 1 M 
DTT was added (at a final concentration of 150 mM) prior to boiling for 5 min to ensure that 
all proteins were denatured. A 10 pi aliquot o f each sample was loaded on the gel along with 10 
pi of a low molecular mass marker (Section 2.3.2). Gels were run using the Biorad Mini- 
Protean gel kit system at 400 V for 1 h or until the dye front was approximately 1 cm from the 
bottom of the gel. Gels were then stained in 0.1% (w/v) Coomassie Brilliant Blue, 10% (v/v) 
acetic acid, 50% (v/v) methanol for 1 h and destained in 10% (v/v) acetic acid, 10% (v/v) 
methanol overnight.
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2.4.7 Immunoblotting using ECL ™  (enhanced chemiluminessence)
Anti-PentaHis-HRP conjugate antibody was supplied by QIAGEN and Anti-GST~HRP 
conjugate antibody was supplied by Amersham Pharmacia Biotech. Immunoblotting protocols 
were carried out as detailed in the manufacturer’s instructions.
2.4.8 Solutions used in immunoblotting 
Transfer buffer (10 x) per litre
25 mM Tris-HCl, pH 1.2, 192 mM glycine, 0.02% (w/v) SDS, 20% (v/v) methanol
2.4.9 Solutions for Anti-PentaHis-HRP conjugate detection
Blocking buffer: 10 mM Tris-HCl pH 7.5, 0.1% (w/v) Blocking reagent, 0.1% (v/v) Tween- 
20 .
TBS buffer: 10 mM Tris-HCl pH 7.5.
TBS-Tween/Triton buffer: 20 mM Tris-HCl pH 7.5, 500 mM NaCl, 0.05% (v/v) Tween-20, 
0.2% (v/v) Triton X-100.
Anti-PentaHis-HRP conjugate antibody: 20 mM Tris-HCl pH 7.5, 1% (w/v) Non-fat milk, 
0.1% (v/v) Tween-20, 1:2500 dilution o f Anti-PentaHis-HRP conjugate antibody.
2.4.10 Solutions for Anti-GST HRP conjugate detection
Blocking buffer: 20 mM Tris-HCl pH 7.5, 5% (w/v) Blocking reagent, 1% (v/v) Tween-20. 
TBS buffer: as above (Section 2.4.8).
TBS-Tween/Triton buffer: as above (Section 2.4.8).
Anti-GST-HRP conjugate antibody: 20 mM Tris-HCl pH 7.5, 0.1% (v/v) Tween-20, 1:5000 
dilution of Anti-GST-HRP conjugate antibody.
2.4.11 Immunoblotting protocol
SDS-PAGE analysis was performed as described in Section 2.4.6. Proteins were then 
electrophoreticaliy transferred to nitrocellulose using the Biorad Mini-Protean gel kit system at 
50 mA for 2 li in 1 x tiansfer buffer. Staining of the nitrocellulose with the non-fixative dye 
Ponceau S was employed to check the efficiency of protein transfer. This was washed off in 
distilled water and the non-specific binding sites were blocked by immersing the nitrocellulose 
in blocking buffer for 1 h at room temperature with shaking. The membrane was washed twice 
for 10 mill in TBS-Tween/Triton buffer then incubated with diluted HRP conjugate antibody 
solution at room temperature for 1 h. The membrane was again washed in TBS-Tween/Triton
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buffer for 10 min and given a final wash in TBS buffer before detection. The detection step was 
carried out as described in the Amersham protocol for ECL detection. In the dark room, 
autoradiography film was placed onto the membrane and exposed for 30 sec initially before 
developing the film using a Kodak X-omat 100 processor.
2.4.12 Solubilisation of expressed fusion proteins
Fusion proteins were expressed as described previously (Section 2.4.1-2.4.2). The pellets were 
then resuspended in the appropriate volume of lysis buffer and disrupted by 3 passes through an 
automatic French pressure cell (pre-cooled on ice) at 750 or 950 psi for small or large-scale 
preparations, respectively. Protease inhibitors were routinely added to prevent degradation of 
protein. A 100 pi aliquot o f this whole cell extract sample was retained before the remainder 
was centrifuged at 4°C in a Beckman J2-21 centrifuge using a JA-17 or JA-14 rotor for small or 
large preparations, respectively. 1 0 0  pi aliquots o f the supernatant and pellet, resuspended in 
the original starting volume of lysis buffer, were retained. An equal volume of Laemmli sample 
buffer was added to these samples and the solubility o f the recombinant protein viewed by 
SDS-PAGE.
2.4.13 Purification of GST-tagged proteins
GST-tagged proteins were purified using the BioCAD® SPRINT™, Perfusion Chromatography® 
System (PE Biosystems). A GSTrapFF 5 ml (Glutathione sepharose) column was routinely 
used.
2.4.14 Preparation of bacterial cell extracts
GST fusion proteins were expressed as described (Section 2.4.1-2.4.2).
The pellet from a 500 ml bacterial cell culture was resuspended in 20 ml 1 x PBS (140 
mM NaCl, 2.7 mM KCl, 10 mM Na2HP0 4 , 1.8 mM KH2PO4, pH 7.3) and the cells disrupted 
under high pressure using a French Pressure cell at 950 psi. Typically 3 passes were made and 
protease inhibitors added to prevent degradation of protein. The supernatant was clarified by 
centrifugation at 10,000 rpm for 15 min at 4°C in a Beckman J2-21 centrifuge using a JA-14 
rotor.
2.4.15 Column purification of GST-tagged proteins
The column was prepared by equilibrating with 5 column volumes of binding buffer (1 x PBS) 
prior to use. Clarified supernatant was loaded onto the column in 5 ml increments. After 
extensive washing of the column in binding buffer, bound GST-tagged protein was eluted in 
elution buffer (10 mM reduced glutathione in 50 mM Tris-HCl, pH 8.0) and 2 ml fractions
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collected. Elution of the protein was monitored by measuring the absorbance at 280 nm. 
Aliquots of the appropriate fractions were then mixed with an equal volume of Laemmli sample 
buffer and analyzed using SDS-PAGE.
2.4.16 Purification of His-tagged proteins
His-tagged proteins were purified using the BioCAD® SPRINT™, Perfusion Chromatography® 
System (PE Biosystems). A POROS® MC (metal chelate) column (4.6 mm/100 mm) was 
routinely used.
2.4.17 Preparation of bacterial cell extracts
His-tagged fusion proteins were expressed as described (Section 2.4.1-2.4.2). The pellet from a 
500 ml bacterial cell culture was resuspended in 20 ml starting buffer (100 mM NaCl, 0.5 mM 
imidazole in 50mM KH2PO4, pH 7.5) and the cells disrupted under high pressure using a 
French Pressure cell at 950 psi. Typically 3 passes were made and protease inhibitors added to 
prevent degradation o f protein. The supernatant was clarified by centrifugation at 10,000 rpm 
for 15 min at 4°C in a Beckman J2-21 centrifuge using a JA-14 rotor.
2.4.18 Column purification of His-tagged proteins
The column was prepared by loading the imidodiacetate binding sites with zinc ions (0.1 M 
ZnCh, pH 4.5-5) for 25 column volumes and then washing with distilled water followed by 
0.5 M NaCl to remove any excess metal ions. The column was then washed with 5 column 
volumes of elution buffer (100 mM NaCl, 500 mM imidazole in 50 mM KH2PO4, pH 7.5). 
Finally the column was equilibrated with starting buffer (100 mM NaCl, 0.5 mM imidazole in 
50 mM KH2PO4, pH 7.5) before use.
Clarified supernatant was loaded onto the column in 5 ml increments. After extensive 
washing of the column in starting buffer bound His-tagged protein was eluted in a linear 
imidazole gradient (0.5 mM -  500 mM) and 2 ml fractions collected. Elution of protein was 
monitored by measuring the absorbance at 280 nm. After all the protein eluted the column was 
regenerated by washing with 15 column volumes of stripping buffer (50 mM EDTA, 1 M 
NaCl). Aliquots of the appropriate fractions were then mixed with an equal volume of Laemmli 
sample buffer and analyzed using SDS-PAGE.
2.4.19 Solubilization of insoluble proteins from inclusion bodies
The following protocol was adapted from the Protein Folding Kit (Novagen).
After induction in E. coli and overexpression of the desired protein (Section 2.4.1), the 
cells were pelleted as normal and resuspended in 0.1-culture volume of Inclusion body wash
54
buffer (10 mM EDTA, 1% (v/v) Triton X-100 in 20 mM Tris-HCl, pH 7.5). Cells were 
disrupted by passage through a French press (Section 2.4.12), and insoluble material pelleted 
by centrifugation at 10,000 rpm for 10 min at 4°C. The pellet was then washed a further twice 
in Inclusion body wash buffer.
Inclusion bodies were resuspended in 50 mM KH2PO4, pH 7.5 (or 150 mM NaF, pH 7.5 
for Circular dichroism experiments) at a concentration of 10-20 mg ml^ and supplemented with 
the appropriate volume of 30% (v/v) N-lauiylsarcosine to give the desired concentration of 
detergent in the buffer, typically 0.1-3% (complete solubilisation was generally achieved with 
0.2% (v/v) detergent). This was incubated at room temperature for 30 min with agitation before 
clarifying any insoluble material by centrifugation at 10,000 rpm for 15 min at 4°C. Samples of 
the supernatant were taken for analysis using SDS-PAGE.
2.4.20 Mass spectrometric data
Mass spectia were recorded in collaboration with Dr. A. Pitt, Sir Henry Wellcome Functional 
Genomics Facility, University o f Glasgow.
Sample preparation
Gel bands were broken into approximately 1 mm cubes and then destained and dehydrated by 
sequential washing with 300 pi of: 25 mM ammonium bicarbonate, 50% 25 mM ammonium 
bicarbonate in acetonitrile and 1 0 0 % acetonitrile, followed by drying in a centrifugal 
evaporator (Univap, Uniscience). Gel slices were re-hydrated in 20 pi of 20 ng mf* trypsin (in 
25 mM ammonium bicarbonate) for 15 min. Additional 25 mM bicarbonate was then added to 
ensure the gel slice was covered and the digest incubated at 37°C overnight. The supernatant 
was removed, acidified by the addition on 1 pi of 5% formic acid and used dhectly for mass 
spectrometry or frozen at -2 0 °C until required. 1 0  pi aliquots of the samples was subjected to 
nLC-MSMS on a QStar Pulsar i electrospray mass spectrometer fitted with a nanospray source 
(Protana), using a 20 micron i.d., 10 micron orifice distally coated electrospray tip mounted in a 
ProADP2 adaptor (New Objective) connected to a nanoflow LC system (EC Packings) with the 
minimum length o f 20 micron i.d. fused silica capillary possible. nLC was performed using a 
0.3 X 5 mm reversed phase trap (PepMap C l 8 , Dionex) and a 75 micron x 15 cm PepMap C l8 
reversed phase column (Dionex) using standaid methodology, with a loading pump flow o f 30 
pi min'^ and a main flow of 200 nl m h f\ Peptides were trapped on the C l8 trap and desalted 
for 5 min before being separated using a 5-40% acetonitrile gradient over 15 min. All solutions 
contained 0.5% formic acid. Mass spectrometric analysis was performed in IDA mode 
(AnalystQS software, Applied Biosystems), selecting the 4 most intense ions for MSMS 
analysis. A survey scan o f 400-1500 Da was collected for 3 sec followed by 3 sec MSMS scans
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of 50-2000 Da using the standard rolling collision energy settings. IDA was triggered for ions 
with charge states 2-4 above a threshold o f 10 counts. Masses were then added to the exclusion 
list for 3 min. Peaks were extracted using the Mascot script (BioAnalyst, Applied Biosystems) 
and automatically exported to the Mascot (Matrix Science) search engine. Data was searched 
against the database using the MASCOT Daemon, with a peptide tolerance of 1.0 Da, an 
MSMS ion tolerance of 0.5 Da allowing for 1 missed cleave and variable methionine oxidation.
2.4.21 Circular dichroism
Circular dichroism (CD) spectra were recorded at 20°C on a JASCO J-810 spectropolarimeter 
(Jasco UK). All spectra were recorded in collaboration with Dr. S. Kelly and Mr. T. Jess in the 
Scottish Circular Dichioism Facility, University o f Glasgow. For CD experiments, purified 
protein samples were routinely prepared in 150 mM NaF, pH 7.5 (Section 2.4.19).
2.5 Fission yeast materials
2.5.1 Fission yeast media
Media used for the propagation o f fission yeast were as described by Moreno et al (1991).
2.5.2 Fission yeast strains
All fission yeast strains used in this thesis are listed in Appendix I. The annotation GG refers to 
the Glasgow lab fission yeast collection number.
2.5.3 Fission yeast plasmid vectors
The pREPl (GB 27) and pREP3X (GB 28) vectors, used for the expression of the His-tagged 
components of the DSCl complex in fission yeast, were obtained fi'om laboratory stocks 
(Appendix III).
- fpREPl; for the expression o f genes under the control of the nmtl (no message in thiamine) 
promoter (Maundrell, 1993).
pREP3X: for the expression o f genes under the control o f the nm tl (no message in thiamine) 
promoter. Derived from the pREPl vector it contains different restriction sites in the polylinker 
(Forsburg, 1993).
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2.6 Fission yeast methods
2.6.1 Fission yeast cell culture
To resuscitate yeast strains from -70°C glycerol stocks, (maintained in 25% glycerol 75% YE) 
cells were streaked onto complete rich medium (YE) plates (Moreno et ah, 1991). The cells 
were then grown at the permissive temperature (25°C or as otherwise indicated for mutant 
strains) for 2 -3  nights and checked microscopically to ensure no contamination had occurred, 
and that the cells were growing normally. A few individual colonies were then picked and 
streaked onto a YE master-plate, which was incubated overnight at 25°C. The master plate was 
used to replica-plate colonies, using a velvet cloth, onto selective medium to confirm the yeast 
strain genotype. Strains containing plasmids or being used in experiments were propagated in 
EMM supplemented with the appropriate amino acids at a concentration of 100 pg ml’  ^
(Moreno et al., 1991). Temperature sensitive mutants were incubated at the resti'ictive 
temperature of 21“C to display their mutant phenotype. Cell number per ml o f liquid culture 
was determined from a sample added to Isoton (Becton Dickinson); following sonication cells 
were counted electronically with a Z2 Coulter Counter. A cell count of 1-2 x 10  ^ cells ml"' 
indicated cells were at exponential phase of growth.
2.6.2 Production of competent fission yeast cells
500 ml o f EMM plus appropriate supplements was inoculated with a 10 ml overnight culture. 
This culture was grown at 25“C until a density of approximately 1 x 10  ^ cells ml"' was 
obtained. The cells were harvested in 50 ml centrifuge tubes by spinning at 3000 rpm for 5 min 
in a chilled desktop centrifuge. As much supernatant as possible was removed and the cells 
gently resuspended m a total of 100 ml o f ice-cold 1 M sorbitol. The cells were centrifuged as 
before and resuspended in 50 ml ice-cold 1 M sorbitol. This was repeated and the cells 
resuspended in 20 ml ice-cold 1 M sorbitol. Finally the cells were centrifuged and resuspended 
in 1-2 ml ice-cold 1 M sorbitol before being frozen at -70°C in 50 jrl aliquots.
2.6.3 Transformation of competent fission yeast
Aliquots of cells were thawed at room temperature and immediately stored on ice. To 50 pi of 
competent cells 1-2 pi of the appropriate plasmid DNA was added. The cell-DNA suspension 
was transferred to a pre-chilled 0.2 cm electroporation cuvette and pulsed at 2.5 kV. 1 ml of 1 
M sorbitol was then immediately added to the cuvette, the cell suspension returned to the 
microfuge tube and placed on ice. The transformation mixture was then plated out onto 
selective EMM, left to air dry, and incubated at permissive temperature for 3-4 days.
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2.6.4 Induction of gene overexpression
Several fission yeast strains containing the pREPl or pREP3X vectors with the appropriate 
insert were used to overexpress components o f the DSCl complex. Isresl cells (GG 146) 
were transformed with the pREP vector alone (GG 796), His-resl^ (GG 790), His-res2^ 
(GG 802), H is-re p t  (GG 811) or His-rep2^ (GG 817) and Eres2 cells (GG 156) were 
transformed with the pREP vector alone (GG 801) or containing His-res2^ (GG 808); 
Appendix I. The pREP vector series uses the nmtl (no message in thiamine) promoter to 
control expression of the inserted genes. Strains were streaked from glycerol stocks onto 
EMM plates containing the appropriate amino acids for nutritional selection of the plasmid,
with and without thiamine at a concentration of 5 pg p f ' {nmtl promoter ‘o ff)  and growth 
was compared at 30°C and 2 EC. For protein extraction, 5ml cultures were grown to 
saturation at 30°C with the appropriate amino acids with and without 5 pg p f ' thiamine. 
These were used to inoculate 200 ml cultures supplemented with the appropriate amino
acids and 5 pg p f ' thiamine (for nm tl promoter ‘o ff  experiments) or without thiamine (for 
nmtl* promoter ‘on’ experiments), and then grown for 16 h. Protein was then extracted for 
use in EMSA experiments as detailed (Section 2.6.5).
2.6.5 Protein extraction from fission yeast
Protein extraction from fission yeast was as described by Ng et al. (2001).
2 0 0  ml cultures of fission yeast cells, in mid-exponential stage of growth, were prepaied 
and harvested by centrifugation at 5000 rpm for 10 min in screw-cap centrifuge tubes. The cell 
pellet was resuspended in 200 pi of ice-cold lysis buffer (50 mM KCl, 50 mM Tris-FlCl pH 8 , 
25% glycerol, 2 mM DTT, 0.1% Triton X-100, 5 pg of protease inhibitors: chymostatin, 
pepstatin, antipain, leupeptin, aprotonin, 0.2 mM PMSF) in 2 ml screw-capped microfuge 
tubes. The cells were pelleted at 13,000 rpm for 1 min at 4°C in a high-speed microcentrifuge 
and again resuspended in 200 pi o f lysis buffer. Acid washed glass beads (425-600 micron, 
Sigma) were added to just beneath the meniscus and the tubes were chilled on ice for 2-3 min 
before being disrupted using a Ribolyser (Hybaid Ltd, UK) with 1 burst at 40 sec, setting 4. 
The cell debris was pelleted by centrifugation at 13,000 rpm for 5 min at 4°C and the protein 
supernatants were transferred to a fiesh chilled microfuge tube, and clarified by centrifugation 
at 13,000 rpm for 30 min at 4°C. Supernatants were transferred to a fresh chilled microfuge 
tube and 5 pi was removed to determine protein concentration, which was estimated using 
Bradford’s reagent (Section 2.4.5) and the remainder of the protein sample was snap fiozen on 
solid CO2, and stored at -70°C.
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Chapter 3
Molecular cloning and expression of individual 
components of the fission yeast DSCl complex
3.1 Introduction
In both budding and fission yeasts the decision to enter the mitotic cell cycle is made at a point 
in late G1 phase known as START (Forsburg and Nurse, 1991). Passage through START and 
entry into S phase requires CDK activity and the activated transcription of genes that are 
essential for S phase. In budding yeast the transcriptional activation o f these genes is dependent 
on the SBF and MBF transcription factor complexes and in fission yeast the MBF counterpart, 
DSCl (Johnston and Lowndes, 1992).
The SBF complex is composed of an ScSwi6p-ScSwi4p heterodimer, which binds to the 
5’ CACGAAA 3’ sequence in the promoters of several genes to regulate their transcription 
(Breeden and Nasmyth, 1987a; Andrews and Herskowitz, 1989a; Taba et al., 1991). Genes 
regulated by SBF include the G1 cyclins CLNJ, CLN2, PCLl and PCL2 (Johnston and 
Lowndes, 1992; Ogas et al., 1991; Measday et al., 1994; Koch and Nasmyth, 1994) and the HO  
endonuclease gene required for the mating type switch (Nasmyth, 1983; Breeden and Nasmyth, 
1987a).
The MBF complex recognises promoters containing the MCB sequence element 5’ 
ACGCGT 3’ (McIntosh et al., 1991; Lowndes et al., 1991) and is composed of ScSwi6 p in 
combination with ScM bplp (Lowndes et al., 1992b; Dirick et a l , 1992; Moll et a l ,  1992; Koch 
et a l, 1993). Targets for MBF regulation in budding yeast include many genes required for 
DNA synthesis and two late G1 cyclins CLB5 and CLB6 (Johnston and Lowndes, 1992; 
McIntosh et a l, 1991; Epstein and Cross, 1992; Schwob and Nasmyth, 1993). More recently a 
genome wide analysis of the SBF and MBF binding patterns has implicated these two 
complexes in the control of many more genes, some of which are transcription factors 
themselves, implying a greater gene regulatoiy role for these complexes than first thought (Iyer 
et a l, 2001; Horak et a l, 2002), In both SBF and MBF, DNA binding is mediated by, ScSwi4p 
and ScMbplp, respectively (Primig et a l, 1992; Dirick et a l, 1992; Koch et a l ,  1993).
In the distantly related fission yeast the transcriptional activation o f at least ten genes 
{cdc22^, cdcl8^, cig2^, cdtl^, rad2l^, suc22^, radll^, ste9^, mikl^ and cdt2^) required for S 
phase and DNA replication is controlled by the DSCl complex (Lowndes et a l ,  1992a; 
Fernandez-Sarabia et a l , 1993; Kelly et a l, 1993; Connolly and Beach, 1994; Hofinann and 
Beach, 1994; Birkenbihl and Subramani, 1995; Harris et a l, 1996; Parker et a l, 1997; Tournier 
and Millar, 2000; Ayte et a l, 2001; Ng et a l, 2001; Yoshida et a l, 2003). Similar to MBF in 
budding yeast, this complex binds to MCB elements in the promoters of these genes. The 
SpReslp, SpRes2p, SpCdclOp and SpRep2p proteins are all components of this complex 
(Lowndes et a l ,  1992a; Tanaka et a l ,  1992; Caligiuri and Beach, 1993; Miyamoto et a l, 1994; 
Zhu et a l, 1994; Nakashima et a l, 1995) with a role in the meiotic cycle proposed for SpReplp 
in place o f SpRep2p (Sugiyama et a l ,  1994; Cunliffe et a l , 2004). At least three of these
59
proteins, namely SpReslp, SpRes2p and SpCdclOp, share close homology to their budding 
yeast counterparts.
A comparison of SBF/MBF/DSCl proteins at the level of primary structure revealed a 
significant degree of homology specifically in their N and C-termini and in two centrally 
located ankyrin repeats. In ScSwi4p and ScM bplp the N-terminus harbours their DNA binding 
capability whilst their C-termini are required for heteromeric complex formation with the C- 
terminus of ScSwi6 p. Similarly, in SpReslp and SpRes2p, the N-terminus contains the DNA 
binding domain and their C-termini bind to SpCdclOp. Common to all six proteins aie the two 
centrally located ankyrin-repeat motifs (Bork, 1993; Sedgwick and Smerdon, 1999). The 
ankyrin repeats, believed to be involved in protein-protein interactions, have been reported to 
be required for interaction with cyclin-CDK complexes (Siegmund and Nasmyth, 1996; Foord 
et al., 1999). Both SpCdclOp and ScSwi6 p also share a putative leucine zipper domain in their 
C termini (Reymond and Simanis, 1993; Sidorova and Breeden, 1993).
Much work has been carried out on these genes and their protein products, both genetic 
and biochemical, in terms o f characterising their biological function (the functional properties 
of these proteins will be discussed in Chapters 4 and 5 of this thesis). In recent years significant 
progress has been made toward elucidating the shucture and function of the ScSwi4p-ScSwi6p- 
ScMbplp family of transcription factors from budding yeast. In contrast, little or no work has 
been carried out to study the 3-D structure of the fission yeast DSCl components and so in 
comparison to their budding yeast homologues, these proteins remain poorly characterised at 
the atomic level.
To date, the 3-D structure o f the DNA-binding domain o f SpMbplp has been 
determined by two independent groups at 2.1 Â resolution using X-ray ciystallograpliy (Taylor 
et al., 1997; Xu et al., 1997), and also more recently using NMR spectroscopy (Nair et al., 
2003). X-ray crystallography was also employed to obtain a detailed structural analysis o f the 
central ankyrin domain of ScSwi6p at 2.1 Â resolution (Foord et al., 1999).
Detailed structural analysis of a protein using methods such as those highlighted above 
requires highly pure, soluble and active preparation in large amounts (5-10 mg). Whilst protein 
purification from the native source is the ideal situation, it can often involve lengthy protocols, 
using several types of chromatography in order to achieve purification to near homogeneity (a 
pre-requisite for detailed biophysical analysis). Furthermore, because many proteins of 
biological interest (and especially cell cycle transcription factors) are present in naturally tiny 
amounts, they are typically recovered in veiy low yields and are therefore not amenable for 
many structural and functional analyses. It is for these reasons that the production of a protein 
of interest is often carried out in a heterologous organism whose molecular mechanisms have 
been specifically engineered to produce a protein in amounts much greater than that available 
from the native source. Indeed, the analysis o f all the budding yeast components of MBF have
60
been possible as a result of expression as recombinant proteins in E. coli. The pET system 
(Novagen) is a widely used prokaryotic system for cloning and expressing recombinant 
proteins in E. coli. Target genes are cloned into pET vectors under the control of the tightly 
regulated T7 RNA polymerase promoter and maintained in hosts that lack a T7 RNA 
polymerase gene. Once established in a non-expression host, the plasmid is then transformed 
into a strain engineered to carry a chromosomal copy of the T7 RNA polymerase gene under 
lacUV5 control. Expression of the protein is then chemically induced by addition of IPTG.
The use of this prokaryotic system is not without limitations, as many of the post- 
translational modifications carried out in eukaryotes are unavailable in this host. Alternatively, 
many researchers therefore exploit a eukaryotic host for recombinant protein expression (the 
methylotrophic yeast Pichia pastoris and baculovirus systems are now widely used). 
Nevertheless, it is important to note that the relative success o f each system used for 
heterologous expression must be determined empirically for each individual protein (many 
proteins that do not express at all, or to low levels, in the eukaryotic systems have often been 
successfully expressed in E. coli and vice versa). As precedent for this project, E. coli, as host 
for heterologous protein expression, was successfully applied permitting detailed structural 
information about the budding yeast MBF components.
The aim of this chapter was to clone the components of the fission yeast DSCl 
transcription factor complex and to express them as His-tagged fusion proteins in E. coli. The 
cloning and expression o f these components using the pET system has the potential to provide 
a reproducible source o f recombinant proteins in amounts suitable for use in future functional 
and biophysical studies.
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3.2 Cloning the resl^ ,^ res2^  ^repÜ  and rep2^ components of DSCl
The plasmids used for the cloning of the DSCl components are listed in Appendix I — GB 121 
{ r e p V \GB 23 { r e p 2 '\GB 164 {resT) and GB 160 {resl").
Previously in our laboratory, PCR o f the cDNAs encoding the components o f the fission 
yeast DSCl complex was performed using primers that permitted the addition of N-terminal 
Ndel and C-terminal SamHI restriction sites. These sites were not present in the open reading 
frames of the genes being cloned. The fidelity of the PCR reactions and the integrity of the 
restriction sites at the ends of each gene were confirmed by DNA sequencing after cloning into 
the vector pBC KS^ (MWG-Biotech -  using oligos listed in Appendix II). The presence o f the 
restriction ends, specifically the N-terminal Nde\ site, allowed cloning into the pET-28c vector 
in the correct reading frame with an N-terminal 6 -histidine tag (His-tag). The inclusion of the 
His-tag provides a means o f conveniently purifying the fusion protein by immobilised metal 
ion affinity chromatography (IMAC). This vector also contains the neomycin 
phosphotransferase gene, conferring kanamycin antibiotic resistance to the cloned plasmid.
The plasmids containing the His-tagged cDNAs of the DSCl components were digested 
with Ndel and Bamldl, as was the pET-28c vector to generate compatible cohesive ends for 
ligation. The vector was also treated with calf intestinal alkaline phosphatase to remove the 
phosphate groups exposed by digestion in order to prevent self-ligation (Methods 2.2.7 and 
2.2.8). The products of the restriction digestions were analysed on a 1.5% (w/v) agarose gel and 
bands of the appropriate size excised and purified using the QIAquick® Gel Extraction Kit 
(Methods 2.2.4 and 2.2.6). 5 pi samples were analysed on a 1.5% (w/v) agarose gel to 
determine the amount of DNA retrieved and thus to empirically determine the vector:insert 
ratio to be used in the subsequent ligation. Ligation reactions were carried out as described 
(Methods 2.2.9) and transformed into E. coli DH5a cells the following day (Methods 2.2.13). 
Transformants were then plated on LB-agar plates supplemented with the antibiotic kanamycin 
(30 pg ml"') and incubated at 37°C overnight. Colonies were selected and cultured overnight at 
37°C in 5 ml LB media supplemented with kanamycin (30 pg ml ').
Plasmid DNA was purified from the overnight cultures as described in Methods section
2.2.5 and analysed by restriction enzyme mapping to confirm the presence of an insert of the 
predicted size (Figures 3.1 and 3.2). Potential positive clones were sequenced (MWG-Biotech - 
using oligos listed in Appendix II) to confirm the presence of insert and ensure that the genes 
had been cloned in-frame with the N-terminal His-tag, After confirmation by restriction 
mapping and DNA sequencing, a positive clone for each gene was stored at -70°C in the lab 
bacterial collection: GB 177 {rep N \  GB 191 {rep2^\ GB 178 {res2^) and GB 201 {resF) - 
Appendix I. These clones were then used for the subsequent overexpression o f heterologous 
protein.
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Figure 3.1 Restriction digestion analyses of the r e p l^ - p E T - 2 H c  and -pET-28c 
plasmids
Clones containing insert were analysed by restriction mapping. Samples of each digest were 
analysed on a 1.5% (w/v) agarose gel stained with ethidium bromide and viewed under UV 
illumination. The 1 kb DNA ladder is shown (M) and sizes are indicated in base-pairs.
Digestion o f the rep/-pET-28c plasmid: 1 Ndel-BamHl 2 EcoRl 3 EcoRW.
Digestion of the rep2-pET-28c plasmid: 4 Nde\-BamH\.
The restriction enzymes used in each digest and the predicted fragment sizes are summarised 
for each clone in Tables 3.1 and 3.2.
Enzyme(s) | Number of Fragments Fragment sizes (bp)
Ndel-BamHl | 2 1420,5330 i
EcoRl 3 370,660,5720
E coR y \2 2300, 4450
Table 3.1 rep/ -pET-28c
1 En^m e(s)__________ ! Number of Fragments ( Fragment sizes (bp)
Ndel-BamHl |2 660, 5330
Table 3.2 rep2-pET-28c
63
M M
30542036
1636
1018
517/506
«M
Figure 3.2 Restriction digestion analyses of the res2-pET-28c and res/^-pET-28c 
plasmids
Clones containing insert were analysed by restriction mapping. Samples of each digest were 
analysed on a 1.5% (w/v) agarose gel stained with ethidium bromide and viewed under UV 
illumination. The 1 kb DNA ladder is shown (M) and sizes are indicated in base-pairs.
Digestion of the res2-pET-28c plasmid: 1 Nde\-BamW\ 2 EcoRI 3 Nco\
Digestion of the res/-pET-28c plasmid: 4 Nde\-BamUl 5 HindWl 6 Xba\
The restriction enzymes used in each digest and the predicted fragment sizes are summarised 
for each clone in Tables 3.3 and 3.4.
[ Enzyme(s) 1 Number of Fragments 1 Fragment sizes (bp)
N d e l - B a m H l 1 ^ [1970,53301 EcoRl 2 1 1530, 5770
N c o l 2 1200, 6100
Table 3.3 rea^2-pET-28c
[ Enzyme(s) 1 Number of Fragments 1 Fragment sizes (bp)
N d e l - B a m H l 2 1 1910, 53301-----
H in d lH 1 ^ 1 1370, 5870
X b a l 2 570, 6670
Table 3.4 r e s  I - p E T - 2 S c
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3.3 Cloning the cdclO^ component of DSCl
The recombinant plasmid containing the cdclO' gene cloned into the Ndel-BamHl sites of pET- 
28c (previously cloned in our laboratory) was found to produce a truncated protein product 
upon overexpression. Subsequent DNA sequencing analysis identified an artificial internal stop 
codon as the cause of this truncation. Site-directed mutagenesis was therefore can ied out to 
remove the internal stop site and is outlined below (details o f the site-directed mutagenesis o f 
cdclO" are described in Methods 2.2.11). The site-directed mutagenesis invokes a G to C single 
base pair substitution at position 426 relative to the ATG. This is a silent mutation changing 
TAG (Stop) to TAG (Tyr) since the wild type cdclO^ gene contains a TAT (Tyr) at the 
corresponding codon. The incorporation o f C rather than T, with respect to wild type, at base 
pair 426 was necessary to remove an internal Ndel site.
3.3.1 Site-directed mutagenesis of cdclCP
The plasmid pET-28c containing a 2,304 bp fragment representing the cdclO^ gene cloned in at 
Ndel-BamHl was obtained from a laboratory stock (GB 130: Appendix I) and used as template 
for site-directed mutagenesis. Figure 3.3 provides a schematic representation of the 
mutagenesis reaction and the primers used.
Initially, two separate PCR reactions were carried out using primer pairs GO 546/GO 
548 and GO 547/GO 459, to generate fragments o f approximately 500 bp and 2000 bp, 
respectively. The products obtained from these PCR reactions are shown in Figure 3.4. Both 
products of the predicted size, containing the G to C substitution at position 426 (as introduced 
by the mutagenic primers GO 547 and GO 548) were gel purified (Methods 2.2.6) and analysed 
by electrophoresis on a 1.5% (w/v) agarose gel (data not shown). 0.5 pi of each purified PCR 
product was then used as template in a single fusion PCR reaction using the primers GO 546 
and GO 459. These primers are complementary to either end of the cdclO^ gene in GB130 and 
incorporate the N-terminal Ndel and C-terminal BamHl sites, respectively. All PCR reactions 
were carried out using the VentR DNA polymerase (New England Biolabs). This enzyme has 
extensive 3’ to 5’ exonuclease proofreading activity, thus helping to minimise errors in base 
mis-incorporation.
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Figure 3.3 PCR strategy for the site-directed mutagenesis of cdcIO*
A schematic representation of the primers used in the site-directed mutagenesis of 
cdclO \ A In separate PCR reactions, 1 and 2, two fragments of the target gene 
were amplified. PCR 1 uses primers GO 546 and GO 548, whereas PCR 2 uses 
primers GO 547 and GO 459. B The two overlapping fragments were then used as a 
template in a fusion PCR reaction, 3, with primers GO 546 and GO 459 to produce 
the full-length mutant DNA.
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Figure 3.4 Site-directed mutagenesis of cdcIO *  by PCR amplification
PCR products were analysed on 1.5% (w/v) agarose gels stained with ethidium bromide. The 
1 kb DNA ladder is shown (M) and sizes are indicated in base-pairs. Arrows indicate PCR 
products of the predicted size, from reactions using primer pairs GO 546/GO 548 and 
GO 547/GO 459. The presence of contaminating PCR products in the GO 546/GO 548 reaction 
was due to non-specific priming in early cycles.
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3.3.2 Cloning the silently mutated cdclO^ gene into pCR2.1®
The TA Cloning® Kit (Invitrogen) was used to clone the blunt-ended PCR product from the 
fusion PCR reaction (Methods 2.2.10).
Cloning of PCR products into the pCR2.1® vector is a one-step method that utilises the 
non-template dependent activity o f Tag polymerase to add single deoxyadenosine (A) to the 3 ’ 
ends of PCR products. The linearised pCR2.1® vector contains single 3’ deoxythymidine (T) 
residues, thus allowing efficient ligation of a PCR insert with vector. VentR DNA polymerase 
was used in the PCR reactions to improve fidelity as it has a much lower rate o f base mis- 
incorporation than Tag polymerase due to intrinsic proofreading activity. However, VentR does 
not leave single 3’ A overhangs, and so a necessary extra final step at the end of the fusion PCR 
reaction was to incubate the reaction mix with Tag at 72°C for 10 min.
3.3.3 Ligation, transformation and identification of clones
After treatment with Tag a PCR product corresponding to the approximate size of the cdclO^ 
gene was gel purified, an aliquot analysed on an agarose gel (data not shown) and used in a 
ligation reaction with the linearised pCR2.1® vector. The cloning of the cdclO^ fusion PCR 
product into the pCR2.1® vector and transformation was as described in Methods section 
2 .2 . 10 .
Transformants were plated on LB-agar plates containing 1.6 mg p f ' X-Gal, 50 pg ml"' 
ampicillin and incubated at 37°C overnight. Colonies were selected according to the blue/white 
screening method and white colonies picked and cultured overnight in LB media supplemented 
with ampicillin (50 pg ml"') at 37°C. Plasmid DNA was purified from the overnight cultures as 
described in Methods section 2.2.5 and analysed by restriction enzyme mapping to confirm the 
presence of an insert of the correct size (Figure 3.5). Potential positive clones were sequenced 
(MWG-Biotech - using oligos listed in Appendix II) to confirm the presence of insert and that 
the site-directed mutagenesis was successful. After confirmation by restriction mapping and 
DNA sequencing, a positive clone was stored at -70°C in the lab bacterial collection as GB 313 
(Appendix I).
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Figure 3.5 Restriction digestion analysis of the recombinant -pCR2.1® plasmid
Clones containing insert were analysed by restriction mapping. Samples of each digest were 
analysed on a 1.5% (w/v) agarose gel stained with ethidium bromide and viewed under UV 
illumination. The 1 kb DNA ladder is shown (M) and sizes are indicated in base-pairs.
Digestion of the c<7c/0-pCR2.1® plasmid: 1 Nde\-Bam\\\ 2 EcoRl.
The restriction enzymes used in each digest and the predicted fragment sizes are summarised 
for each clone in Table 3.5.
Enzyme(s) Number of Fragments Fragment sizes (bp)
N d e \ - B a m H \ 2 1 2300,39301 ........
EcoRl 2 1 2400,3830
Table 3.5 cdclO^-pCR2.
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3.3.4 Cloning the silently mutated cdclO^ gene into pET-14b
The plasmid GB 313, containing the cdclO^ fusion PCR product, was digested with Ndel and 
BamHl as was the pET-14b vector to generate cohesive ends for ligation. The vector was also 
treated with calf intestinal alkaline phosphatase, to remove the phosphate groups exposed by 
digestion and so prevent self-ligation (Methods 2.2.7 and 2.2.8). The products of the restriction 
digests were analysed on a 1.5 % (w/v) agarose gel and bands of the appropriate size excised 
and purified using the QIAquick® Gel Extraction Kit (Methods 2.2.4 and 2.2.6). 5 pi samples 
were analysed on a 1.5 % (w/v) agarose gel to determine the amount o f DNA retrieved and thus 
to empirically determine the vector:insert ratio to be used in the subsequent ligation reaction. 
Ligation reactions were carried out as described (Methods 2.2.9) and transformed into E. coli 
DH5a cells the following day (Methods 2.2.13).
Transformants were then plated on LB-agar plates supplemented with the antibiotic 
ampicillin (50 pg ml"') and incubated at 3TC  overnight. Colonies were selected and cultured 
overnight at 37°C in 5 ml LB media supplemented with ampicillin (50 pg ml"').
Plasmid DNA was purified from the overnight cultures as described in Methods section
2.2.5 and analysed by restriction enzyme mapping to confirm the presence of an insert o f the 
correct size (Figure 3.6). Potential positive clones were sequenced (MWG-Biotech - using 
oligos listed in Appendix II) to confirm the presence o f insert and that the gene had been cloned 
in-frame with the N-terminal His-tag. After confirmation by restriction mapping and DNA 
sequencing, a positive clone was stored at -70°C in the lab bacterial collection as GB 314 
(Appendix I). This clone was then used for the subsequent overexpression of heterologous 
protein.
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Figure 3.6 Restriction digestion analysis of the recombinant cdIc/O-pET-14b 
plasmid
Clones containing insert were analysed by restriction mapping. Samples o f each digest were 
analysed on a 1.5% (w/v) agarose gel stained with ethidium bromide and viewed under UV 
illumination. The 1 kb DNA ladder is shown (M) and sizes are indicated in base-pairs.
Digestion of the -pET-14b plasmid: 1 Nde\-Bam\\\ 2 Pst\.
The restriction enzymes used and the expected fragment sizes produced from each digest are 
summarised for each clone in Table 3.6.
Enzyme(s) Number of Fragments
N d e \ - B a m H \ 2
P s t l 2
Fragment sizes (bp)
I 2300, 4660 
I  2250, 4710~
Table 3.6 cdclOt-pEY-XAh
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3.4 Overexpression of the recombinant proteins
The previously isolated clones, containing insert for each component o f the DSCl complex, 
were then transformed into the E. coli expression strain BL21 (DE3) CodonPlus-RIL and small 
scale protein inductions performed to test for successful overexpression of each protein 
(Methods 2.4.1).
An aliquot o f a 5 ml overnight culture supplemented with either kanamycin (30pg/ml) or 
ampicillin (50 pg ml '), as appropriate, was subcultured into a fresh 50 ml culture and grown 
with shaking at 37°C until the optical density reached - 0 .5  at 600 nm. Expression of protein 
was then induced by the addition of IPTG to a final concentration of 1 mM. Inductions were 
initially carried out at 37°C and 1 ml samples were removed at the point of induction (0 h) and 
at hourly intervals thereafter for 3 h. Samples were then pelleted by centrifugation, resuspended 
in Laemmli sample buffer and analysed by 10% (w/v) SDS-polyacrylamide gel electrophoresis 
and Coomassie blue staining. The results of each recombinant protein induction aie shown in 
Figures 3.7-3.9. Immunoblot analysis was also carried out, using an antibody directed against 
the His-tag, to confirm that the N-terminus was intact (Figures 3.10-3.12).
All five proteins were successfully expressed at 37°C using this system, although His- 
Reslp and His-Rep2p were only observed by immunoblotting. The His-Reslp and His-Res2p 
proteins resolved with a M  ^approximately 75,000, while their predicted values are 74,604 and 
75,864, respectively. The His-Replp and His-Rep2p proteins resolved with a Mr approximately 
55,000 and 30,000, while their predicted values are 54,781 and 26,831, respectively. The His- 
CdclOp protein resolved with a Mr approximately 90,000 while the predicted value is 87,676. 
Once the proteins had been successfully expressed it was then necessary to test their solubility.
This was achieved by breaking open the bacterial cells, by either chemical or mechanical 
means, to release the protein into the extracellular environment. Insoluble proteins and cellular 
debris are typically removed by centrifugation with any soluble protein being retrieved from 
the supernatant. The discussion of the solubility of these recombinant proteins is delayed until 
Chapter 5 where it is discussed with relevance to the biological activity of the recombinant 
DSC 1 components in vitro.
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Figure 3.7 Overexpression of His-Reslp and His-Replp
His-Reslp and His-Replp were overexpressed at 37°C in BL21 (DE3) CodonPlus-RIL cells by 
induction with 1 mM IPTG. Samples (1 ml) were removed at the point o f induction (0 h) and at 
hourly intervals thereafter for 3 h. Samples were centrifuged and pellets resuspended in 
Laemmli sample buffer (10 pi / 0.1 absorbance unit) then denatured by boiling for 5 min in the 
presence of DTT (150 mM). Samples were then analysed on a 10 % SDS-polyacrylamide gel 
stained with Coomassie brilliant blue. Expression of His-Reslp was not detected by Coomassie 
blue staining under these conditions (the anticipated position of His-Reslp is indicated by the 
arrow). Expression of His-Replp was observed in lanes 1-3 (indicated by the arrow). Molecular 
weight markers are shown (MJ with sizes indicated in kDa.
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Figure 3.8 Overexpression of His-Res2p and His-CdcIOp
His-Res2p and His-CdclOp were overexpressed at 37°C in BL21 CodonPlus (DE3)-RIL cells 
by induction with I mM IPTG. Samples (I ml) were removed at the point of induction (0 h) 
and at hourly intervals thereafter for 3 h. Samples were centrifuged and pellets resuspended in 
Laemmli sample buffer (10 pi / 0.1 absorbance unit) then denatured by boiling for 5 min in the 
presence of DTT (150 mM). Samples were then analysed on a 10 % SDS-polyacrylamide gel 
stained with Coomassie brilliant blue. Expression of His-Res2p and His-CdclOp was observed 
in lanes 1 -3 in both cases (indicated by arrows). Molecular weight markers are shown (MJ with 
sizes indicated in kDa.
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Figure 3.9 Overexpression of His-Rep2p
His-Rep2p was overexpressed at 37°C in BL21 CodonPlus (DE3)-R1L cells by induction with 
1 mM IPTG. Samples (1 ml) were removed at the point of induction (0 h) and at hourly 
intervals thereafter for 3 h. Samples were centrifuged and pellets resuspended in Laemmli 
sample buffer (10 pi / 0.1 absorbance unit) then denatured by boiling for 5 min in the presence 
of DTT (150 mM). Samples were then analysed on a 10 % SDS-polyacrylamide gel stained 
with Coomassie brilliant blue. Expression of His-Rep2p was not detected by Coomassie blue 
staining under these conditions (the anticipated position of His-Rep2p is indicated by the 
arrow). Molecular weight markers are shown (MJ with sizes indicated in kDa.
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Figure 3.10 Immunoblot analysis of overexpressed His-Reslp and His-Res2p
A His-Reslp and B His-Res2p were overexpressed at 37°C in BL21 CodonPlus (DE3)-RIL 
cells by induction with 1 mM IPTG. Samples (1 ml) were removed at the point of induction (0 
h) and at hourly intervals thereafter for 3 h. Immunoblotting was carried out as described 
(Methods 2.4.7-2.4.11) and blots were probed with Anti-PentaHis-HRP conjugate antibody 
(Qiagen) at 1:2500. Expression of His-Reslp and His-Res2p was observed in lanes 1-3 in both 
cases. Molecular weight markers are shown (Mr) with sizes indicated in kDa.
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Figure 3.11 Immunoblot analysis of overexpressed His-Replp and His-Rep2p
A His-Replp and B His-Rep2p were overexpressed at 37°C in BL21 CodonPlus (DE3)-RIL 
cells by induction with 1 mM IPTG. Samples (1 ml) were removed at the point of induction (0 
h) and at hourly intervals thereafter for 3 h. Immunoblotting was carried out as described 
(Methods 2.4.7-2.4.11) and blots were probed with Anti-PentaHis-HRP conjugate antibody 
(Qiagen) at 1:2500. Expression of His-Replp and His-Rep2p was observed in lanes 1-3 in both 
cases. Molecular weight markers are shown (MJ with sizes indicated in kDa.
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Figure 3.12 Immunoblot analysis of overexpressed His-CdclOp
His-CdclOp was overexpressed at 37°C in BL21 CodonPlus (DE3)-RIL cells by induction with 
1 mM IPTG. Samples (1 ml) were removed at the point o f induction (0 h) and at hourly 
intervals thereafter for 3 h. Immunoblotting was carried out as described (Methods 2.4.7- 
2.4.11) and blots were probed with Anti-PentaHis-HRP conjugate antibody (Qiagen) at 1:2500. 
Expression of His-CdclOp was observed in lanes 1-3 as indicated by the arrow (basal 
expression was observed in lane 0 h - see text for discussion). Molecular weight markers are 
shown (Mr) with sizes indicated in kDa.
78
3.5 Discussion
In this chapter the cloning strategy has been described which allowed the successful and 
reproducible overexpression of the individual components of the fission yeast DSCl complex 
as analysed by SDS-PAGE, followed by Coomassie blue staining and immunoblotting.
High-level expression of the Res2p, Rep Ip and CdclOp components of DSCl as His- 
tagged fusion proteins was achieved as visualised by SDS-PAGE and Coomassie blue staining 
(Figures 3.7-3.8). Upon immunoblot analysis of His-CdclOp some basal expression was seen at 
0 h (Figure 3.12). High-level basal expression can often result in plasmid toxicity causing 
prevention of growth and eventually leading to plasmid loss. However, the low levels of basal 
expression seen with His-CdclOp had no such adverse effects. The overexpression of the His- 
R eslp and His-Rep2p components was achieved at lower levels, such that they were detectable 
only by immunoblotting (Figures 3.7, 3.10 and 3.9, 3.11, respectively). Attempts to optimise 
the expression of all the recombinant proteins made use of alternative E. coli host strains, each 
with subtle molecular differences. Expression of each recombinant protein was tested in E. coli 
BL21 (DE3) pLysS cells. These cells contain a plasmid that provides a source of T7 lysozyme, 
which binds to T7 RNA polymerase, serving to minimise basal transcription. Furthermore, with 
specific regard to overexpression of His-Reslp and His-Rep2p, the BL21Star™ (DE3) strain 
was also tested. The BL21Star™ (DE3) strain carries a mutated RNase enzyme that lacks the 
ability to degrade mRNA. Consequently, mRNAs expressed in this strain are typically more 
stable, resulting in increased protein expression. However, despite the use of these and other 
host stiains, optimal conditions for each recombinant protein were achieved using the BL21 
(DE3) CodonPlus-RIL cells. This observation was attributed to the fact that BL21 (DE3) 
CodonPlus-RIL cells contain extra copies of several IRNA species that are ‘rare’ to E. coli. 
Most amino acids are encoded by more than one codon and each organism has a bias for 
particular codons for certain amino acids. Therefore, in each cell of that organism, the tRNA 
population will reflect the codon bias in the mRNA. As fission yeast proteins were being 
expressed in E. coli, differences in codon usage between the two organisms could result in 
aberrant translation. The tRNAs that are required and abundant in fission yeast might be absent 
or in short supply in E. coli. This can lead to inefficient translation and incoiporation of the 
wrong amino acid as a result o f ‘rare’ tRNA depletion in E. coli. Use of an E. coli strain which 
has extra copies of these ‘rare’ tRNAs engineered on a plasmid can often be used to overcome 
such problems.
The expression of soluble recombinant proteins suggests that they are capable of folding 
into their native or near-native state in E. coli. Production of soluble protein in this case also 
indicates that the presence of the N-terminal His-tag does not affect folding or expression in 
this host.
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The solubility of the recombinant proteins produced in this chapter is discussed in 
Chapter 5 where their activities are analysed by in vitro assay. The following Chapter 4 
discusses the use of fission yeast, the organism from which these proteins are derived, as a host 
to assay the effects of the N-terminal His-tag on their biological activity in vivo.
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Chapter 4
Biological activity assays of recombinant DSCl 
proteins in vivo
4.1 Introduction
Chapter 3 described the cloning o f the fission yeast genes of DSCl components cdclO^, r e s t ,  
res2^, r e p t  and rep2^ into the bacterial expression vector pET-28c (pET-14b for cdclO^), in- 
frame with an N-terminal His-tag. Overexpression of each protein in E. coli has the potential to 
produce sufficient amounts to allow detailed stiuctural analyses, with the addition o f the His- 
tag to facilitate purification by means o f affinity chromatography.
The function of a protein is dictated by its 3-D architecture. Even a single amino acid 
change in the native sequence can dramatically alter protein activity, exemplified in this context 
by the sc tl-b l mutant of r e s t ,  and various point mutants of cdclO^ (Caligiuri and Beach, 1993; 
Reymond et al., 1992). Therefore, as the N-terminal His-tag is naturally absent from these 
proteins, its presence may affect their function. In this chapter therefore, a study was 
undertaken to examine possible effects o f the N-terminal His-tag on the biological activity of 
these proteins when produced in vivo.
Current models predict that the fission yeast mitotic DSCl complex is composed of the 
SpCdclOp, SpReslp, SpRes2p and SpRep2p proteins (SpRep2p is replaced by SpReplp in the 
meiotic cycle). SpCdclOp was the first component of DSCl to be identified (Lowndes et al., 
1992). The identification of the cdclO^ gene product as a physical component of the DSCl 
complex, coupled to the availability of conditional lethal cdclO mutants (Reymond et al., 
1992), allowed the identification o f further DSCl components, through yeast genetic 
suppressor analysis.
SpReslp and SpRes2p were first identified by their genetic interaction with c d c l l t . 
Both proteins were subsequently shown to interact with each other. The r e s t  gene was 
identified as a high copy suppressor o f the cdclO-129 mutant and is required for passage of 
START (Tanaka et al., 1992). In addition, the r e s t  gene could almost completely suppress a 
AcdclO deletion mutant. In contrast, the cdclO^ gene could not rescue cells deleted for r e s t .  
Furthermore, the putative SpReslp protein showed significant homology to both SpCdclOp and 
ScSwi6p and in particular to the DNA binding domain of ScSwi4p. Moreover, the r e s t  gene 
was cloned independently as an extragenic suppressor of the cdclO-129 mutant, and shown to 
be part of the DSCl band-shift activity (Caligiuri and Beach, 1993).
Cells deleted for r e s t  can grow, albeit poorly, at 30°C but show severe heat and cold 
sensitivities, resulting in a lethal phenotype at 36°C and 2VC  (Tanaka et al., 1992; Caligiuri 
and Beach, 1993). The observation that cells deleted for the r e s t  gene could proceed through 
the cell cycle at 30°C prompted the search for a gene redundant in function with r e s t  and 
ultimately to the identification of SpRes2p.
Cloned by its ability to rescue the heat and cold sensitivities of the Aresl mutant, the 
res2^ gene could also effectively suppress the cdclO-129 mutant at restrictive temperature, but
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unlike r e s t ,  was unable to rescue a AcdclO strain. In conti’ast to r e s t ,  deletion of re s t' 
showed no apparent defects in mitotic growth, although defects in the meiotic cycle indicated 
res2^ may have a major role (Miyamoto et al., 1994). The res2^ gene was also cloned 
independently in a genetic screen designed to identify SpCdclOp binding proteins, and was 
subsequently shown to bind to MCB elements in vitro, m association with SpCdclOp (Zhu et 
a l , 1994).
The r e p t  gene was isolated as an extragenic suppressor of the cdcl 0-129 mutant at 
restrictive temperatme but, like res2^, was unable to rescue a AcdclO mutant. In addition, r e p t  
could effectively suppress the heat and cold sensitivities of the Aresl null mutant. Similar to 
cells deleted for res2^, the Arepl mutant had no apparent mitotic defects, but instead was 
defective in the meiotic cycle (Sugiyama et a l, 1994).
The fact that the r e p t  gene was not expressed in mitosis but could rescue the cdclO-129 
and Aresl mutants, led to the search for a r e p t  like gene acting in mitosis. Consequently, the 
rep2'^ gene was cloned by its ability to rescue the cdclO-129 mutant at restrictive temperature. 
In addition, rep2^ could suppress the heat and cold sensitivities of the Aresl mutant, whereas 
cells deleted for rep2^ were viable at 30“C but showed cold sensitivity at 18°C (Nakashima et 
a l, 1995).
Thus, a common property o f these genes (with the exception o f cdclO^) is their ability to 
rescue the heat and cold sensitivities of a Aresl mutant at 36°C and 2TC , and these properties 
were exploited to assay the biological activity of the recombinant His-tagged proteins. If  the 
His-tag does not affect their function, the recombinant proteins should behave similarly to their 
wild type counterparts in rescuing a Aresl mutant.
A further characteristic of cells deleted for either r e s t  or res2^ is loss of DSCl as 
detected in vitro by band-shift analysis (Zhu et a l, 1997; Ayte et a l ,  1997). The loss o f this 
band-shift activity in strains deleted for either r e s t  or res2'^ can be reconstituted by 
introduction of either the r e s t  or res2~^  gene on a plasmid, respectively. However, expression 
of the r e s t  or res2^ gene in strains deleted for either res2^ or r e s t ,  respectively, does not 
result in reappearance o f this band-shift activity (Zhu et a l, 1997).
These observations, together with the demonstration that the DSCl complex could be 
super-shifted in band-shift analysis using antibodies specific to either SpCdclOp, SpReslp or 
SpRes2p, was the first evidence to suggest that a single complex containing all three proteins 
existed (Zhu et a l ,  1997; Ayte et a l , 1997). These obsei"vations revised initial proposals that 
suggested that, similar to the role of ScSwibp m the SBF and MBF complexes of budding 
yeast, the SpCdclOp protein o f fission yeast was a common subunit of two distinct DNA 
binding complexes. Earlier models proposed that a SpRes 1 p-SpCdc 1 Op DSCl complex acted 
primarily in the mitotic cycle, whilst a SpRes2p-SpCdcl0p complex behaved similarly in the
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meiotic cycle (Miyamoto et al., 1994; Zhu et al., 1994). The existence of a single fission yeast 
DSCl complex was confirmed by the demonstration that a SpCdcl0p-SpReslp-SpRes2p 
heteromeric complex existed throughout the mitotic cell cycle (Whitehall et al., 1999).
In addition to the genetic suppressor activities mentioned above, the abilities of both 
His-Reslp and His-Res2p to participate in the DSCl complex were assessed. In the case of 
His-Reslp and His-Res2p, the ability of these proteins to participate in a DSCl complex 
produced in vivo can be tested. The SpReplp protein, however, is not expressed during the 
mitotic cycle and so does not form a part of the DSCl complex under these conditions 
(although it is postulated to form part of DSCl in the meiotic cycle; Sugiyama et al., 1994; 
Cunliffe et al., 2004) thus precluding the use of this assay for His-Replp. The SpRep2p protein 
binds to SpRes2p in vitro and both SpReslp and SpRes2p in vivo (Nakashima et al., 1995; 
Sturm and Okayama, 1996). Nevertheless, the DSCl band-shift activity is not lost in a Arepl 
mutant background suggesting that the DSCl complex can still form in the absence of SpRep2p 
(Baum et a l, 1997).
To summarise, the ectopic expression of H is-rest, His-res2^, H is-rep t  or His-rep2^ in 
a Aresl mutant o f fission yeast, allows an in vivo test for gene function via rescue o f a 
conditional-lethal mutant phenotype at restrictive temperature. With respect to H is-re s t  and 
His-res2^, expression o f these cDNAs in both Aresl and Aresl mutants, respectively, should 
allow reconstitution o f the DSCl band-shift activity. These methods were exploited to assay the 
biological activities of recombinant DSCl components.
The aim of this chapter was to clone the recombinant components of the DSCl complex 
into the fission yeast expression vector pREP and using these constructs, assay the effect of the 
His-tag on the biological activities of these proteins in vivo.
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4.2 The fission yeast expression vector pREP
The fission yeast thiamine-repressible expression vectors pREPl and pREP3X were used to 
clone the recombinant DSCl components for the in vivo experiments (Appendix I- GB27 and 
GB28).
In pREP, genes are cloned downstieam of the thiamine repressible n m t t  {not made in 
diiamine) promoter (Maundrell, 1992). As the name suggests, transcription of genes under the 
control of this promoter is regulated by the presence of thiamine. In the absence o f thiamine 
transcription is induced, whereas repression is achieved by addition of 5 pg p f ' thiamine to the 
growth medium. Nevertheless, despite addition of thiamine, transcription from the n m t t  
promoter is often not completely repressed. The ability to switch off transcription depends on 
the cloned gene. For example, many genes under n m t t  control retain their suppressor activity 
despite the presence o f thiamine whereas, at this same dosage, transcription of other genes may 
be switched off (Maundrell, 1992; Forsburg, 1993). Thus, the effect o f expressing a gene under 
n m t t  control, in either the presence or absence o f thiamine, must be determined empirically.
The availability of suitable restriction sites within the multiple cloning region of the 
pREP3X vector allowed cloning o f the H is-rest, H is-rep t  and H is-rept' cDNAs, following 
PCR amplification. In contrast, the His-res2^ cDNA was cloned into the pREPl vector in a 
modified directional cloning procedure, reflecting the suitability of restriction sites present 
within the insert and multiple cloning region o f the vector. Both pREPl and pREP3X are 
derived from the parent pREP vector series and differ in only two restriction sites within their 
multiple cloning regions (pREP3X contains a Xhol site in addition to a Ball site in place of 
Ndel in pREPl).
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4.3 Cloning recombinant His-resl^, His~res2^, His-repl^ and His-rep2^ 
components of DSCl
The recombinant plasmids, containing the H is-rest, His-res2^, H is-rep t  and H is-rept' 
cDNAs, were cloned (Chapter 3) and are listed in Appendix I - GB 177 (H is-rep t), GB 191 
(H is-rep2 \ GB 178 (His-res2^) and GB 201 (H is-rest). These plasmids were used as 
templates in PCR reactions, using primers GO 458 and GO 459, designed to add 5’ Sali and 3’ 
BarnHi restriction sites (upstream of the His-tag and immediately following the stop codon), 
respectively. Addition of these resti'iction sites was necessary to facilitate cloning into the 
pREPSX vector. In contrast, His-res2* cloned into pREPI, due to the presence o f a Sali 
restriction site within the open reading frame of the resT^ gene (Section 4.3.3).
4.3.1 Ciomn^,His-rest^His-rept and His-rep2^ cDNAs into pREP3X
Figure 4.1 provides a schematic representation of the PCR reactions and the primers used. PCR 
reactions were perfoiTned using the VentR DNA polymerase. Conditions for PCR were 
essentially as described with the annealing temperature at 50°C (Methods 2.2.3). PCR products 
of the predicted size were gel purified (Methods 2.2.6) and analysed by electi'ophoresis on a 1.5 
% (w/v) agarose gel (Figure 4.2).
4.3.2 Ligation, transformation and identification of clones
5 pi o f each purified PCR product was digested with Sali and BamHl, as was the pREPSX 
vector, to generate compatible cohesive ends for ligation. The vector was also treated with calf 
intestinal alkaline phosphatase (Methods 2.2.7 and 2.2.8). The products of the restriction 
digestions were analysed on a 1.5 % (w/v) agarose gel and bands of the appropriate size 
excised and purified using the QIAquick® Gel Extraction Kit (Methods 2.2.4 and 2.2.6). 5 pi 
samples were analysed on a 1.5 % (w/v) agarose gel to assay the amount of DNA retrieved to 
determine the vector:insert ratio to be used in the ligation. Ligation reactions were carried out 
as described (Methods 2.2.9) and transformed into E. coli DH5a cells the following day 
(Methods 2,2.13).
Transformants were then plated on LB-agar plates supplemented with the antibiotic 
ampicillin (50 pg ml^) and incubated at 37°C overnight. Colonies were selected and cultured 
overnight at 37°C in 5 ml LB media supplemented with ampicillin (50 pg ml ').
Plasmid DNA was purified from the overnight cultures as described in Methods section
2.2.5 and analysed by restriction enzyme mapping to confirm the presence of an insert o f the 
predicted size (Figures 4.3 - 4.5). Potential positive clones were sequenced (MWG-Biotech -  
using oligos listed in Appendix II) to confirm the presence of insert and fidelity o f the PCR 
reactions. After confirmation by restriction mapping and DNA sequencing, a positive clone for
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each gene was stored at -70“C in the lab bacterial collection: GB 202 (His-repV), GB 343 {His- 
re p l')  and GB 203 (H is-rest)  - Appendix I.
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B IATG
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I
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IG TCG ACATC A G tT G T A C
BamHl
^""^ G A T C CCCTAGG
Figure 4.1 Schematic representation of the PCR reactions for pREP3X cloning
The white arrow represents the ORFs of the r e s t ,  r e p t  and r e p t  cDNAs cloned into pET28c 
at Ndel-BamH\ sites. The His-tag is boxed in green, the black lines represent pET vector 
flanking sequence and arrows indicate the positions of restriction sites.
A Restriction map representing the Ndel-BamHl fragment of each cDNA cloned into the pET- 
28c vector (Chapter 3). The ATG supplied by the vector is indicated upstream of the His-tag.
B The positions o f the primers used in the PCR reactions are indicated in relation to the 
corresponding sequence o f the pET-28c vector. GO 458 adds a Sal\ site (GTCGAC) upstream 
of the ATG and His-tag. GO 459 includes the BamH\ (GGATCC) site immediately 
downstream of the stop codon.
C A schematic representation of the DNA fragments produced following PCR.
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Figure 4.2 PCR amplification of H is-rep t, His-rep2* and H is-res t
PCR products were analysed on a 1.5% (w/v) agarose gel stained with ethidium bromide and 
viewed under UV illumination. The 1 kb DNA ladder is shown (M) and sizes are indicated in 
base-pairs. PCR products o f the predicted size, from reactions using primer pairs 
G0458/G0459 are shown in lanes 1 H is-rep t 2 His-rep2' and 3 H is-re s t. The His-repT 
DNA sequence resolves at the 1636 bp marker (the r e p t  cDNA is 1419 bp long), His-rep2' 
resolves between the 517 bp and 1018 bp markers (the repi' cDNA is 660 bp long) and the 
H is-rest DNA sequence resolves between the 1636 bp and 2036 bp markers (the r e s t  cDNA 
is 1914 bp long).
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Figure 4.3 Restriction digestion analysis of the recombinant H i s - r e s t - p R E P 3 X  plasmid
Clones containing insert were analysed by restriction mapping. Samples of each digest were 
analysed on a 1.5% (w/v) agarose gel stained with ethidium bromide and viewed under UV 
illumination. The 1 kb DNA ladder is shown (M) and sizes are indicated in base-pairs.
Digestion of the recombinant ///5-re57 ’-pREP3X plasmid: 1 Nde\-BamH\ 2 Sal\-BamH\
3 Hindlll.
The restriction enzymes used in each digest and the predicted fragment sizes are summarised in 
Table 4.1. Fragments marked (*) appear as a result of partial digest.
1 Enzyme(s) Number of Fragments Fragment sizes (bp) I
1 N d e l - B a m H l 4 7600, 700*, 
1900, 800
1 S a B - B a m H l 2 8400,1900
1 H i n d l l l
1 ^ 7600, 700*,2200, 500........  ...
Table 4.1 ///5-mv7^-pREP3X
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Figure 4.4 Restriction digestion analysis of the recombinant H i s - r e p t - p R E F 3 \  plasmid
Clones containing insert were analysed by restriction mapping. Samples of each digest were 
analysed on a 1.5% (w/v) agarose gel stained with ethidium bromide and viewed under UV 
illumination. The 1 kb DNA ladder is shown (M) and sizes are indicated in base-pairs.
Digestion of the recombinant His-rep t-pR EP3X  plasmid: 1 Nde\-BamH\ 2 Sal\-BamH\
3 HindlW.
The restriction enzymes used in each digest and the predicted fragment sizes are summarised in 
Table 4.2. Fragments marked (*) appear as a result of partial digest.
Enzyme(s) Number of Frf^ments Fragment sizes (bp)
\ N d e l - B a m H l 4 1 7600, 200*, 
1400, 800
S a l l - B a m H l 2 I 8400,1400
I H i n d l l l 4 1 7500, 300*, 
1200,1100
Table 4.2 H is-rep t -pRE?3X
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Figure 4.5 Restriction digestion analysis of the recombinant H is - r e p 2 ^ - p iR E 9 y X  plasmid 
Clones containing insert were analysed by restriction mapping. Samples of each digest were 
analysed on a 1.5% (w/v) agarose gel stained with ethidium bromide and viewed under UV 
illumination. The 1 kb DNA ladder is shown (M) and sizes are indicated in base-pairs.
Digestion of the recombinant His-rep2^-pKEP3X plasmid: 1 Sal\-Bam\\\.
The restriction enzymes used in each digest and the predicted fragment sizes are summarised in 
Table 4.3
1 Enzyme(s) Number of Fragments 1 Fragment sizes (bp) :
1 S a l \ - B a m H \ 2 ! 8400, 700.i .
Table 4.3 His-rep2" -pREP3X
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4.3.3 Cloning recombinant cDNA into pREPl
As mentioned, the pREPSX vector was unsuitable for cloning the His-res2^ cDNA, owing to a 
Sail restriction site within the open reading fi'ame of the res2"' gene. Alternatively, the His- 
res2'*' cDNA was cloned into the pREPl vector. The pREPl and pREP3X vectors are 
essentially identical differing only in the restriction sites available within their multiple cloning 
regions. The plasmid containing the His-res2 ' cDNA (GB 178) was digested with Xbal and 
BamHl (which cut upstream of the His-tag and immediately following the stop codon, 
respectively). Importantly, iheXbal enzyme cleaves upstream of an ATG which is 5’ to, and in­
frame with, the His-tag. The inclusion of an ATG is necessaiy due to the destruction of the 
pREPl vector supplied ATG, within the Ndel site, in the subsequent cloning procedure. The 
pREPl vector was digested with Ndel and BamHd and treated with calf intestinal alkaline 
phosphatase, in preparation for ligation. The products o f the restriction digestions were 
analysed on a 1.5% (w/v) agarose gel and bands o f the appropriate size excised and purified 
using the QIAquick® Gel Extraction Kit (Methods 2.2.4 and 2.2.6). 5 pi samples were analysed 
on a 1.5% (w/v) agarose gel, again to allow determination o f the vector: insert ratio to be used 
in the subsequent ligation. The ligation reaction was carried out essentially as described 
(Methods 2.2.9), although in two steps owing to the incompatible Xbal and Ndel restriction 
ends of the insert and vector, respectively. An initial ligation reaction was carried out for 30 
min, to allow the compatible BamHl ends to ligate. 0.5 pi of Mung bean nuclease (an enzyme 
which degrades single stranded nucleotides) was then added to remove the Xbal and Ndel 
overhangs, creating blunt ends. Finally, 0.5 pi of T4 DNA ligase was added to ligate the blunt 
ends (Figure 4.6). Ligation reactions were then transformed into E, coli DH5a cells the 
following day (Methods 2.2.13).
Transformants were plated on LB-agar plates supplemented with the antibiotic 
ampicillin (50 pg ml ') and incubated at 37°C overnight. Colonies were selected and cultured 
overnight at 37°C in 5 ml LB media supplemented with ampicillin (50 pg ml"').
As before; following plasmid DNA purification, restriction enzyme mapping (Figure 
4.7) and DNA sequencing (MWG-Biotech - using oligos listed in Appendix II); a positive 
clone was stored at -70“C in the lab bacterial collection: GB 195 (res2 ^ ) - Appendix I.
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Figure 4.6 Cloning the His-res2^ cDNA into pREPl using Mung Bean nuclease
The white arrow represents the ORF of the res2* cDNA cloned into pET-28c at Nde\-BamH\ 
(Chapters). The His-tag is boxed in green, the black lines represent pET vector flanking 
sequence and arrows indicate the positions o f restriction sites. The red lines represent pREPI 
vector sequence.
A The plasmid containing the His-res2 cDNA (GB 178) was digested with Xbal and BamHl to 
excise the His-res2 cDNA. The Xbal enzyme cleaves upstream of the pET vector supplied 
ATG, which is in-frame with the His-tag.
B The pREPI vector was digested with Ndel and BamHl. An initial ligation reaction was then 
carried out for 30 min to allow the compatible BamHl ends between the insert and vector to 
ligate.
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TCTAGAC GTATAC
Ndel
ATGTAG
BamHl
GATCCCCTAGG
Mung Bean 
nuclease
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DNA ligase
Figure 4.6 Cloning the H is - r e s 2 ^  cDNA into pREPl using Mung Bean nuclease
C Mung bean nuclease was then added to remove the Xbal and Ndel overhangs of the insert 
and vector, respectively. Degradation of the single stranded nucleotides creates blunt ends and 
destroys the pREPl supplied ATG.
D Finally, the blunt ends are ligated by DNA ligase, placing the His-res2 cDNA under nmtl 
control.
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Figure 4.7 Restriction digestion analysis of the recombinant -pREP 1 plasmid
Clones containing insert were analysed by restriction mapping. Samples of each digest were 
analysed on a 1.5% (w/v) agarose gel stained with ethidium bromide and viewed under UV 
illumination. The 1 kb DNA ladder is shown (M) and sizes are indicated in base-pairs.
Digestion of the recombinant His-res2^-pKE?\ plasmid: 1 Nde\-Bam\\\ 2  Nco\.
The restriction enzymes used in each digest and the predicted fragment sizes are summarised in 
Table 4.4
E^zyme(s) Number of Fragments Fragment sizes (bp) {
N d e l - B a m H l 2 7600,1900 I
N c o l 2 9100,1200 11
Table 4.4 -pREP 1
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4,4 Biological activity assays -  rescuing Nresl lethal phenotype
The lethal phenotype of the dj'esl mutant, at 2 r c ,  can be rescued by expression o f the full- 
length wild type resl^, res2^, repl^ or rep2^ cDNAs (Tanaka et al., 1992; Miyamoto et al., 
1994; Sugiyama et al., 1995; Nakashima et al., 1995). Accordingly, expression of the 
corresponding recombinant cDNAs, each having an N-terminal His-tag, would be expected to 
behave similarly, if the tag does not affect the function of the proteins. Therefore, following 
successful cloning of the recombinant His-resX, His~res2^, His-repP  and His-rep2^ cDNAs 
into the pREP vector each construct was subsequently transformed into the fission yeast àresl 
strain (GG 146 - Appendix I and Methods 2.6.3) and stored at -70°C in the lab fission yeast 
collection, àresl cells were also transformed with the empty pREP vector to act as a negative 
control (GB 28 - Appendix I),
To assess the ability of the His-resX, His-res2'^^ His-repN  and His-rep2"^ cDNAs to 
rescue the cold sensitivity o f a Aresl mutant at 21°C, cells were streaked from -70°C glycerol 
stocks onto EMM plates containing adenine (for nutritional selection of the plasmid), in either 
the presence {nmtl promoter ‘o f f)  or absence {nmtl promoter ‘on’) of thiamine at a 
concentration of 5 pg pf^ (Methods 2.6.4). Rescue of the lethal phenotype of the Aresl mutant 
at 2TC  was compared between strains transformed with //A-re.s7^-pREP3X, //A-re52’^ -pREPl, 
T/w-rqpT^-pREPSX or 77/5-re/?2 ^-pREP3 Xand the empty pREP vector. In all four cases the 
Aresl mutant was viable at the restrictive temperature, whereas cells containing the empty 
vector were not, indicating the recombinant cDNAs could function in a similar fashion to their 
wild type counterparts (Figures 4.8 - 4.11).
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Figure 4.8 Expression of H is - r e s l ^  rescues the growth defect of the A r e s l  mutant at 21°C
The Aresl strain (GG 146) was transformed with pREP3X (GG 796) or //w-my7^-pREP3X 
(GG 790). Transformants were allowed to grow at 30°C on EMM + thiamine (5 pg p f '), then 
streaked out onto the same medium and incubated at 21°C for 6 -8  days.
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Figure 4.9 Expression of H is - r e s 2 ^  rescues the growth defect of the A r e s l  mutant at 21°C
The Aresl strain (GG 146) was transformed with pREP3X (GG 796) or His-res2^-pREPl (GG 
802). Transformants were allowed to grow at 30°C on EMM + thiamine (5 pg p f '), then 
streaked out onto the same medium and incubated at 21°C for 6 -8  days.
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Figure 4.10 Expression of H is - r e p  1* rescues the growth defect of the A r e s l  mutant at 21°C
The Aresl strain (GG 146) was transformed with pREP3X (GG 796) or His-repV-pREP'iX 
(GG 811). Transformants were allowed to grow at 30°C on EMM + thiamine (5 pg p f '), then 
streaked out onto the same medium and incubated at 2 TC for 6 -8  days.
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Figure 4.11 Expression of H is - r e p ï"  rescues the growth defect of the Ares/ mutant at 21 °C
The Ares/ strain (GG 146) was transformed with pREP3X (GG 796) or ///s-re/?2"-pREP3X 
(GG 817). Transformants were allowed to grow at 30°C on EMM + thiamine (5 pg p f ’) then 
streaked out onto the same medium and incubated at 21°C for 6 -8  days.
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4.5 Biological activity assays -  rescuing DSCl binding activity
The expression o f either the wild type resl^ or res2^ cDNAs in plasmids has the ability to 
restore in vitro DSCl DNA-binding activity to either l^resl or à.res2 mutants, respectively, that 
is otherwise absent in these strains (Zhu et ah, 1997). Expression of the recombinant His~resP 
or His-res2^ cDNAs in such deletion strains would be expected to give similar results, if the 
tags do not affect their function. Therefore, this assay was used as another way to test the 
activities of the recombinant His-Reslp and His-Res2p proteins.
The electrophoretic mobility-shift assay (EMSA), often referred to as the gel retardation 
or band-shift assay, allows detection of sequence specific DNA/protein interactions in vitro. 
This technique is based on the effect of bound protein(s) on the electrophoretic mobility o f a 
radio-labelled DNA fragment. DNA molecules are naturally negatively charged and therefore 
migrate toward the positive electrode in an electric field. Furthermore, in an acrylamide gel, 
DNA molecules aie separated according to their size, small molecules having the highest 
mobility and vice versa. In addition, protein bound to a particular DNA fragment will further 
retard its mobility. In this assay a radio-labelled DNA fragment (or ‘probe’), of specific 
sequence, is incubated with a protein extract from the cells under investigation. Any protein(s) 
capable of binding to the DNA fragment will form a complex and the DNA/protein mix is then 
electrophoresed on a non-denaturing acrylamide gel. The radio-labelled DNA fragment is then 
visualised by autoradiography and unbound DNA, which runs proportional to its size, appears 
at the bottom of the gel. However, the mobility of any DNA bound by protein is retarded, 
causing a visible ‘band-shift’, relative to the unbound probe. Furthermore, following detection 
o f such a band-shift activity, the specificity of interaction between the DNA fragment and the 
protein(s) can be analysed. For example, in a ‘self-competition’ experiment, addition o f an 
identical (but non radio-labelled) DNA fragment will compete with the radio-labelled DNA for 
protein binding, if  binding is specific to that sequence. Addition o f increasing amounts of such 
‘eold-competitor’ DNA, results in loss of the radioactive signal by titration, and so the band- 
shift is diminished and is no longer visible, following autoradiography.
A more stringent test o f binding specificity is possible using a mutated version of the 
DNA fragment. Indeed, alteration o f as few as one or two base pairs, can result in loss of 
binding, such is the specificity often observed by sequence specific DNA-binding proteins. 
Therefore, such tests of specificity allow distinction between complexes formed by specific and 
non-specific DNA-binding proteins.
The EMSA assay was used to originally identify the DSCl complex in fission yeast 
(Lowndes et al., 1992). In these experiments the DNA fragments used as probes were derived 
from sections o f the cdc22^ promoter, that contain MCB sequences in two clusters, with one 
cluster named MCBl and the other MCB2 (Maqbool et al, 2003). In the following assays a
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DNA probe containing the MCBl cluster was used, and a mutated M CBlm probe was used to 
test specificity. Using protein extracted from h resl cells, transformed with //A-re5 7 ^-pREP3 X, 
His-res2^-^WEP\ or pREP3X, and /S.res2 cells, transformed with H is-rest-pK ^V ^X , His- 
rc52^-pREPl or pREP3X (Appendix I) the ability of His-Reslp or His-Res2p to reconstitute the 
DSCl band-shift activity was assayed.
For protein exhaction, 5 ml cultures were grown to mid-log phase at 30°C, with the
appropriate amino acids, in the presence (for nmtl promoter ‘o f f  experiments) or absence (for
nm tl promoter ‘on’ experiments) o f thiamine (5 pg p f'). Cultuies (200 ml), in the presence or 
absence of thiamine (5 pg p f ') , were then inoculated with the 5 ml pre-cultures and grown for 
16 h. Protein was then extracted for use in EMSA experiments as detailed (Methods 2.6.5). 
Figures 4.12-4.14 show the results of these EMSA assays.
Upon expression o f His-Res2p in àres2 cells a ‘DSCl-like’ band-shift activity, 
comparable to the DSCl complex formed in wild-type extracts, was present. Importantly, this 
band-shift was not observed in àres2 cells alone or lsres2 cells containing empty vector. 
Furthermore, this complex bound specifically to the MCBl element, as judged by self­
competitor analysis and an inability to bind the mutated M CBlm sequence (Figures 4.12-4.13). 
However, this complex did not super-shift using an antibody directed against the His-tag (data 
not shown). In contrast to His-Res2p in Arc«2 cells, a DSCl-like band-shift activity was not 
detected when His-Reslp was expressed in Isresl cells, either in the absence or presence of 
thiamine (Figure 4.14).
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Figure 4.12 ‘DSCl-like’ complex is detected in tsresl cells expressing His-Res2p
EMSA analysis o f protein extracts prepared from wild-type cells (GG 217), t^es2  cells (GG 
156), tsres2 cells transformed with pREP3X (GG 801) or Ares2 cells transformed with His- 
re.$2-pREPl (GG 808). Protein extracts were prepared and incubated with a radio-labelled 
probe derived from the cdc22' promoter (MCBl). To confirm the specificity of the retarded 
complex an excess of unlabelled MCBl probe was added to lane 9, GG 808. The upper arrow 
indicates the position of the putative DSCl complex and the lower arrow denotes unbound 
radio-labelled probe.
1 =  free M C B  1 probe
2 =  w ild -typ e  protein extract + M C B  I probe
3 =  w ild -typ e  protein extract +  M C B l probe
4  =  tSres2 protein extract + M C B  1 probe
5 =  Ares2 : pR E P3X  protein extract + M C B l probe
6 =  àres2  : pR E P 3X  protein extract + M C B  1 probe
7 =  tSres2 : His-res2^-pRE?\ protein extract +  M C B l probe
8 =  /Sres2 : His-res2^-pRE?\ protein extract + M C B l probe
9  =  A res2 : His-res2^-pKEP\ protein extract +  e x c e ss  un labelled  M C B l probe
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Figure 4.13 ‘DSCl-Uke’ complex is detected in tsresl cells expressing His-Res2p
EMSA analysis of protein extracts prepared from wild-type cells (GG 217), tsres2 cells (GG 
156), tvres2 cells transformed with pREP3X (GG 801) or lSres2 cells transformed with His- 
-pREPl (GG 808) grown in either the presence or absence of thiamine. Protein extracts 
were prepared and incubated with a radio-labelled probe derived from the cdc22^ promoter 
(MCBl) or with a probe containing a mutated MCBl (MCBlm) element to check the 
specificity of the retarded complex. The upper arrow indicates the position o f the DSCl 
complex and the lower arrow denotes unbound radio-labelled probe.
1 =  free M C B l probe
2 =  w ild -type protein extract + M C B l probe
3 =  w ild -typ e  protein extract + M C B lm  probe
4 =  tsres2 protein extract + M C B l probe
5 =  àres2 : pR E P3X  protein extract + M C B l probe
6 =  A/-C52 : His-res2^-pKEP\ protein extract (+  th iam ine) + M C B l probe
7 =  àres2  : His-res2^-pKEP\ protein extract + M C B l probe
8 =  tSres2 protein extract + M C B lm  probe
9  -  àres2 : pR E P 3X  protein extract protein extract + M C B lm  probe
\0  = /Sres2 . His-res2^-pKE?\ protein extract ( + thiam ine) + M C B lm  probe  
1 1 =  Ares2 : His-res2^-pKE?\ protein extract + M C B lm  probe
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Figure 4.14 ‘DSCl-like’ complex is not detected in dj-esi cells expressing His-Reslp
EMSA analysis of protein extracts prepared from wild-type cells (GG 217), ISresl cells (GG 
146), Arcs/ cells transformed with pREP3X (GG 796) or Arcs/ cells transformed with His- 
rcs/ -pREP3X (GG 790) or /7/s-rcs2-pREP 1 (GG 802) grown in the presence or absence of 
thiamine. Protein extracts were prepared and incubated with a radio-labelled probe derived
from the cdc22^ promoter (MCBl). Protein extracts prepared from Arcs2 cells (GG 156) and
Arcs2 cells transformed with 7//s-rcs2-pREPl (GG 808) grown in the presence of thiamine 
were incubated with the same probe and with an excess of unlabelled MCBl probe for 
comparison. The upper arrow indicates the position of the DSCl complex and the lower arrow 
denotes unbound radio-labelled probe.
1 = free MCBl probe
2 = wild-type protein extract + MCBl probe
3 = Arcs/ protein extract + MCBlm probe
4 = Arcs/ : pREP3X protein extract + MCBl probe
5 = Arcs/ : ///s-rcs/'-pREP3X protein extract (+ thiamine) + MCBl probe
6 = Arcs/ : ///s-rcs/-pREP3X protein extract + MCBl probe
7 = Arcs/ : ///s-rcs2 -pREP 1 protein extract (+  thiamine) +  MCBl probe
8 = Arcs/ : ///s-rcs2-pREPl protein extract + MCBl probe
9 = Arcs2 protein extract protein extract + MCB 1 probe
10 = lSres2 : ///s-rcs2'^-pREPl protein extract (+ thiamine) + MCBl probe
11 = Arcs2 : ///s-rcs2"^-pREPl protein extract (+ thiamine) + excess un label led MCB 1 probe
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4.6 Discussion
In this chapter a series o f assays have been described, designed to assess the effect o f an N- 
terminal His-tag on the biological activities of the SpReslp, SpRes2p, SpReplp and SpRep2p 
proteins of the fission yeast DSCl complex. To this end, a cloning strategy was designed 
allowing directional cloning of the respective recombinant cDNAs into the fission yeast 
overexpression vector pREP.
The recombinant cDNAs, H is-re s f, His-res2'^, H is-rep t and His-rep2^ were able to 
rescue the cold-sensitivity of a Aresl mutant at 21°C (Figures 4.8-4.11). Notably, this rescue 
was most efficient when cells were grown in the presence of thiamine. As outlined in Section 
4.2, genes under the control of the n m t t  promoter may still be expressed despite the presence 
of the transcriptional repressor thiamine. With respect to His-resl^, His-res2^, H is-rep t  and 
His-rep2^ suppression of the cold-sensitive lethality of a Aresl mutant was possible at levels o f 
transcription achieved in the presence of thiamine. This was not surprising given that the rescue 
o f a Aresl mutant was achieved by expression of the wild-type r e s t  cDNAs from the SV40 
promoter (Tanaka et al., 1992). The level o f ti’anscription from the pREP vector, in the presence 
o f thiamine, is comparable with that seen from an induced SV40 promoter (Forsburg, 1993).
With respect to His-Res2p, reconstitution of a ‘DSCl-like’ band-shift activity has been 
demonstrated upon expression of this protein in a Ares2 mutant (Figures 4.12-4.13). In 
comparison, the DSCl band-shift activity was lost in protein extracts prepared from the Ares2 
strain (Figures 4.12-4.13). This ‘DSCl-like’ band-shift activity was reduced in protein extracts 
prepared from Ares2 cells expressing His-Res2p in the presence of thiamine (Figure 4.13). 
Additionally, this DSCl-like complex bound specifically to the MCBl element, was competed 
by addition of an identical non radio-labelled probe and did not bind to a mutated M CBlm 
sequence. Thus, from these results, it is likely that the ‘DSCl-like’ complex observed in Ares2 
cells expressing His-Res2p is similai'to the wild-type DSCl complex.
In contrast, expression o f His-Res2p in Aresl cells did not reconstitute the DSCl band- 
shift complex nor did expression of His-Reslp Ares2 cells (Figure 4.14 and data not shown). 
Despite expression o f His-Reslp in the Aresl mutant background, a ‘DSCl-like’ band-shift 
activity was not observed (Figure 4.14). Intriguingly, although the DSCl complex was not 
detected in vitro when His-Res2p was expressed in Aresl cells, both the heat and cold sensitive 
lethality of these cells was rescued by expression of this protein from the pRBP vector (Figure 
4.9 this study, and Zhu et al., 1997). Therefore, as suggested by Zhu and co-workers, detection 
of the DSCl complex in vitro does not correlate with loss of transcriptional activity per se.
Nevertheless, the successful reconstitution of the DSCl band-shift in Aresl cells 
expressing SpReslp has been reported (Caligiuri and Beach, 1993) and failure to do so in this 
study may reflect inclusion of the His-tag. The ability of the His-Reslp protein to efficiently
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rescue the cold sensitive lethality o f a Aresl mutant suggests that inclusion of the His-tag does 
not affect function, but rather some other property such as protein stability. For example, levels 
of the His-Reslp protein may be at a level sufficient to rescue the Aresl cells and form an 
active DSCl eomplex in vivo, but this complex cannot be detected in vitro. Indeed, despite the 
efficient rescue of the cold-sensitive lethality of Aresl cells by all of the recombinant proteins 
(indicating they are all expressed and functional) none have been detected by immunoblotting 
using an antibody directed against the His-tag. In addition, a super-shift of the DSCl-like 
eomplex, reconstituted by expression o f /ft'^-re^i ’-pREPl in Ares2 cells, was not detected using 
this same antibody.
The inability to deteet the recombinant proteins, or to super-shift the ‘DSCl-like’ 
complex containing His-Res2p, may be a result of cleavage at the N-tenninus and thus loss of 
the His-tag. The presence o f a thrombin cleavage site immediately downstream of the His-tag 
supports this explanation. However, we are unaware of any fission yeast thrombin 
homologue(s), and given that the cleavage process is a highly specific sequence-dependent 
reaction, a degenerate protease would be unlikely to cleave at this site. Importantly, the use of a 
recombinant protein expression system in fission yeast using tags containing thrombin and 
enterokinase cleavage sites has been reported (Lu et al. 1997). Also, the function o f both 
SpReslp and SpRes2p requires an intact N-terminus (Tanaka et al., 1992; Ayte et al,, 1995; 
Zhu et a l , 1997).
Whilst the His-tag has no apparent effects on the function o f these proteins, the 
incorporation of the tag may affect their stability and expression level, such that they are not 
deteetable by immunoblotting. In addition, with respect to the super-shift experiment, the His- 
tag is at the N-terminus. Given that binding o f both SpReslp and SpRes2p to DNA is mediated 
by their N-termini, it is possible that the His-tag may be masked by interaction with the DNA 
and/or components of the DSCl complex and so is occluded from binding to the monoclonal 
antibody.
Even so (for reasons outlined in Chapter 3), it is our intention to study the structures of 
these recombinant proteins when produced in E. coli. Differences in protein production 
between eukaryotes and prokaryotes, particularly in post-translational modification, are well 
documented (Sudbery, 1996). Such differences may be manifested in alterations of protein 
structure and activity. It is encouraging that the results described in this chapter indicate these 
recombinant proteins can function normally in fission yeast (in comparison to their wild type 
counterparts). As the presence of the His-tag appears to impart no obvious impediment to the 
function of these proteins in vivo, it is likely that its inclusion does not significantly alter their 
structure. Having assessed the effect of the His-tag on the function of these proteins in vivo, in 
the following chapter, the recombinant proteins, when produced in E. coli, are analysed to
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assess their solubility and ultimately their biological activity. As discussed in Chapter 3, the 
expression of soluble recombinant proteins in E, coli suggests they are capable of folding into 
their native or near-native state, and that the tag does not disrupt folding or expression. 
Following production of soluble protein the biological activity of the recombinant protein may 
then be assayed.
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Chapter 5
Biological activity assays of recombinant DSCl 
proteins in vitro
5.1 Introduction
Chapter 4 focused on the analysis o f the biological activity of recombinant DSCl components, 
when produced in vivo. The results of these assays indieated that addition of the N-terminal 
His-tag (required for affinity purification) did not affect the eellular function of these proteins. 
Therefore, it is unlikely that the presence of this tag alters protein structure, to the detriment of 
function.
Detailed structural information is obtained through biophysical studies using techniques 
such as X-ray crystallography, nuclear magnetic resonance (NMR), circular dichroism (CD), 
surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC). With the 
exception of SPR, these teehniques require milligram quantities of protein. To obtain sufficient 
quantities of material for such studies, the fission yeast DSCl components have been over­
expressed as His-tagged fusion proteins, using E. coli as a heterologous host. Despite the 
apparent activity of the recombinant His-Reslp, His-Res2p, His-Replp and His-Rep2p proteins 
in vivo, it is still necessary to ensure that these proteins, when produced in vitro, are 
biologically active, as this will be the source for structural analysis.
To date, the fission yeast DSCl components have been poorly characterised in terms of 
3-dimensional sfructure. These studies have been limited to secondary structure predictions 
based on sequence alignments and homology with their budding yeast counterparts. Significant 
information has been obtained regarding the domain architecture of these proteins, revealing 
the regions that are important for their funetion. Mueh o f this information has been obtained 
through the in vivo analysis of mutated, truncated and hybrid proteins. In addition to this, 
studies of in vitro translated and bacterially expressed proteins have also contributed to 
understanding about their functions.
Analysis of truncated and mutant SpCdclOp proteins in vivo has indicated that the 
central ankyrin repeats and C-terminal region are important for function. The C-terminal region 
o f SpCdclOp has been implieated in protein-protein interactions with itself and/or SpReslp 
(Reymond and Simanis, 1993). The majority of cdclO temperature sensitive mutants contain 
lesions that map to either the central ankyrin repeats, or within the C-terminus (Reymond et al., 
1992), and the C-terminally ti uncated SpCdclO-C4p mutant, displays increased MCB-regulated 
gene expression in vivo, implying an important regulatoiy function for this region (Mclnerny et 
al., 1995). Together, these results define important roles for both the centrally located ankyrin 
repeats and the C-terminus of SpCdclOp.
The CdclOp protein is unable by itself to bind to MCB-DNA in vitro (Zhu et al., 1994; 
Ayte et al., 1995). However, it is required for the MCB-specific DNA binding of both SpReslp 
and SpRes2p. EMSA analysis using in vitro translated protein has revealed that SpReslp 
cannot bind MCB-DNA in the absence o f SpCdclOp, although SpRes2p does so very weakly
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(Zhu et al., 1997). In eontrast, bacterially expressed SpReslp binds specifically to MCB-DNA 
on its own, although this was dependent on an N-terminal fusion partner (Ayte et al., 1995; 
Ayte et al., 1997). Both SpReslp and SpRes2p share significant homology in their N-termini 
and in the centrally located ankyrin repeats, but diverge in their C-terminal region. Whilst 
SpReslp and SpRes2p can functionally substitute for each other with respect to their mitotie 
roles, SpReslp is unable to mimic the meiotic role of SpRes2p (Sturm and Okayama, 1996).
Analysis of hybrid proteins, generated by fusing together different domains of SpReslp 
and SpRes2p, has revealed that the functional specificity of both SpReslp and SpRes2p is 
dictated almost entirely by their C-terminal region (Sturm and Okayama, 1996; Zhu et al., 
1997). The meiotic-specific funetion of SpRes2p lies within this C-terminal region in addition 
to a domain required for interaction with SpRep2p (Sturm and Okayama, 1996). Similarly, 
yeast two-hybrid analysis has revealed the domains responsible for the transcriptional 
activation and SpRes2p-binding activities of SpRep2p (Tahara et al., 1998). Binding assays 
have shown that bacterially expressed GST-Rep2p binds to in vitro translated SpRes2p 
(Nakashima et al., 1995; Sturm and Okayama, 1996). SpRes2p binds to bacterially expressed 
GST-Res2p, GST-CdclOp and GST-Reslp in vitro, whereas SpReslp binds only GST-Res2p 
and GST-CdclOp, but not GST-Reslp (Ayte et al., 1997). Notably, however, there have been 
no reported studies on the SpReplp protein, either in vivo or in vitro, and as such the functional 
properties and domain architecture of this protein remain poorly characterised.
Using the EMSA technique, the ability (and therefore the biological activity) of 
bacterially produced His-Reslp and His-Res2p to bind to MCB elements in vitro can be 
assayed. The biological activity o f bacterially produced His-CdclOp may be similarly assayed, 
following successful co-expression with either His-Reslp or His-Res2p. In contrast, assay of 
the biological activity of both SpRepl and SpRep2p is not so facile. The absence o f any GST- 
fusions of these DSCl components precludes binding assays with bacterially expressed His- 
Rep2p or His-Replp. The ability of either protein to participate in an in vitro band-shift 
complex with either His-Reslp and/or His-Res2p may be assessed. Indeed, following 
expression and/or eo-expression o f the respective DSCl components it might be possible to 
reconstitute a recombinant DSCl complex in vitro. An in vitro reconstituted complex has the 
potential to provide an ideal model system for structural and functional studies.
In order to assess the biological activity of the recombinant DSCl components they 
must firstly be solubilised following suecessful overexpression. For experimental analysis o f a 
protein it is essential that, following release from the cell, it be released into a solvent in which 
it is stable. Upon release from its native environment, a protein is exposed to foreign conditions 
and agents that may cause irreversible damage. The nature of the solvent is therefore critical. 
Exposure to proteolytic enzymes, oxidising agents or extremes o f temperature and pH can all 
have adverse effects on the native structure of a protein. Also, due to the multiple acid-base
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groups present in the amino acid side-chains, the structure and thus solubility of a protein will 
also depend on the ionic composition/polarity o f the solvent. As a result, proteins are routinely 
dissolved in buffer solutions, effective over a pH range at which the protein is stable. The 
addition of protease inhibitors and reducing agents can help to maintain the integrity o f a 
protein in solution and procedures o f protein preparation and purification are routinely carried 
out on ice, as many proteins are thermally labile.
The unique 3-D arrangement of the constituent amino acids of a protein dictates its 
physieochemical properties. Thus, the optimal eonditions in which a protein is both soluble and 
stable, following release into the extracellular milieu, must be determined empirically. With 
respect to heterologous expression systems, the host strain and growth conditions can equally 
affect the ability to obtain soluble protein following overexpression. For example, the choice of 
host strain can affect the folding, and thus structure, of the protein expressed. Manipulation of 
induction conditions can affect the rate and level of protein synthesis that in turn can affect 
solubility. Consequently, the preparation o f soluble recombinant protein can often be one o f the 
lengthiest stages in a purifieation stiategy.
The aim of this chapter, therefore, was to assay the biological activity o f the 
recombinant DSCl components when produced in vitro. Following successful overexpression 
(Chapter 3), the solubility o f each protein is discussed followed by a series of experiments 
designed to test their in vitro biological activity using EMSA,
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5.2 Solubility of the recom binant DSCl proteins
The successful eloiiing and overexpression o f the full-length recombinant His-tagged DSCl 
component polypeptides (His-Reslp - 75 kDa, His-Res2p - 75 kDa, His-Replp - 55 kDa, His- 
Rep2p - 30 kDa and His-CdclOp - 90 kDa), in E. coli has been described in Chapter 3. For 
experimental analysis, these recombinant proteins must be both soluble and stable following 
release from bacteria.
Lysis of E. coli cells is routinely achieved by sonication, enzymatic lysis or mechanical 
disruption. The mechanical disruption method was favoured for this work, using a French 
Pressure appaiatus. The French Press was chosen as it was extremely reproducible and the most 
convenient method available, particularly when managing large volumes of bacterial culture. 
The solubility of all proteins described in this chapter was routinely assessed (Methods 2.4.12). 
Following overexpression, cells were harvested by centrifugation and the pellet re-suspended in 
an appropriate volume of lysis buffer. Cells were then disrupted by passage through an 
automatic French pressure cell. Subsequently, an aliquot of this whole cell extract, together 
with samples of supernatant and pellet (obtained following centrifugation), were analysed by 
SDS-polyacrylamide gel electrophoresis. The solubility of each protein was determined by 
comparing the ratio present in the supernatant/pellet, following Coomassie blue staining or 
immunoblotting.
As discussed previously, the ability to produce soluble protein is dependent on multiple 
factors. Several parameters were altered in an attempt to aehieve optimal conditions for the 
production of soluble protein, for each of the recombinant DSCl components. Despite 
manipulation of lysis buffer eomposition (i.e. pH, salt concentration and buffer salt) no 
significant change was obseiwed, with respect to the solubility o f His-Reslp, His-Replp, His- 
Rep2p or His-CdclOp. Consequently, these proteins were routinely dissolved in 50 mM 
KH2PO4, pH 7.5 (the optimal buffer conditions achieved). Figures 5.1-5.4, therefore allow a 
comparison of soluble protein production under 4 different induction eonditions. Figures 5.1,
5.2 and 5.5 show the solubility o f His-Replp, His-CdclOp and His-Res2p following 
overexpression at different temperatures as viewed by Coomassie blue staining. Figures 5.3 and 
5.4 show the solubility of His-Reslp and His-Rep2p at different temperatures as viewed by 
immunoblotting. Immunoblot analysis of both His-Reslp and His-Rep2p was necessary due to 
the low expression level of these proteins (Chapter 3).
His-Reslp was detected in the soluble fraction at 37°C (Figure 5.3 B) whereas His- 
Rep2p was completely insoluble following induction at this temperature (Figure 5.4 B). Both 
His-Reslp and His-Rep2p were partially soluble at all other temperatures tested (Figures 5.3 
and 5.4). The fact that expression of these latter two proteins was detectable only by 
immunoblotting (under all conditions tested) reflects their low level of expression. Such low-
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level expression may account for detection of both proteins in the soluble fraction, under most 
conditions tested. However, the low yield of these proteins imposes resti'ictions on their use for 
detailed structural work although the observation that at least 50% of these proteins were 
soluble was encouraging. In contrast, the high levels of protein obtained following 
overexpression of His-Replp and His-CdclOp may contribute to their insolubility. High-level 
overexpression o f proteins can result in the physiological solubility limit o f the cell being 
exceeded. Both of these proteins were insoluble and appeared in the pellet under all of the 
conditions tested (Figures 5.1 and 5.2).
Figure 5.5 shows that at 15°C, approximately 100 % of His-Res2p was recovered in the 
supernatant. Importantly, the ability to produce soluble His-Res2p was not solely reliant on 
manipulation of the growth conditions. In addition, the nature of the lysis buffer was crucial. 
Indeed, the production o f soluble His-Res2p highlights the delicate balance o f conditions 
required to obtain soluble protein (Section 5.3). Even so, assuming that this protein is correctly 
folded and active, following a scaling up in the process, structural studies should now be 
possible.
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Figure 5.1 SDS-PAGE analysis o f His-Replp solubility
His-Replp was overexpressed in BL21 CodonPlus (DE3)-R1L cells for 3 h at either 30°C (A) 
or 37°C (B) by induction with 1 mM IPTG. Alternatively overexpression was carried out at 
15°C (C) or 22°C (D) by induction with 0.2 mM IPTG. Samples (1 ml) were removed at the 
point of induction (0 h). The bacterial culture was then centrifuged, the pellet resuspended in 5 
ml lysis buffer, and cells lysed by French pressure disruption. This whole cell extract (W) was 
then separated into soluble (S) and insoluble (P) fractions by centrifugation. The pellet was 
resuspended in 5 ml lysis buffer. The 0 h samples were centrifuged, the pellets resuspended in 
Laemmli sample buffer (10 p.1/0.1 absorbance unit) and denatured by boiling for 5 min in the 
presence o f DTT (150 mM). Samples (1 ml) of the whole cell extract, the soluble fraction and 
the resuspended pellet were diluted with an equal volume of Laemmli sample buffer and 
similarly denatured. Samples were then analysed on a 10% SDS-polyacrylamide gel stained 
with Coomassie brilliant blue. Molecular weight markers are shown (MJ with sizes indicated in 
kDa.
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Figure 5.2 SDS-PAGE analysis of His-CdclOp solubility
His-CdclOp was overexpressed in BL21 CodonPlus (DE3)-RIL cells for 3 h at either 30°C (A) 
or 37”C (B) by induction with 1 mM IPTG. Alternatively overexpression was carried out at 
15°C (C) or 22°C (D) by induction with 0.2 mM IPTG. Samples (1 ml) were removed at the 
point o f induction (0 h). The bacterial culture was then centrifuged, the pellet resuspended in 5 
ml lysis buffer, and cells lysed by French pressure disruption. This whole cell extract (W) was 
then separated into soluble (S) and insoluble (P) fractions by centrifugation. The pellet was 
resuspended in 5 ml lysis buffer. The 0 h samples were centrifuged, the pellets resuspended in 
Laemmli sample buffer (10 p.1/0.1 absorbance unit) and denatured by boiling for 5 min in the 
presence of DTT (150 mM). Samples (1 ml) of the whole cell extract, the soluble fraction and 
the resuspended pellet were diluted with an equal volume of Laemmli sample buffer and 
similarly denatured. Samples were then analysed on a 10% SDS-polyacrylamide gel stained 
with Coomassie brilliant blue. Molecular weight markers are shown (MJ with sizes indicated in 
kDa.
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Figure 5.3 Immunoblot analysis of His-Reslp solubility
His-Reslp was overexpressed in BL21 CodonPlus (DE3)-R1L cells for 3 h at either 30°C (A) or 
37°C (B) by induction with 1 mM IPTG. Alternatively overexpression was carried out at 15°C 
(C) or 22°C (D) by induction with 0.2 mM IPTG. Samples (1 ml) were removed at the point of 
induction (0 h) and at 3 h or 16 h. The bacterial culture was then centrifuged, the pellet 
resuspended in 5 ml lysis buffer, and cells lysed by French pressure disruption. This whole cell 
extract (W) was then separated into soluble (S) and insoluble (P) fractions by centrifugation 
and samples (1 ml) taken. Samples from 0 h and 3 or 16 h were centrifuged, the pellets 
resuspended in Laemmli sample buffer (10 p.1/0.1 absorbance unit) and denatured by boiling for 
5 min in the presence of DTT (150 mM). All other samples were diluted with an equal volume 
of Laemmli sample buffer and similarly denatured. Samples were then analysed by 
immunoblotting as described (Methods 2.4.7-2.4.11). Blots were probed with Anti-PentaHis- 
HRP conjugate antibody (Qiagen) at 1:2500. The positions of molecular weight markers are 
indicated (MJ in kDa.
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Figure 5.4 Immunoblot analysis of His-Rep2p solubility
His-Rep2p was overexpressed in BL21 CodonPlus (DE3)-R1L cells for 3 h at either 30°C (A) 
or 37°C (B) by induction with 1 mM IPTG. Alternatively overexpression was carried out at 
15°C (C) or 22°C (D) by induction with 0.2 mM IPTG. Samples (1 ml) were removed at the 
point o f induction (0 h) and at 3 h or 16 h. The bacterial culture was then centrifuged, the pellet 
resuspended in 5 ml lysis buffer, and cells lysed by French pressure disruption. This whole cell 
extract (W) was then separated into soluble (S) and insoluble (P) fractions by centrifugation 
and samples (1 ml) taken. Samples from 0 h and 3 or 16 h were centrifuged, the pellets 
resuspended in Laemmli sample buffer (10 pl/0.1 absorbance unit) and denatured by boiling for 
5 min in the presence of DTT (150 mM). All other samples were diluted with an equal volume 
of Laemmli sample buffer and similarly denatured. Samples were then analysed by 
immunoblotting as described (Methods 2.4.7-2.4.11). Blots were probed with Anti-PentaHis- 
HRP conjugate antibody (Qiagen) at 1:2500. The positions of molecular weight markers are 
indicated (Mr) in kDa
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Figure 5.5 SDS-PAGE analysis of His-Res2p Solubility
His-Res2p was overexpressed in BL21 CodonPlus (DE3)-RIL cells for 3 h at either 30°C (A) or 
37°C (B) by induction with 1 mM IPTG. Alternatively overexpression was carried out at 22°C 
(C) or 15°C (D) by induction with 0.2 mM IPTG. Samples (1 ml) were removed at the point of 
induction (0 h) and at 3 h or 16 h. The bacterial culture was then centrifuged, the pellet 
resuspended in 5 ml lysis buffer, and cells lysed by French pressure disruption. This whole cell 
extract (W) was then separated into soluble (S) and insoluble (P) fractions by centrifugation 
and samples (1 ml) taken. Samples from 0 h and 16 h were centrifuged, the pellets resuspended 
in Laemmli sample buffer (10 pi / 0.1 absorbance unit) and denatured by boiling for 5 min in 
the presence o f DTT (150 mM). All other samples were diluted with an equal volume of  
Laemmli sample buffer and similarly denatured. Samples were then analysed on a 10% SDS- 
polyacrylamide gel stained with Coomassie brilliant blue. Molecular weight markers are shown 
(Mr) with sizes indicated in kDa.
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5.3 The effect of salt concentration on His Res2p solubility
Lysis buffer composition plays a crucial role in determining both the solubility and stability of 
a protein following release from the cell. Attempts to enhance the solubility of His-Replp and 
His-CdclOp were refractory to manipulation of both growth and lysis buffer conditions. In 
contrast, His-Res2p was significantly affected. Initial attempts to obtain soluble His-Res2p, 
following overexpression at 37°C or 30°C, coupled with a screening of different lysis buffer 
conditions, were unsuccessful. A small amount of His-Res2p was retrieved in the supernatant 
following overexpression at 22”C and overexpression at 15°C yielded significantly more 
soluble protein and manipulation of lysis buffer composition enhanced this further.
Following overexpression at 15°C, the concentration o f salt in the lysis buffer proved 
pivotal in the ability to obtain soluble His-Res2p, following release from the cell. In lysis 
buffers containing > 0.3 M NaCl (such concentrations of salt are routinely used in buffers due 
to the requirements of purification procedures), His-Res2p was almost exclusively present in 
the insoluble pellet (Figure 5.6 B and C). In contrast, reduction or complete removal of the salt 
concentration had a profound effect (Figure 5.6 A and D). In buffer solutions with either no or 
minimal salt (< 0.1 M NaCl), His-Res2p was completely soluble (although a minute amount is 
present in the pellet at 100 mM NaCl). In contrast, even a slight increase to 300 mM NaCl 
resulted in approximately 100% o f expressed protein becoming insoluble; a similar effect was 
observed following lysis in buffers containing IM  NaCl.
The solubility o f His-Res2p was extremely sensitive to salt concentration. This serves as 
an excellent example o f the sensitivity o f a protein to its immediate environment. The 
sensitivity of His-Res2p to high NaCl concentration has implications for the purification of this 
protein and is discussed in Chapter 6.
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Figure 5.6 Effect of salt concentration on the solubility of His Res2p
His-Res2p was overexpressed at 15°C in BL21 CodonPlus (DE3)-RIL cells by induction with 
0.2 mM IPTG. Samples (1 ml) were removed at the point of induction (0 h) and at 16 h. The 
bacterial culture was then centrifuged, and the pellet resuspended in 5 ml lysis buffer; (A) 
50mM KH2PO4 , pH 7.5; (B) A + IM NaCl; (C) A + 0.3M NaCl and (D) A + O.lMNaCl. Cells 
were then lysed by French pressure disruption. The whole cell extract (W) was separated into 
soluble (S) and insoluble (P) fractions by centrifugation and samples (1 ml) taken. All samples 
were centrifuged, the pellets resuspended in an equal volume o f Laemmli sample buffer and 
denatured by boiling for 5 min in the presence of DTT (150 mM). Samples were then analysed 
on a 10% SDS-polyacrylamide gel stained with Coomassie brilliant blue. Molecular weight 
markers are shown (Mr) with sizes indicated in kDa.
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5.4 Biological activity assays -  His-Reslp and His-Res2p
Both SpReslp and SpRes2p, when produced in vitro, can bind specifically to MCB elements in 
vitro as detected by EMSA. Detection of both SpReslp and SpRes2p MCB-specific DNA- 
binding complexes was dependent on co-expression with SpCdclOp, although SpRes2p alone 
could bind very weakly (Zhu et al., 1994; Zhu et al., 1997).
The ability o f the bacterially produced His-Reslp and His-Res2p proteins to bind MCB 
elements in vitro was tested. Soluble extracts from E. coli cells, expressing either His-Reslp or 
His-Res2p (Methods 2.4.1 and 2.4.12), were incubated with a radio-labelled DNA probe and 
used in EMSA experiments. The DNA probe was identical to that detailed in Chapter 4 and 
contained the MCBl cluster derived from the cdc22'^ promoter (Maqbool et al., 2003). The 
mutated M CBlm probe was again used to test specificity. Despite repeated attempts, binding of 
either His-Reslp or His-Res2p to MCBl DNA using the EMSA was not detected under these 
conditions (Figure 5.7).
However, as mentioned above, binding o f either SpReslp or SpRes2p to MCB DNA in 
vitro was reportedly dependent on and/or enhanced by, the presence o f SpCdclOp and so co­
expression of His-CdclOp with His-Reslp or His-Res2p was also attempted. It is possible that 
these proteins may associate in a co-translational manner in vivo. Therefore, co-expression with 
His-CdclOp in E. coli might replicate this scenario since association of proteins as folding 
intermediates can increase stability and thus, successful co-expression has the potential to 
enhance protein solubility.
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Figure 5.7 His-Reslp and His-Res2p binding to MCB motifs in  v itro
EMSA analysis o f protein extracts prepared from E. coli BL21 (DE3) CodonPlus-RIL cells 
transformed with pET-28c (GB 7), His-resl -piET-2^Q (GB 201) or His-res2 -pET-2%c, (GB 
178). Protein extracts were prepared and incubated with a radio-labelled probe derived from the 
cdc22^ promoter (MCBl). To test the specificity o f protein binding to the MCB sequence a 
probe containing a mutated MCBl element (MCBlm) was included (lanes 3, 6, 7, 10, 11, 14 
and 15). A protein extract from wild-type fission yeast cells (GG 217) was incubated with 
MCBl and forms the characteristic DSCl band-shift (lane 2). The upper and lower arrows on 
the left indicate the positions of the fission yeast DSCl complex and unbound radio-labelled 
probe, respectively.
1 =  free M C B l probe
2 =  w ild -type protein extract + M C B l probe
3 =  w ild -type protein extract + M C B lm  probe
4  and 5 =  His-resT-pET-2%c protein extract + M C B l probe
6 and 7 =  His-resr-pEY-2%c protein extract +  M C B lm  probe  
8 and 9  =  His-res2^-pEY-2%c protein extract + M C B l probe  
10 and 11 =  His-res2^-pE\-2%c protein extract + M C B lm  probe  
12 and 13 =  pE T -28c  protein extract +  M C B l probe  
14 and 15 =  pE T -28c  protein extract + M C B lm  probe
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5.5 Cloning of resl^^ repl^ and rep2
To ensure that two proteins are co-expressed from separate plasmids in the same E. coli cell, 
there must be selection for both plasmids. Both resV  and res2' were cloned into the 
kanamycin resistant pET-28c vector, whereas cdclO' was cloned into the ampicillin resistant 
pET-14b (Chapter 3). The pET-14b plasmid is essentially identical to pET-28c, containing an 
N-terminal His-tag upstream of Ndel-BamHl multiple cloning sites. However, in contrast, pET- 
14b contains the p-lactamase gene, conferring ampicillin resistance. The cloning o f resHiresT^ 
and cdclO' into plasmids with different antibiotic resistance markers allows phenotypic 
selection of co-transformants. Further to such studies using His-CdclOp, co-expression between 
other DSCl components was investigated. To this end, resl ' was cloned into pET-14b to allow 
co-expression studies with Res2p. In addition, repE  and rep i' were cloned into pET-14b to 
facilitate co-expression studies with these proteins.
Cloning of these cDNAs into pET-14b was performed as described previously (Chapter 
3, section 3.2). Clones containing insert were analysed by restriction enzyme mapping and 
DNA sequencing (MWG-Biotech -  using oligos listed in Appendix II) and a positive clone for 
each gene was stored at -70°C in the lab bacterial collection: GB 299 {resE), GB 289 {repE') 
and GB 310 irep2^') -  Appendix I.
Following optimisation o f conditions, each clone was successfully over-expressed in the 
BL21 (DE3) CodonPlus-RIL strain. The expression levels and solubility were comparable to 
that achieved when these same cDNAs were expressed from the pET-28c vector: both His- 
Reslp and His-Rep2p were detectable only by immunoblot and were soluble, whereas His- 
Replp was detected by Coomassie blue staining and was insoluble (data not shown).
5.6 Co-expression of recombinant DSCl components in E, coli
Following co-transformation (Methods 2.2.13) into BL21 (DE3) CodonPlus-RIL cells and 
small-scale protein inductions, the ability o f two proteins to co-express was determined by 
Coomassie blue staining or immunoblottmg, following SDS-PAGE.
Upon testing different combinations of DSCl components, only co-expression of His- 
Res2p with His-Rep2p was detected: only His-Res2p was visualised by Coomassie staining 
whereas both proteins were detected by immunoblotting (Figure 5.8).
Unfortunately, despite successful co-expression, incubation o f a soluble crude protein 
extract from His-Res2p/His-Rep2p co-expressing cells with MCBl did not produce a 
detectable band-shift as detected by EMSA (data not shown). In addition, mixing o f crude 
soluble extracts containing His-Reslp and His-Res2p was tested. Furthermore, reconstitution of 
the DSCl band-shift complex following mixing o f crude His-Reslp and His-Res2p bacterial 
supernatants with fission yeast protein extracts prepared from their respective deletion mutants
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(His-Res2p to hresl  and His-Reslp to bresl cells) was attempted. However, using either of 
these approaches, no MCB-specific DNA-binding activity was detected (data not shown).
Neither bacterially expressed His-Reslp nor His-Res2p appeared able to bind MCB- 
DNA in vitro. Despite successful expression of soluble His-Rep2p, the lack o f a definitive 
assay has precluded the assignment of activity to this protein. Due to the insoluble nature of 
both His-CdclOp and His-Replp, these proteins have been refractory to similar analysis.
In contrast, the bacterial expression of a biologically active Res Ip protein has been reported 
(Ayte et al., 1995). A GST-Reslp fusion protein was shown to bind specifically to MCB 
elements in vitro. The DNA binding ability o f this recombinant protein was attributed to 
SpReslp homodimerisation, artificially promoted by the GST moiety. Accordingly, it was 
reasoned that the inability o f either His-Reslp or His-Res2p to bind MCB-DNA might reflect 
the self-dimerisation potential of these proteins in vitro. It is possible that the soluble His- 
Reslp and His-Res2p proteins are correctly folded but cannot homodimerise, thus precluding 
DNA-binding. An investigation was undertaken to assess the ability o f Res Ip and Res2p to 
bind specifically to MCB DNA, when bacterially expressed as GST fusion proteins. The 
production of both SpReslp and SpRes2p as GST-fusion proteins will also allow assay o f His- 
Rep2p via binding assays.
124
0 16 W
His-Res2p
His-Rep2p
Figure 5.8 Co-expression of His-Res2p and His-Rep2p in E . c o l i
His-Res2p and HisRep2p were co-expressed at 15°C in BL21 CodonPlus (DE3)-RIL cells by 
induction with 0.2 mM IPTG. Samples (1 ml) were removed at the point of induction (0 h) and 
at 16 h. The bacterial culture was then centrifuged, the pellet resuspended in 5 ml 50mM 
KH2 PO4 , pH 7.5 and cells lysed by French pressure disruption. The whole cell extract (W) was 
separated into soluble (S) and insoluble (P) fractions by centrifugation and samples (1 ml) 
taken. Samples from 0 h and 16 h were centrifuged, the pellets resuspended in Laemmli sample 
buffer (10 pl/0.1 absorbance unit) and denatured by boiling for 5 min in the presence o f DTT 
( 150 mM). All other samples were diluted with an equal volume of Laemmli sample buffer and 
similarly denatured. Samples were then analysed on a 10% SDS-polyacrylamide gel stained 
with Coomassie brilliant blue. Immunoblotting was carried out as described (Methods 2.4.7- 
2.4.11 ) and blots were probed with Anti-PentaHis-HRP conjugate antibody (Qiagen) at 1:2500. 
The positions o f molecular weight markers are indicated (Mr) in kDa.
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5.7 Cloning resÜ  and res2^ cDNAs into pGEX-KG
The r e s t  and res2^ cDNAs (Appendix I; GB 201 and GB 178, respectively) were amplified by 
PCR using primer pairs GO 464/GO 466 i r ^ s t )  and GO 465/GO 466 {rest"). Primers GO 464 
and GO 465 were designed to add a 5’ Sma\ restriction site immediately upstream of the ATG 
of r e s t  and res2^, respectively. Primer GO 466 adds a 3’ Xho\ restriction site downstream of 
the stop codon of each cDNA. Addition o f these restriction ends was necessary to facilitate 
directional cloning into the pGEX-KG vector, in-frame with an N-terminal GST-tag.
Figure 5.9 provides a schematic representation of the PCR reaction and the primers 
used. All PCR reactions were carried out using the VentR DNA polymerase (New England 
Biolabs).
5.7.1 Cloning r e s t  and res2* cDNAs into pCR2.1®
Following PCR amplification, each reaction mix was incubated with Taq polymerase at 72°C 
for 10 min to allow cloning into the linearised pCR2.1® vector. The cloning o f PCR products 
using the TA Cloning® Kit (Invitrogen) has been described previously (Chapter 3, Section 
3.3.2-3.3.3). Use of the TA Cloning® Kit, as an intermediate cloning step, was necessary due 
to the difficulty in digesting the Smal and Xhol restriction ends present at the end of a PCR 
product (reshiction enzymes often require substantial flanking sequence around their 
recognition site to digest efficiently). Following cloning into the TA vector, the cDNAs can 
then be easily excised for cloning into pGEX-KG.
Plasmid DNA was purified from overnight cultures (Methods 2.2.5) and analysed by 
restriction enzyme mapping to confirm the presence of an insert o f the correct size (Figures 
5.10A and 5.11 A). Potential positive clones were sequenced (MWG-Biotech -  using oligos 
listed in Appendix II) to confirm the presence of insert and the fidelity of the PCR. A positive 
clone for both r e s t  and res2^ was stored at -70°C in the lab bacterial collection (Appendix I - 
GB 300 and GB 302).
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5.7.2 Cloning r e s t  and res2^ cDNAs into pGEX-KG
The plasmids GB 300 {rest') and GB 302 {res2 t were digested with Smal and Xhol as was the 
pGEX-KG vector to generate cohesive ends for ligation. The vector was also treated with calf 
intestinal alkaline phosphatase (Methods 2.2,7 and 2.2.8). The products of the restriction 
digests were analysed on a 1.5 % (w/v) agarose gel (Figures 5.10A and 5.1 lA) and bands of the 
appropriate size excised and purified using the QIAquick® Gel Extraction Kit (Methods 2.2.4 
and 2.2.6). 5 pi samples were analysed on a 1.5 % (w/v) agarose gel to determine the 
vector; insert ratio to be used in the subsequent ligation reaction. Ligation reactions were carried 
out as described (Methods 2.2.9) and transformed into E. coli DH5a cells the following day 
(Methods 2.2.13). Plasmid DNA was purified from overnight cultures (Methods 2,2.5) and 
analysed by reshiction enzyme mapping (Figures 5.1 OB and 5.1 IB) and DNA sequencing 
(MWG-Biotech -  using oligos listed in Appendix II) to confirm cloning was in-frame with the 
N-terminal GST-tag. A positive clone for both G ST -rest and GST-res2^ was stored at -70°C in 
the lab bacterial collection (Appendix I - GB 309 and GB 318, respectively).
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A ICATATGGTATAC
Bam\\\
i
GO 464/GO 465 Nde\
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I
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ggGCc c t ta g *-
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TCGAGAGCTC
Figure 5.9 Schematic representation of the PCR amplifications for pGEX-KG cloning
The white arrow represents the ORFs of the r e s t  and rest' cDNAs cloned into pET 28c at 
Nde\-Bam\\\. The His-tag is boxed in green, the black lines represent pET vector flanking 
sequence and the position o f restriction sites are indicated by arrows.
A Restriction map representing the Nde\-Bam\\\ fragment of each cDNA cloned into the pET- 
28c vector (Chapter 3).
B The positions o f the primers used in the PCR reaction are indicated in relation to the 
corresponding sequence o f the pET-28c vector. GO 464 and GO 465 add a Sma\ site 
(CÇCGGG) immediately upstream of the ATG of r e s t  and resl"', respectively. GO 466 
includes the pET-28c Xhol (CTCGAG) site downstream of the stop codon.
C A schematic representation of the DNA fragments produced following PCR.
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5.10 Restriction digestion analyses of the -pCR2.1® and -pGEX-KG plasmids
Clones containing insert were analysed by restriction mapping. Samples of each digest (5 pi) 
were analysed on a 1.5% (w/v) agarose gel stained with ethidium bromide and viewed under 
UV illumination. The 1 kb DNA ladder is shown (M) and sizes are indicated in base-pairs.
A Digestion of the rc5/CpCR2.1® plasmid: 1 EcoK\ 2 Sma\-Xho\.
B Digestion of the rgj:/-pGEX-KG plasmid: 1 Hind\\\ 2 Sac\.
The restriction enzymes used in each digest and the predicted fragment sizes are summarised 
for each clone in Tables 5.1 and 5.2.
Enzyme(s) Number of Fragments Fragment sizes (bp) {
E com 2 3900,1900
Sma\-Xho\ 2
.
3900,1900
Table 5.1 rt?5/'-pCR2.l'
Enaq^me(s) Number of Fragments F rom en t sizes (bp)
HindVW 2 5600,1300
Sac\ 2 5200,1700
Table 5.2 rea / -pGEX-KG
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5.11 Restriction digestion analyses of the -pCR2.1® and rex2 -pGEX KG plasmids
Clones containing insert were analysed by restriction mapping. Samples of each digest (5 pi) 
were analysed on a 1.5% (w/v) agarose gel stained with ethidium bromide and viewed under 
UV illumination. The 1 kb DNA ladder is shown (M) and sizes are indicated in base-pairs.
A Digestion of the -pCR2.1® plasmid: 1 EcoRI 2 Sma\-Xho\.
B Digestion of the -pGEX-KG plasmid: 1 Sal\ 2 EcoK\.
The restriction enzymes used in each digest and the predicted fragment sizes are summarised 
for each clone in Tables 5.3 and 5.4. Fragments marked (*) appear as a result of partial digest.
Enzyme(s) 1 Number of Fragments 1 Fr%ment sizes (bp)
EcoRl 1 ^ 3900,2000*,1500,500
S m a \ - X h o \ 2 3900, 2000
Table 5.3 -pCR2.l‘
Eng^me^) Number of Fragments ! Fragment sizes (bp)
S a i l 1 2 5200,1700
EcoRl 2 5400,1500
Table 5.4 -pGEX-KG
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5.8 Overexpression and solubility of GST-Reslp and GST-Res2p
As described for the His-tagged recombinant proteins (Chapter 3 and this Chapter), in order to 
obtain optimal conditions for the overexpression and solubility of both GST-Res 1 p and GST- 
Res2p, several E, coli expression strains were tested, together with a variety of growth and lysis 
buffer conditions. As before, the E. coli expression strain BL21 (DE3) CodonPlus-RIL gave 
optimal results for both recombinant proteins, following transformation with the clones 
containing the G ST -rest and GST-res2^ cDNAs. Small-scale protein inductions were carried 
out to test for successful overexpression o f each protein (Methods 2.4.1 and 2.4.12). Aliquots 
of the induction at 0 h and 3 h or 16 h together with samples of the whole cell extract (W), 
supernatant (S) and pellet (P) were then analysed by SDS-PAGE and the solubility o f each 
protein determined by viewing after Coomassie blue staining or immunoblotting. Figures 5.12 
and 5.13 show the overexpression and solubility of GST-Reslp and GST-Res2p at different 
temperatures as viewed by Coomassie blue staining. The GST-Reslp and GST-Res2p proteins 
resolve with a Mr approximately 98,000 (GST is a protein with a Mr value of 26,000). Figure 
5.14 shows immunoblot analysis of the overexpression and solubility of GST-Reslp and GST- 
Res2p. For comparison, overexpression of the GST moiety alone is similarly depicted in Figure 
5.15.
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Figure 5.12 Overexpression of GST-Reslp
GST-Reslp was overexpressed at 30°C (A) or 15“C (B) in BL2I CodonPlus (DE3)-R1L cells 
by induction with 1 mM or 0.2 mM IPTG respectively. Samples (1 ml) were removed at the 
point of induction (0 h) and at 3 h or 16 h. The bacterial culture was then centrifuged and the 
pellet resuspended in 5 ml 1 x PBS. Cells were lysed by French pressure cell disruption. This 
whole cell extract (W) was then separated into soluble (S) and insoluble (P) fractions by 
centrifugation and samples (1 ml) taken. Samples from 0 h and 3 h were centrifuged, the pellets 
resuspended in Laemmli sample buffer (10 p.1/0.1 absorbance unit) and denatured by boiling for 
5 min in the presence of DTT (150 mM). All other samples were diluted with an equal volume 
of Laemmli sample buffer and similarly denatured. Samples were then analysed on a 10% 
SDS-polyacrylamide gel stained with Coomassie brilliant blue. Molecular weight markers are 
shown (Mr) with sizes indicated in kDa.
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Figure 5.13 Overexpression of GST-Res2p
GST-Res2p was overexpressed at 30°C (A) or 15°C (B) in BL21 CodonPlus (DE3)-R1L cells 
by induction with 1 mM or 0.2 mM IPTG respectively. Samples (1 ml) were removed at the 
point of induction (0 h) and at 3 h or 16 h. The bacterial culture was then centrifuged and the 
pellet resuspended in 5 ml 1 x PBS. Cells were lysed by French pressure cell disruption. This 
whole cell extract (W) was then separated into soluble (S) and insoluble (P) fractions by 
centrifugation and samples (1 ml) taken. Samples from 0 h and 3 h were centrifuged, the pellets 
resuspended in Laemmli sample buffer (10 pl/0.1 absorbance unit) and denatured by boiling for 
5 min in the presence of DTT (150 mM). All other samples were diluted with an equal volume 
of Laemmli sample buffer and similarly denatured. Samples were then analysed on a 10% 
SDS-polyacrylamide gel stained with Coomassie brilliant blue. Molecular weight markers are 
shown (Mr) with sizes indicated in kDa.
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Figure 5.14 Immunoblot analysis of GST-Reslp and GST-Res2p
GST-Reslp (A) and GST-Res2p (B) were overexpressed at 15°C in BL21 CodonPlus (DE3)- 
RIL cells by induction with 0.2 mM IPTG. Samples (1 ml) were removed at the point of 
induction (0 h) and at 16 h. Each bacterial culture was then centrifuged and the pellets 
resuspended in 5 ml 1 x PBS. Cells were lysed by French pressure cell disruption. The whole 
cell extracts (W) were then separated into soluble (S) and insoluble (P) fractions by 
centrifugation and samples (1 ml) taken. Samples from 0 h and 16 h were centrifuged, the 
pellets resuspended in Laemmli sample buffer (10 pl/0.1 absorbance unit) and denatured by 
boiling for 5 min in the presence o f DTT (150 mM). All other samples were diluted with an 
equal volume of Laemmli sample buffer and similarly denatured. Samples were then analysed 
on a 10 % SDS-polyacrylamide gel stained with Coomassie brilliant blue. Immunoblotting was 
carried out as described (Methods 2.4,7-2.4.11) and blots were probed with Anti-GST-HRP 
conjugate antibody (Amersham) at 1:2500. The positions of molecular weight markers are 
indicated (Mr) in kDa.
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Figure 5.15 Immunoblot analysis of GST
GST was overexpressed at 15°C in BL21 CodonPlus (DE3)-RIL cells by induction with 0.2 
mM IPTG. Samples (1 ml) were removed at the point of induction (0 h) and at 16 h. The 
bacterial culture was centrifuged and the pellet resuspended in 5 ml 1 x PBS. Cells were lysed 
by French pressure cell disruption. The whole cell extract (W) was separated into soluble (S) 
and insoluble (P) fractions by centrifugation and samples (1 ml) taken. Samples from 0 h and 
16 h were centrifuged, the pellets resuspended in Laemmli sample buffer (10 pl/0.1 absorbance 
unit) and denatured by boiling for 5 min in the presence of DTT (150 mM). All other samples 
were diluted with an equal volume of Laemmli sample buffer and similarly denatured. Samples 
were then analysed by immunoblotting as described (Methods 2.4.7-2.4.11). Blots were probed 
with Anti-GST-HRP conjugate antibody (Amersham) at 1:2500. The positions of molecular 
weight markers are indicated (Mr) in kDa.
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5.9 Biological activity assays - GST-Reslp and GST-Res2p
Bacterially expressed GST-Reslp bound specifically to MCB elements in vitro (Ayte et a l, 
1995). Accordingly, the EMSA technique was employed to assay the biological activity o f the 
recombinant GST-Reslp and GST-Res2p proteins.
Recombinant GST-Reslp and GST-Res2p were individually overexpressed at 15°C 
(Section 5.8) and recovered in the supernatant fraction. Soluble protein extracts (Methods 
2.4.14) were incubated with a radio-labelled MCBl DNA probe and used in EMSA 
experiments as described (Methods 2.2.14 - 2.2.16). The results o f this assay are shown in 
Figure 5.16. Incubation of either GST-Reslp or GST-Res2p with MCBl produced a co- 
migratory band-shift activity. In contrast, this band-shift activity was absent from extracts of 
GST alone incubated with M CBl. Both the GST-Reslp and GST-Res2p band-shift activities 
were specific to the MCBl element, as judged by competition analysis and an inability to bind 
the mutated M CBlm sequence. Notably, both of these band-shifts were of a greater mobility 
than the DSCl band-shift formed in wild-type fission yeast extracts, consistent with the 
absence of SpCdclOp, SpRep2p and SpRes2p or SpReslp, respectively. In addition, the 
presence o f the GST-tag, in both GST-Reslp and GST-Res2p containing complexes, was 
confirmed by a super-shift following addition o f an anti-GST antibody (Figure 5.17).
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Figure 5.16 GST-Reslp and GST Res2p bind specifically to M CBl DNA in  v itro
EMSA analysis of protein extracts prepared from E. coli BL21 (DE3) CodonPlus-RIL cells 
transformed with pGEX-KG (GB 159), -pGEX-KG (GB 309) or G ST-rest-pG EX-
KG (GB 318). Protein extracts were prepared and incubated with a radio-labelled probe derived 
from the cdc22^ promoter (MCBl). To check the specificity o f the retarded complex an excess 
of unlabelled MCBl probe was added (lanes 6 and 9) or a probe containing a mutated MCBl 
(MCBlm) element (lanes 4, 7 and 10) or an excess o f unlabelled MCBlm (lanes 11 and 12). A 
protein extract from wild-type fission yeast cells (GG 217) was incubated with MCBl and 
forms a characteristic DSCl band-shift for comparison (lane 2). The upper and lower arrows on 
the left indicate the positions of the DSCl complex and the unbound radio-labelled probe, 
respectively. The arrow on the right indicates the GST-Reslp and GST-Res2p band-shifts.
1 = free MCBl probe
2 = wild-type protein extract + MCBl probe
3 = pGEX-KG protein extract + MCBl probe
4 = pGEX-KG protein extract + MCBlm probe
5 = GST-rest-^GEX-KG protein extract + MCBl probe
6 = -pGEX-KG protein extract + excess unlabelled MCB 1 probe
7 = GST-rest-pGEX-KG protein extract + MCBlm probe
8 = G5'7’-re52'-pGEX-KG protein extract + MCBl probe
9 = G5"T-re.$2-pGEX-KG protein extract + excess unlabelled MCBl probe
10 = G.5T-rgj2-pGEX-KG protein extract + MCBlm probe
11 = GiST-re^ /'^ -pGEX-KG protein extract + excess unlabelled MCBlm probe
12 = GST-res2" -^pGEX-KG protein extract + excess unlabelled MCBlm probe
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Figure 5.17 Super-shift EMSA assay of GST-Reslp and GST-Res2p with Anti-GST 
antibody
EMSA analysis of protein extracts prepared from E. coli BL21 (DE3) CodonPlus-RIL cells 
transformed with pGEX-KG (GB 159), pG ST-rest (GB 309) or pGST-res2^ (GB 318). Protein 
extracts were prepared and incubated with a radio-labelled probe derived from the cdc22^ 
promoter (MCBl). Protein extracts mixed with probe were incubated with various dilutions of 
an anti-GST antibody prior to loading on a 2% SeaPlaque: 1% agarose gel. A protein extract 
from wild-type fission yeast cells (GG 217) was incubated with MCBl and forms a 
characteristic DSCl band-shift for comparison (lane 2). The upper and lower arrows on the left 
indicate the positions of the DSCl complex and the unbound radio-labelled probe, respectively. 
The green arrow indicates the super-shifted GST-Res2p complex.
1 =  free M C B  1 probe
2 =  w ild -typ e  protein extract + M C B  1 probe
3 =  pG E X -K G  protein extract +  M C B l probe
4  =  pG E X -K G  protein extract +  M C B l probe + A n ti-G ST  (1 :1 )
5 =  -pG E X -K G  protein extract t M C B l probe
6  =  GST-resI-pGEX-KG  protein extract + M C B  1 probe + A n ti-G ST  (1 :1 )
7 =  GST-rest-pGEX-KG  protein extract +  M C B l probe +  A nti-G ST  (1 :2 )
8 =  /  -pG E X -K G  protein extract + M C B l probe +  A n ti-G ST  (1 :5 )
9 =  -pG E X -K G  protein extract +  M C B l probe + A nti-G ST  (1 :1 0 )
10 =  GST-rest-pGEX-KG  protein extract  ^ M C B l probe + A n ti-G ST  (1 :5 0 )
11 =  GiST-re52^-pGEX-KG protein extract +  M C B l probe
12 =  GST-res2"^-pGEX-KG protein extract + M C B l probe +  A n ti-G ST  (1
13 =  GST-res2^-pGEX-KG protein extract +  M C B l probe + A n ti-G ST  (1
14 =  -pG E X -K G  protein extract t M C B l probe + A n ti-G ST  (1
15 =  G 5T -re52L pG E X -K G  protein extract +  M C B l probe + A n ti-G ST  (1
16 =  GST-res2^-pGEX-KG protein extract + M C B l probe + A n ti-G ST  (1
1)
2) 
5) 
10) 
5 0 )
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5.10 Discussion
In this chapter, attempts to obtain soluble recombinant protein, following overexpression of 
His-Reslp, His-Res2p, His-Replp, His-Rep2p or His-CdclOp in E. coli, have been described. 
Following this, a series of assays have been described to determine the biological activity of 
these soluble recombinant proteins when produced in vitro.
The ability to obtain a soluble protein, following release from the cell, can be dependent 
on several factors. With respect to heterologous protein production, not only must the 
conditions within the cell be suitable, facilitating efficient translation and protein folding, but 
also the protein must then be recovered and maintained in a solvent in which it is stable. 
Accordingly, a series o f growth and lysis buffer conditions were screened, in attempts to 
recover each of the recombinant proteins in a soluble form.
The major advantage o f heterologous expression systems is for the production of 
substantial quantities o f recombinant protein. This is often counterbalanced by the affect that 
such high levels can impose on solubility. Indeed, recombinant protein may comprise >50% of 
total cell protein, and this can result in the formation of insoluble aggregates. Expression at 
lower temperatures, in combination with a reduced concentration of inducing agent, can often 
aid in the production of soluble protein (Schien and Noteborn, 1988). It has been suggested that 
lowering the induction temperature can slow down the rate o f translation. In turn, the amount of 
protein that accumulates in a given time is reduced and as a result, the protein has more time to 
fold correctly, helping to prevent formation o f insoluble aggregates.
Initial attempts to obtain soluble protein following overexpression of the His-tagged 
proteins at 37°C were unsuccessful, with the exception of His-Reslp. Given that the expression 
of His-Reslp was at a relatively low level (detectable only by immunoblotting), the partial 
solubility of this recombinant protein at this, and indeed all temperatures tested may reflect this 
observation. Similarly, His-Rep2p (also detectable only by immunoblot analysis) although 
completely insoluble at 37°C, appeared in the supernatant following expression at 30°C, 22“C 
or 15°C. Conversely, both His-Replp and His-CdclOp were present in the insoluble fraction 
under all conditions tested, perhaps reflecting higher expression levels. These proteins may 
therefore be present as inclusion bodies, which can form for several reasons. The recombinant 
protein may require post-translational modification and/or molecular chaperones in order to 
fold correctly. In addition, the high levels of protein expressed within the cell may account for 
dense packing and aggregation (Lilie et al., 1998).
Even so, inclusion bodies can often be a useful source of pure protein. The solubilisation 
and purification o f both His-Reslp and His-CdclOp from inclusion bodies is discussed in detail 
in Chapter 6.
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In contrast the solubility of His-Res2p increased significantly following induction at 
15°C for 16 h. The ability to produce soluble His-Res2p was not solely dependent on finding 
the appropriate induction conditions, but was equally reliant on the composition o f the lysis 
buffer. Using the variant solubility o f His-Res2p in buffers o f different salt concentration as an 
example, one of the many parameters that can dramatically affect the solubility of a protein has 
been highlighted. Furthermore, the apparent insolubility of His-Res2p in NaCl concentrations 
> 300 mM has important consequences for the purification of this protein (discussed in Chapter 
6).
Following production of soluble His-Reslp (albeit at low levels) and His-Res2p, these 
recombinant proteins were assayed for biological activity. Crude soluble extracts from E. coli, 
expressing either His-Reslp or His-Res2p, were incubated with a radio-labelled MCB probe. 
However, an in vitro MCB DNA-binding activity was not detected with either o f these proteins 
using this technique.
Co-expression o f His-CdclOp with either His-Reslp or His-Res2p was attempted. 
Unfortunately, co-expression of either protein with His-CdclOp proved unsuccessful, in terms 
o f detectable protein (either His-Reslp or His-Res2p were detected but not His-CdclOp by 
Coomassie blue staining or immunoblotting). In addition, co-expression of either His-Reslp or 
His-Res2p with each other and with His-Replp or His-Rep2p was tested. Association o f these 
proteins might facilitate MCB-specific DNA binding of the His-Resp subunits in the absence of 
His-CdclOp. However, although co-expression o f His-Res2p/His-Rep2p was detected, and both 
of these proteins were present in the soluble fraction (as determined by immunoblotting -  
Figure 5.8), use o f this protein extract did not yield detectable MCB binding in vitro.
These observations suggest that neither bacterially produced soluble His-Res 1 p or His- 
Res2p has DNA-binding activity. There are a number of possible explanations why the His- 
tagged Resp proteins cannot bind to DNA in vitro. The His-tag, present at the N-terminus of 
these proteins, may prevent proper folding and therefore occlude DNA-binding. To counter this 
possibility the presence of a His-tag at either the N- or C-terminus had no adverse effect on the 
specific DNA-binding properties of bacterially expressed ScSwidp or ScMbplp (Taylor et al., 
2000).
With respect to the results observed with His-Reslp, it has been reported that in vitro 
translated SpReslp cannot bind to MCB DNA, in the absence of SpCdclOp (Ayte et al., 1995). 
Similarly, the MCB-specific DNA binding activity o f in vitro translated SpRes2p was 
dependent on co-expression with SpCdclOp, although a weak band-shift activity was detected 
with SpRes2p alone (Zhu et al., 1997).
The inability to co-express either His-Reslp or His-Res2p with His-CdclOp has 
precluded a definitive analysis o f the dependency o f these proteins upon His-CdclOp, for their 
DNA-binding activity in vitro. Using His-Res2p alone, no MCB specific band-shift activity
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was detected. Pertinent to this result, Zhu and co-workers previously reported an inability to 
detect a MCB-specific DNA-binding complex by EMSA with in vitro translated SpReslp, 
using three different MCB containing probes (Zhu et al., 1994). Therefore, the ability of 
SpReslp alone to bind to MCB DNA in vitro may not be straightforward.
Intriguiiigly, it has been shown that C-terminal truncation of in vitro produced SpReslp 
enhances MCB-specific DNA-binding. The C-termini of SpReslp and SpReslp are responsible 
for binding to SpCdclOp (Ayte et al., 1995; Zhu et a l, 1997). The fact that only a weak band- 
shift was detected with SpReslp alone, and that this was markedly increased by the presence of 
SpCdclOp, suggested that in the absence o f SpCdclOp, the ability o f SpReslp to bind DNA is 
compromised (Zhu et a l, 1997).
In agreement with this observation, analysis of the ScSwi4p protein in vitro suggests 
that, in the absence o f ScSwi6p, the C-terminus of ScSwi4p is involved in contact with the N- 
terminal DNA-binding domain. This has led to the proposal that control of DNA-binding in 
ScSwi4p may be mediated, at least in part, through intramolecular auto-inhibition, in the 
absence of ScSwibp (Baetz and Andrews, 1999).
Given the extensive sequence homology between the SpRes 1 p/SpReslp and ScSwi4p 
proteins at the N and C-termini, it is tempting to suggest that such a mode of DNA-binding 
regulation may be conserved. It is perhaps relevant that the co-expression experiments o f Zhu 
and co-workers utilised in vitro translated protein made in rabbit reticulocyte lysates and so it is 
possible that the DNA-binding activity exhibited by these proteins reflects a requirement for 
post-translational modification that only occurs in eukaryotes.
Arguing against this, bacterially expressed SpReslp has been shown to bind specifically 
to MCB DNA by EMSA. This band-shift activity was attributed to the artificial homo­
dimerisation o f SpReslp imparted by the GST moiety (Ayte et a l ,  1995). Further evidence for 
this was demonstrated by the MCB-specific binding of SpReslp when fused at its N-terminus 
to the Epstein Barr Virus ZEBRA domain, a protein with intrinsic dimérisation potential (Ayte 
et a l, 1997).
Such results have led these authors to attribute the apparent inability o f SpReslp to bind 
DNA in vitro, to homodimerisation potential. SpReslp can homodimerise in vitro, in a 
SpCdclOp-dependent manner (Zhu et al. 1997). Both SpReslp and SpReslp are believed to 
form heterodimers in the mitotic DSCl complex in vivo (Ayte et a l ,  1997; Whitehall et a l , 
1999).
This suggestion prompted an investigation to determine if GST-Reslp and GST-Reslp 
could bind specifically to MCB DNA, in contrast to the His-tagged isoforms. Following 
cloning into a GST expression vector and successful overexpression of soluble protein, the 
ability o f GST-Reslp and GST-Reslp to bind specifically in vitro to MCB DNA was assayed. 
In accordance with the results o f Ayte and co-workers, GST-Reslp produced a MCB-specific
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band-shift complex. Notably, expression of SpReslp as a GST-fusion protein also conferred 
MCB-specific DNA-binding. Both DNA-binding activities were co-migratory (a slightly 
stronger complex was detected with GST-Reslp -  most likely reflecting the higher level of 
expression of this protein). The presence of the GST-tag in each band-shift complex was 
confirmed following super-shift analysis, using an anti-GST antibody (Figure 5.17).
The fact that E. coli is capable o f producing biologically active GST-Reslp and GST- 
Reslp (in terms of MCB-specific DNA binding), indicates that post-translational modification 
is not essential for the DNA-binding activity o f these proteins in vitro. Furthermore, although 
the band-shift activities are MCB-specific, the artificial dimérisation imparted by the GST 
moiety may confer this DNA binding capability. Indeed, if  this were found to be true, then the 
inability of His-Reslp or His-Reslp to bind DNA might reflect the monomeric nature of these 
proteins in vitro. If either homo- or heterodimerisation in vitro is dependent on SpCdclOp 
(outwith artificial means), then the His-Resp proteins may not be inactive per se. The soluble 
nature of these proteins suggests that they may be correctly folded and so analysis o f these 
proteins may still be worthwhile.
It should be noted that in all assays using GST-Reslp and GST-Reslp, crude soluble 
protein exti'acts were used. As is apparent from both Coomassie blue staining and 
immunoblotting, these extracts contain a heterogeneous population of both GST-Reslp and 
GST-Reslp proteins. In both cases the band-shift was reliant on the presence of either GST- 
Reslp or GST-Reslp (no specific complex was detected using extracts fiom E. coli expressing 
the GST-tag alone). Nevertheless, the possibility that MCB-specific DNA-binding is conferred 
by C-terminally truncated, rather than full-length, GST-Reslp or GST-Reslp molecules cannot 
be excluded. Such an explanation would correlate with relief o f C-terminal mediated auto- 
inhibiton. The smeared appearance of the band-shift complex in both cases indicates such 
heterogeneity and has been noted by Ayte and co-workers (Ayte et al., 1995).
Despite the apparent MCB-specific DNA binding capacity o f GST-Reslp and GST- 
Reslp, a more definitive answer regarding the DNA-binding properties of these proteins 
requires further analysis. A more direct analysis toward answering these questions necessitates 
purification of these proteins. Firstly, with respect to GST-Reslp and GST-Reslp, purification 
of full-length protein will allow determination of the nature of the DNA-binding activity. Is the 
MCB-specific DNA-binding activity generated by full-length GST-Res 1 p/GST-Reslp, or 
instead C-terminally truncated isoforms? In addition, thrombin cleavage o f the GST-tag and 
purification of the resultant Reslp and Reslp proteins will allow separation of the effects of the 
GST-tag on DNA-binding. The presence o f the GST-tag may stabilise these proteins and allow 
them to fold correctly. In contrast, the artificial homo-dimerisation imparted by the GST moiety 
may be required for DNA-binding.
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Similarly, there are un-resolved issues over the results of the in vitro assays with both 
His-tagged Reslp and Reslp. Thrombin cleavage of the His-tag from purified His-Reslp and 
His-Reslp will allow separation of the effects of the His-tag, if any, on DNA-binding. 
Purification of these proteins and recovery in sufficient amounts will provide valuable material 
for use in biophysical studies allowing an analysis of the structure of these proteins. O f 
particular interest will be a comparison of the His-tagged and GST-tagged isoforms. In 
addition, purification of the GST-Resp proteins described in this chapter will allow an analysis 
o f the activity o f His-Replp using in vitro binding assays.
In the following chapter the purification of these recombinant proteins is described, to 
permit detailed functional, and ultimately structural, analyses.
143
Chapter 6
Purification of recombinant DSCl proteins
6.1 Introduction
Chapter 5 focused on analysis of the biological activity of recombinant DSCl components, 
when produced in vitro. These experiments showed that, when bacterially expressed as GST- 
fusion proteins, both R eslp and Reslp bound specifically to MCB containing DNA in EMSA 
assays. In contrast, their respective His-tagged isoforms displayed no such detectable DNA- 
binding activity. Similar assays using His-Replp were inconclusive and both His-Replp and 
His-CdclOp were insoluble following overexpression. This precluded in vitro assays using 
either of these latter two proteins.
As discussed in the previous chapter, analysis of these results has raised several issues 
regarding the behaviour o f the recombinant GST-Resp and His-Resp proteins in vitro. 
Specifically, with respect to both GST-Reslp and GST-Reslp, the nature of the protein 
responsible for MCB-specific DNA-binding has still to be fully resolved. In vitro DNA-binding 
assays employed crude soluble bacterial extracts, containing a heterogeneous mix of both full- 
length and truncated GST-Resp proteins. The effect(s) of the GST moiety upon DNA-binding 
requires further investigation, particularly with regard to in vitro homodimerisation and so the 
His-tagged isoforms o f  R eslp and R eslp merit further analysis. The inability of the His-Resp 
proteins to bind MCB-DNA in vitro may reflect an inability to homodimerise. Removal o f the 
His and GST moieties will allow separation of the effect of these tags, if any, upon the 
behaviour o f these proteins in vitro.
Detailed analysis of a protein requires it is free of any contaminants that may interfere 
with or influence its activity. In order to obtain a greater understanding o f the behaviour of 
these recombinant proteins in vitro, purification must be undertaken. Purification o f either 
GST-Reslp or GST-Reslp will also allow in vitro binding assays with His-Replp. Importantly, 
recovery of protein in sufficient yield and purity will also provide valuable material for detailed 
structural studies.
The purification o f a protein from the many macromolecular compounds within a cell 
can often be a formidable task, particularly if  it is present in low abundance. In addition, the 
protein may exist in several different isoforms within the cell. Such micro-heterogeneity can be 
problematic when attempting to obtain a homogeneous preparation, required for detailed 
structural studies. As discussed in Chapter 3, biophysical analyses require large amounts of 
pure and active protein that are often extremely difficult to obtain from the native source. 
Overexpression of proteins of interest, as recombinants with fusion tags in bacteria, often 
simplifies purification and increases yield.
Expression o f a protein with a fusion tag is primarily useful for purification purposes; in 
some cases expression, solubility and stability may also be enhanced. The highly specific 
binding properties o f the fusion tag can be exploited in affinity chromatography, providing a
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relatively straightforward means o f purification (generally applicable to any protein containing 
the tag). Inclusion o f a genetically engineered protease recognition sequence at the C-terminus 
of the tag allows cleavage either during or after purification. The bacterial overexpression and 
solubility of each o f the fission yeast DSCl components, with an N-terminal His-tag, has been 
described previously (Chapter 3, Section 3.4). Both Reslp and R eslp have also been bacterially 
expressed as N-terminal GST-fusions (Chapter 5, section 5.8). Both the pET-28c and pGEX- 
KG vectors contain thrombin cleavage sites immediately C-terminal to their His and GST-tags, 
respectively.
The glutathione -S-transferase enzyme has a subunit Mr of 26 kDa, and is frequently used 
as an N-terminal fusion partner in recombinant protein studies. GST-fusion proteins can then be 
purified based on their affinity for glutathione (Smith and Johnson, 1988). Similarly, fusion of 
a 6-Histidine-tag to the N or C-terminus o f a protein affords a simple means o f purification by 
exploiting the affinity o f histidine for transition metal ions (Porath et al., 1975; Smith et al., 
1988). In both cases, the fiision proteins can then be purified, following binding to their 
respective ligands (immobilised on a chromatographic support), by mass-action competitive 
binding. Elution is achieved by addition o f reduced glutathione for GST-fusions, whereas 
imidazole competes with His-tagged proteins.
Ideally, for purification using these methods, the protein should be in soluble form. Even 
so, recoveiy of pure and active protein from insoluble aggregates is not unprecedented. Both 
His-Replp and His-CdclOp were insoluble under all conditions tested, which prevented assay 
of their activities in vitro. The presence o f insoluble proteins in inclusion bodies, however, 
often provides a convenient and straightforward means of obtaining pure protein in high yield 
(Carrio and Villaverde, 2002). The material present within inclusion bodies frequently 
represents mis-folded aggregates o f protein. Accordingly, recoveiy of active protein from 
inclusion bodies routinely involves re-folding, which can often be an extremely complex 
process. Even so, several proteins purified from inclusion bodies have been found to obtain 
significant secondary and tertiary structure, with some displaying significant activity (Carrio 
and Villaverde, 2002). Purification o f His-Replp and His-CdclOp from inclusion bodies has 
the potential to provide a reproducible source o f active protein in high yield.
In this chapter, purification of the recombinant DSCl components is described with 
view to more definitive functional analyses in vitro. Following purification, attempts to obtain 
preliminary structural data for these proteins are described.
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6.2 Purification of Recombinant His-tag fusion proteins using the 
BioCAD® system
Cloning, overexpression and solubility o f the recombinant His-tagged DSCl components has 
been described previously (Chapters 3 and 5).
The His-Reslp, His-Res2p and His-Rep2p recombinant proteins were purified from 
large-scale bacterial cultures by the method of Immobilised Metal ion Affinity 
Chromatography - IMAC (Porath et al., 1975; Smith et al., 1988) using the BioCAD® 
SPRINT™ Perfusion Chromatography® system (Methods 2.4.16-2.4.18). This is a fully 
automated purification system that employs a pre-programmed purification protocol. The 
ultraviolet (UV) elution profile is monitored at 280 nm, and can be plotted against a choice of 
parameters (e.g. % elution buffer, pH and conductivity).
In IMAC, a metal chelating group (typically imidodiacetate; CH2N(CH2C02')2) is 
immobilised on a hydrophilic chromatographic support. The imidodiacetate groups chelate 
transition metal ions, allowing the remaining co-ordination sites to interact with proteins. The 
type o f metal ion used can affect the binding strength, with copper providing tightest binding 
(Cu^^ > Ni^^ > Zn^^ > Co^^). Proteins bind to these metal co-ordination sites through their 
surface amino acids, in particular histidine. Thus, proteins with a high availability of histidine 
residues (i.e. high affinity for transition metal ions) bind to the column, whilst other proteins 
elute during washing steps. Therefore, fusion of a 6-histidine tag to a recombinant protein 
provides an efficient handle for purification by this method. The active group in histidine, 
involved in binding to the metal co-ordination sites, is imidazole. Elution o f bound protein is 
therefore achieved through mass action competitive binding, by a gradient of increasing 
imidazole concentration. Following initial trial purifications (e.g. using cobalt or nickel) the 
optimal conditions for binding and elution were achieved using zinc.
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6.2.1 Purification of His-Reslp and His-Rep2p
Large-scale protein induction, preparation of clarified supernatant and preparation of the 
metal chelate column for purification, were carried out as described (Methods 2.4.17 and 
2,4.18). Clarified supernatant was manually injected onto the POROS MC column in 5 ml 
aliquots, in the presence of Starting buffer. Elution of bound protein was achieved by an 
increasing linear gradient o f imidazole (0.5 mM-500 mM), and was monitored by observing the 
absorbance profile at 280 nm plotted against % elution buffer; 2 ml fractions were collected 
automatically.
The results depicted in Figure 6.1 represent a typical purification run for His-Reslp, as 
recorded by the BioCAD® system. A single sharp peak in absorbance was initially observed, 
encompassing fractions ~6 to 9, followed by a gradual decline that levelled off around fraction 
20. Samples of peak fractions were taken and analysed by SDS-PAGE and Coomassie blue 
staining, or immunoblotting using an antibody directed against the His-tag (Figures 6.2 and 6.3, 
respectively). The majority o f protein, corresponding to the approximate Mr o f His-Reslp 
(75 kDa), eluted in fr actions 8 and 9, with faint bands of similar size visible in fractions 10 
through 14. The sharp peak seen in Figure 6.1 correlated with the major bands detected in 
fractions 8 and 9 following Coomassie blue staining. However, immunoblot analysis of these 
same fractions indicated that a single protein corresponding to the expected size of His-Reslp 
was present in fractions 10-14 only (Figure 6.3 - a faint band of the expected size was also seen 
in fraction 9; fraction 14 is not shown on the blot). These results, indicated that the major peak 
observed was not consistent with elution of His-Reslp and was most likely due to non-specific 
binding o f E. coli protein(s). Instead, His-Reslp appeared to elute in the shoulder to the right o f 
this major peak, with the amount of Flis-Reslp retrieved following purification by this method 
being veiy low (Figure 6.2).
Similar results were obtained for His-Rep2p (data not shown). Manipulation of 
chromatography conditions had no significant effect on protein yield. A scale-up in the process 
was carried out in an attempt to maximise the amount of protein loaded, but was similarly 
ineffectual. The inability to purify appreciable amounts of His-Reslp or His-Rep2p was, 
therefore, attributed to the low levels at which these proteins were overexpressed. Attempts to 
increase the expression levels of these proteins have been described previously (Chapter 3, 
Section 3.4). The results presented represent the optimal conditions achieved to date. The 
inability to purify His-Reslp or His-Rep2p in significant amounts has implications for the 
future functional and structural study o f these proteins.
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Figure 6.2 SDS-PAGE analysis o f His-Reslp from IMAC purification
His-Reslp was overexpressed in BL21 CodonPlus (DE3)-RIL cells for 16 h at 15°C by 
induction with 0.2 mM IPTG. The bacterial culture (routinely 500 ml) was then centrifuged, the 
pellet resuspended in 20 ml lysis buffer, and cells lysed by French pressure disruption. The 
soluble fraction was obtained following centrifugation and loaded onto the column in 5 ml 
aliquots. Peak fractions were collected automatically and samples (100 p.1) taken. All samples 
were diluted in an equal volume o f Laemmli sample buffer and denatured by boiling for 5 min 
in the presence of DTT (150 mM). Samples were then analysed on a 10% SDS-polyacrylamide 
gel stained with Coomassie brilliant blue. Molecular weight markers are shown (MJ with sizes 
indicated in kDa. The arrow indicates the expected position o f full-length His-Reslp and 
numbers above each lane correspond to the fraction numbers indicated on the BioCAD® trace 
(Figure 6.1).
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Figure 6.3 Immunoblot analysis of His-Reslp from IMAC purification
The peak fractions shown in Figure 6.2 were also analysed by immunoblot analysis. Following 
SDS-PAGE and transfer to nitrocellulose, the blot was probed with Anti-PentaHis-HRP 
conjugate antibody (Qiagen) at 1:2500. The positions of molecular weight markers are 
indicated (MT in kDa. The arrow indicates the expected position o f full-length His-Reslp. A 
sample of the His-Reslp supernatant loaded onto the column is shown (lane S) and numbers 
above each lane correspond to the fraction numbers indicated on the BioCAD® trace (Figure 
6 . 1).
150
6.2.2 Purification of His-Res2p
Large-scale protein induction, preparation o f clarified supernatant and preparation of the metal 
chelate column for purification, were carried out as described (Methods 2.4.17 and 2.4.18). 
Loading of supernatant and elution were carried out as described previously for purification o f 
His-Reslp (Section 6.2.1) and 2 ml fractions collected automatically. The results depicted in 
Figure 6.4 represent a typical purification run for His-Res2p, as recorded by the BioCAD® 
system. A single peak in absorbance was observed, encompassing fractions ~6 to 13, that 
peaked at fractions 9-10 and reached its nadir around fraction 17. Samples of peak fractions 
were taken and analysed by SDS-PAGE and Coomassie blue staining, or immunoblotting using 
an antibody directed against the His-tag (Figures 6.5 and 6,6, respectively). The majority of 
protein, corresponding to the approximate Mr o f His-Res2p (75 kDa), eluted in fractions 7 
through 13, as viewed by Coomassie blue staining, coincident with the major peak in 
absorbance (compare Figures 6.4 and 6.5). Immunoblot analysis o f these same fractions 
detected a single protein corresponding to the expected size of His-Res2p; a faint band o f the 
expected size was also seen in fraction 9 (Figure 6.6). These results indicated that the major 
peak in absorbance was consistent with elution of His-Res2p.
Purification of recombinant His-Res2p using this method yielded significant amounts o f 
protein (typically 5-10 mg 1"^ culture). Despite such a successful yield, the purity was 
compromised. A single contaminating protein was consistently observed to co-purify with His- 
Res2p, in all peak fractions analysed. This contaminant protein was ~ 60 kDa in size as viewed 
by Coomassie blue staining (compare with Figure 5.1 Chapter 5, for approximate size). In 
contrast to His-Res2p, this protein was not detected by immunoblotting using anti-His 
antibody.
In an attempt to remove this impurity, ion-exchange chromatography was attempted. 
This technique separates proteins by exploiting differences in ionic binding strength. The 
requirement for high salt concentrations in buffers used in this technique was complicated by 
the insolubility o f His-Res2p in NaCl concentrations >100mM (Chapter 5 Section 5.3). 
Following IMAC, dialysis of eluted protein into ion-exchange buffers frequently resulted in 
protein precipitation, precluding use of this technique.
The inability to detect the contaminant protein following immunoblot analysis, with 
anti-His antibody, demonstrated that this protein did not contain the N-terminal His-tag that 
was present in full-length His-Res2p. It was therefore assumed that the co-purifying protein 
was either from E. coli, bound non-specifically to the column (or to His-Res2p), or 
alternatively an N-terminally degraded product of His-Res2p (missing the His-tag).
Close examination of the immunoblot analysis o f His-Res2p purification revealed a 
small protein of approximately 20 kDa (Figure 6.6). It was therefore possible that this 
represented the N-terminal His-tag ‘fragment’ missing from the ‘truncated’ contaminant
151
protein. In order to identify the contaminant and confirm that the 75 kDa protein was His- 
Res2p, mass spectrometric analysis was undertaken. In the following section, the 75 kDa 
protein assumed to be His-Res2p is referred to as protein X and the co-purifying 60 kDa 
contaminant as protein Y.
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Figure 6.5 SDS-PAGE analysis o f His-Res2p from IMAC purification
His-Res2p was overexpressed in BL21 CodonPlus (DE3)-R1L cells for 16 h at 15°C by 
induction with 0.2 mM IPTG. The bacterial culture (routinely 500 ml) was then centrifuged, the 
pellet resuspended in 20 ml lysis buffer, and cells lysed by French pressure disruption. The 
soluble fraction was obtained following centrifugation and loaded onto the column in 5 ml 
aliquots. Peak fractions were collected automatically and samples (100 p.1) taken. All samples 
were diluted in an equal volume of Laemmli sample buffer and denatured by boiling for 5 min 
in the presence of DTT (150 mM). Samples were then analysed on a 10% SDS-polyacrylamide 
gel stained with Coomassie brilliant blue. The molecular weight markers are shown (Mr) with 
sizes indicated in kDa. The upper arrow indicates the expected position o f full-length His- 
Res2p and the lower arrow indicates the position of the co-purifying protein. Numbers above 
each lane correspond to the fraction numbers indicated on the BioCAD® trace (Figure 6.4).
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Figure 6.6 Immunoblot analysis o f His-Res2p from IMAC purification
Peak fractions (7-12) from the purification were collected and samples taken. Samples were 
then analysed on a 10% SDS-polyacrylamide transferred to nitrocellulose and blotted with 
Anti-PentaHis-HRP conjugate antibody (Qiagen) at 1:2500. The positions of molecular weight 
markers are indicated (Mr) in kDa. The arrow indicates the expected position o f full-length His- 
Res2p. A sample of the His-Res2p supernatant loaded onto the column is shown (lane S) and 
numbers above each lane correspond to the fraction numbers indicated on the BioCAD® trace 
(Figure 6.4).
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6.2.3 Identification of protein X and protein Y
The identity of proteins X and Y, purified by IMAC in section 6.2.2, were confirmed by mass 
spectrometric analysis. Protein identification by mass spectiometry was carried out in the Sir 
Henry Wellcome Functional Genomics Facility (University o f Glasgow) using standard 
methodology (Methods 2.4.20). A brief overview of this technique and its application to protein 
identification is described.
6.2.4 Protein identification by mass spectrometry
Mass spectrometry is a highly accurate and sensitive analytical technique used for measuring 
molecular weight. The molecular masses of proteins, and other biomolecules, can be accurately 
determined to within 0.01% of their total molecular weight (Pitt, 1996). Mass spectrometric 
analysis is achieved through the initial generation o f gas phase ions o f the molecule o f interest, 
followed by analysis o f the mass to charge (m/z) ratio o f these ions. A mass spectrometer is 
essentially composed o f three main parts: a source, in which ions are generated from the 
substance to be analysed; an analyser, in which ions are separated according to their mass; and 
a detector, in which a signal produced from the separated ions is transmitted to a data system 
where it is recorded in the foim of a mass spectrum. There are several variations o f this 
technique, primarily differing in the types of ionisation source and analyser used.
The application o f mass spectromefry to biochemical analysis is particularly 
advantageous for protein identification by peptide sequencing, using tandem mass spectrometry 
(MS/MS). An MS/MS instrument typically contains two analysers separated by a collision cell. 
The first analyser is used to select sample ions according to their mass to chai’ge (m/z) ratio. 
These selected (or ‘parent’) ions are then passed into the collision cell where they are 
fragmented by collision with gas molecules. The fiagment (or ‘daughter’) ions are then 
analysed by the second analyser, again according to their m/z ratio. This technique is of 
particular use for generating peptide sequence information since the daugliter ions (i.e. 
fragmented peptide) derive from a specifically selected parent ion (i.e. intact peptide), allowing 
information dependent on the amino acid sequence of the peptide to be obtained (Sheehan, 
2000).
A schematic diagram, representing the process of protein identification using MS/MS is 
shown in Figure 6.7. The protein to be analysed must firstly be digested by a protease (e.g. 
trypsin). This generates peptides that are characteristic to the digest pattern o f that protein. 
Clean up and separation o f fiagments in a digest mixture (e.g. by chromatography) prior to 
delivery into the source, allows the sequential analysis of individual peptides. Each o f these 
peptides is then introduced into the mass spectrometer and, following ionisation, analysed 
(‘weighed’) to produce a mass spectrum. Analysis of the mass spectra produced from the intact 
peptides (known as a peptide mass fingerprint), can be used to search an on-line database in an
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attempt to identify the protein. In addition, subsequent selection of specific parent ions and 
passage into the collision cell (where they are fragmented) produces a daughter ion mass 
spectrum. As fragmentation generally occurs by breaking of one of the peptide bonds in the 
molecule, a set o f fragments is generated where the difference in mass between the fragments 
can be used to deduce the amino acid sequence. Consequently, the database search using 
MS/MS ion data is more specific, as it contains primary structure information. Protein 
identification is ultimately accomplished using complex computer algorithms that compare the 
experimental data (i.e. peptide molecular weights from the digested protein and/or MS/MS ion 
data from one or more o f these peptides^, with values calculated from a comprehensive primaiy 
structure database. The Mascot computer program searches primaiy structure databases for 
proteins matching the experimental data (www.matrixscience.com). A probabilistic scoring 
algorithm is then applied allowing proteins to be ranked in order of closest match. The absolute 
score reflects the fit o f the theoretical and experimental data, and is typically reported as - 
10*logio(P), where P is the probability. Thus, a low probability (that the experimental and 
calculated data match is random) is reflected in a high score (e.g. a P value of 10'^° becomes a 
score o f 200). Furthermore, the significance o f a match is measured against a threshold score, 
calculated for a random hit against a given database using the search parameter set chosen for 
the individual search. The threshold has a default setting of 5%, such that, scores below the 
threshold have a > 5% probability that the match is random. Conversely, scores above the 
threshold have a < 5% probability that the match is random.
Mass spectral data from proteins X and Y was used in a Mascot search. In both cases the 
top scoring protein was Res2p from S. pombe, with protein scores o f 239 and 160, for X and Y 
respectively (the tlueshold value was 74). These scores represent the probability of a random 
match of approximately 1 in 10^  ^ and 1 in 10 ,^ respectively. Therefore, it was concluded that 
protein X (approx. 75 kDa) was full-length His-Res2p whereas the co-purifying protein Y 
(approx. 60 kDa) was an N-terminally truncated product of FIis-Res2p. This was backed up by 
the absence from the dataset for the ti’uncated form of some N-terminal peptides identified in 
the full-length transcript. The number o f peptides matched and % sequence coverage o f Res2p, 
from the database search using experimental data from proteins X and Y, are shown in Figures 
6.10 and 6.11, respectively. Figures 6.8 and 6.9 depict chromatographic and mass spectral data 
obtained from analysis of protein X and are shown as examples. Similar data was retrieved 
from analysis of protein Y (data not shown).
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FTNNYDCQTF
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Figure 6.10 Matched peptides from protein X
The amino acid sequence o f SpRes2p is shown above with matched peptides 
from the MS/MS ion data search of protein X, shown in red. Sequence 
coverage was 43% and 38 peptides were matched. The daughter ion mass 
spectrum of the peptide underlined (QDTLNEISR) is shown in Figure 6.9B.
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Figure 6.11 Matched peptides from protein Y
The amino acid sequence o f SpRes2p is shown above with matched peptides 
from the MS/MS ion data search of protein Y, shown in red. Sequence 
coverage was 33% and 23 peptides were matched.
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6.3 Purification of GST-Reslp and GST-Res2p
Cloning, overexpression and solubility o f the recombinant GST-Reslp and GST-Res2p 
proteins has been described previously (Chapter 5 Sections 5.7-5.8). GST-Reslp and GST- 
Res2p were purified from large-scale bacterial cultures by affinity chromatography using the 
BioCAD® SPRINT™ Perfusion Chromatography® system, attached to a GSTrap FF 5 ml 
column (Methods 2.4.13-2.4.15).
Large-scale protein induction and preparation of clarified supernatants for purification 
were carried out as described (Methods 2.4.2 and 2.4.14). Clarified supernatant was manually 
injected onto the GSTrap FF 5 ml column in 5 ml aliquots, in the presence o f 1 x PBS. Elution 
of bound protein was achieved by addition of elution buffer (containing 10 mM reduced 
glutathione), and was monitored by obseiwing the absorbance profile at 280 nm; 2 ml fractions 
were collected automatically.
The results depicted in Figure 6.12 represent a typical purification run for GST-Res2p, 
as recorded by the BioCAD® system. A single peak in absorbance was observed, encompassing 
fractions ~ 6 to 8. Samples o f peak fractions were taken and analysed by SDS-PAGE and 
Coomassie blue staining (Figure 6.13). The majority o f protein, corresponding to the 
approximate M  ^ of GST-Res2p, eluted in fractions 7 and 8 with a faint band o f similar size 
visible in fraction 9. Indeed, the peak seen in Figure 6.10 correlated with the major bands 
detected in fractions 7 and 8 following Coomassie blue staining. Therefore, these results 
indicated that the major peak in absorbance was consistent with elution o f GST-Res2p.
Despite the majority of GST-Res2p being present in the supernatant fraction, the yield 
following purification was poor. Similar results were obtained upon purification of GST-Reslp 
with even lower yield (attributed to the lower expression levels observed with this protein, in 
comparison to GST-Res2p - data not shown).
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Figure 6.13 SDS-PAGE analysis of GST-Res2p from the GSTrap column
GST-Res2p was overexpressed in BL21 CodonPlus (DE3)-RIL cells for 16 h at 15°C by 
induction with 0.2 mM IPTG. The bacterial culture (routinely 500 ml) was then centrifuged, the 
pellet resuspended in 20 ml lysis buffer, and cells lysed by French pressure disruption. The 
soluble fraction was obtained following centrifugation and loaded onto the column in 5 ml 
aliquots. Peak fractions were collected automatically and samples (100 pi) taken. All samples 
were diluted in an equal volume of Laemmli sample buffer and denatured by boiling for 5 min 
in the presence o f DTT (150 mM). Samples were then analysed on a 10% SDS-polyacrylamide 
gel stained with Coomassie brilliant blue. Molecular weight markers are shown (MJ with sizes 
indicated in kDa. The arrow indicates the expected position o f full-length GST-Res2p. The 
whole cell extract (W), soluble (S) and insoluble (P) samples are shown and numbers above 
each lane correspond to the fraction numbers indicated on the BioCAD® trace (Figure 6.12).
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6.4 Purification of H is-Replp and His-CdclOp from inclusion bodies
As described previously, both His-Replp and His-CdclOp were insoluble following 
overexpression in E. coli under all conditions tested (Chapter 5, Sections 5.2 and 5.10). 
Consequently, this prevented assay of their biological activity in vitro. In addition, with regard 
to His-CdclOp, this also had implications for the in vitro assays of His-Reslp and His-Res2p 
(Chapter 5, Sections 5.6 and 5.10).
High-level overexpression of recombinant proteins in E. coli can often result in the 
formation of inclusion bodies. Inclusion bodies are thought to contain aggregates of mis-folded 
protein. Although the protein may contain the correct primaiy structure, proper folding (and 
hence full biological activity) may require post-translational modification and/or molecular 
chaperones (Lilie et al, 1998). The accumulation of a recombinant protein in inclusion bodies 
can nevertheless have a number of advantages: primarily, accumulation of high levels of 
protein in a very pure form. Native protein can be recovered following solubilisation of 
inclusion bodies in denaturing solvents or detergents, followed by re-folding/re-naturation and 
so the solubilisation and purification o f His-Replp and His-CdclOp from inclusion bodies was 
attempted.
6.4.1 Solubilisation of His-Replp and His-CdclOp using N-lauroylsarcosine
Solubilisation o f both His-Replp and His-CdclOp was based on the adaptation o f a technique 
described in the Novagen protein folding kit. Attempts to solubilise both proteins were made in 
a range of detergents, with greatest success found with buffers containing N-lauroylsarcosine. 
This is an anionic detergent that has been reportedly successful in solubilising proteins from 
inclusion bodies to their native or near native state, without affecting biological activity 
(Frangioni & Neel, 1993).
His-Replp and His-CdclOp were overexpressed in E. coli as described (Methods 2.4.1). 
Cells were harvested by centrifugation and the pellet resuspended in an appropriate volume of 
inclusion body wash buffer. Inclusion bodies were isolated following cell disruption and 
centrifugation as described (Methods 2.4.19). Subsequently, aliquots of the whole cell extract, 
supernatant and pellet (obtained following centrifugation), were analysed by SDS- 
polyacrylamide gel electrophoresis. The solubility of each protein was estimated by visual 
comparison o f the amounts present in supernatant and pellet fractions, following Coomassie 
blue staining. Figures 6.14 and 6.15 show the results obtained following solubilisation and 
purification o f His-Replp and His-CdclOp, respectively, from inclusion bodies using 
N-lauroylsarcosine. Both proteins were approximately 100% soluble in buffer containing 0.3% 
(w/v) N-lauroylsarcosine.
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Figure 6.14 SDS-PAGE analysis of His-Replp solubilised in N-lauroylsarcosine
His-Replp was overexpressed in BL21 CodonPlus (DE3)-R1L cells for 3 h at 37'C by 
induction with 1 mM IPTG. Samples (1 ml) were removed at the point o f induction (0 h) and at 
3 h. The bacterial culture was then centrifuged, the pellet resuspended in 5 ml Inclusion body 
wash buffer, and cells lysed by French pressure disruption. This whole cell extract (W) was 
then separated into soluble (S) and insoluble (P) fractions by centrifugation and samples (1 ml) 
taken. The pellet was washed extensively in Inclusion body wash buffer prior to resuspension 
in 50 mM KH2 PO4 , pH 7.5, supplemented with either 0.1% (v/v) or 0.3% (v/v) 
N-lauroylsarcosine. Following agitation and centrifugation and an aliquot o f supernatant taken 
for analysis. Samples from 0 h and 3 h were centrifuged, the pellets resuspended in Laemmli 
sample buffer (10 pl/0.1 absorbance unit) and denatured by boiling for 5 min in the presence of  
DTT (150 mM). All other samples were diluted with an equal volume of Laemmli sample 
buffer and similarly denatured. Samples were then analysed on a 10% SDS-polyacrylamide gel 
stained with Coomassie brilliant blue. The arrow indicates the expected position o f full-length 
His-Replp. Molecular weight markers are shown (Mr) with sizes indicated in kDa.
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Figure 6.15 SDS-PAGE analysis of His-CdclOp solubilised in N-lauroylsarcosine
His-CdclOp was over-expressed in BL21 CodonPlus (DE3)-R!L cells for 3 h at 37°C by 
induction with 1 mM IPTG. Samples (1 ml) were removed at the point o f induction (0 h) and at 
3 h. The bacterial culture was then centrifuged, the pellet resuspended in 5 ml Inclusion body 
wash buffer, and cells lysed by French pressure disruption. This whole cell extract (W) was 
then separated into soluble (S) and insoluble (P) fractions by centrifugation and samples (1 ml) 
taken. The pellet was washed extensively in Inclusion body wash buffer prior to re-suspension 
in 50 mM KH2PO4 , pH 7.5, supplemented with either 0.1% (v/v) or 0.3% (v/v) N- 
lauroylsarcosine. Following agitation and centrifugation an aliquot o f supernatant was taken for 
analysis. Samples from 0 h and 3 h were centrifuged, the pellets resuspended in Laemmli 
sample buffer (10 pl/0.1 absorbance unit) and denatured by boiling for 5 min in the presence of 
DTT (150 mM). All other samples were diluted with an equal volume of Laemmli sample 
buffer and similarly treated. Samples were then analysed on a 10% SDS-polyaciylamide gel 
stained with Coomassie brilliant blue. The arrow indicates the expected position o f full-length 
His-CdclOp. Molecular weight markers are shown (Mr) with sizes indicated in kDa.
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6.5 Investigating the structure and function of the purified 
recombinant DSCl proteins
Attempts to purify His-Reslp, His-Rep2p, GST-Reslp and GST-Res2p were unsuccessful in 
that both yield and purity were unsatisfactory. In contrast, purification of His-Res2p, His- 
Replp and His-CdclOp yielded amounts sufficient to allow detailed structural analyses to be 
undertaken. However, the issue o f whether these latter thiee recombinant proteins were 
biologically active remained unresolved.
Following purification o f these proteins, attempts were made to recover them in buffer 
solutions more appropriate for biophysical analyses. With respect to His-Res2p, the high 
concentration of imidazole present in the elution buffer had to be removed. Similarly, the level 
o f N-lauroylsarcosine may have to be reduced or removed to permit structural studies o f His- 
Replp and Flis-CdclOp. Buffer exchange is routinely achieved by dialysis, involving multiple 
changes of buffer through a semi-permeable membrane with a molecular weight cut-off, or 
centrifugation using a centricon tube (Methods 2.4.3-2.4.4). Using either approach, all three 
proteins frequently precipitated despite attempting a variety of conditions (e.g. temperature) 
and buffers. In addition, thrombin cleavage of His-Res2p was unsuccessful despite 
manipulation of cleavage conditions. Unfortunately, due to time constraints, studies using 
purified His-Res2p and His-CdclOp in band-shift assays were not initiated. Nevertheless, initial 
attempts to obtain structural information from His-CdclOp and His-Replp were undertaken.
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6.6 C ircular dichroism
Detailed structural information from a protein is typically obtained from high-resolution 
techniques such as X-ray crystallography and NMR spectroscopy. Both of these techniques 
require significant amounts of material (several tens of mg) and results are rarely rapidly 
obtained. Indeed, for successful X-ray analysis crystals must be produced that diffract 
sufficiently to permit structural detail at the atomic level. Typically, this may take several 
weeks, months or even years to achieve. Furthermore, in NMR, full structural determinations 
are limited to small proteins of maximal molecular weight ~ 30 kDa.
In contrast, circular dichroism (CD) studies require significantly less material (1-2 mg 
ml'^ or less) and results are rapidly obtained (typically within a few hours). Despite these 
advantages, this is a lower resolution technique and so detailed structural information is not 
generally obtained from CD spectra. However, the secondary structure content of a protein can 
be empirically determined. Perhaps the most valuable use of CD is in the study of protein 
folding and protein-protein, protein-nucleic acid and protein-ligand interactions.
CD is a spectroscopic technique that involves measurement of the differential absorption 
of the left and right circularly polarised components of plane-polarised light. Upon passage 
through an optically active sample, one of these components (i.e. left or right) will be absorbed 
to a greater extent than the other (as a result of the asymmetric nature of chiral molecules). 
Consequently, subsequent recombination o f these eomponents generates elliptically polarised 
light. The occurrence of ellipticily is called circular dichroism. CD spectra are recorded in a 
spectropolarimeter where the differential absorption of left and right circularly polarised light is 
detected and converted into units of ellipticity, 0  (degrees cm^ dmof^).
CD measurements can be performed in two main spectral regions, the far-UV region 
(240-180 nm) and the near-UV region (320-260 nm). In the far-UV region the principal 
absorbing species is the peptide bond and so the CD spectrum is sensitive to the main chain 
conformation. The common secondary structure motifs, a-helix, [3-sheet and P-turn exhibit 
distinct CD spectra in this region, therefore CD studies can be used to estimate the secondaiy 
structure content o f a protein. In addition, random coil, representing regions of a protein that do 
not encompass the major secondary structural motifs, can be identified as it absorbs in a region 
similar to that of p-sheet (Kelly and Price, 2000).
Several computer progi ams are available to estimate the secondary structure content of a 
protein from the properties o f its CD spectra (Provencher and Glockner, 1981; Sreerama and 
Woody, 1993). Experimental CD values are compared to a database containing CD spectra of 
proteins whose structures have been solved by X-ray diffraction. Using this approach, a 
secondary structure content estimate of the protein is obtained. The validity of these estimates 
can then be compared/contrasted with previous known data. Therefore, CD spectra can provide
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low-resolution (yet reliable) secondaiy structural information on a protein. In the near UV 
region the environment o f aromatic amino acids such as tryptophan, tyrosine, phenylalanine 
and cystinyl groups can be detected. In a folded protein the side chains of these amino acids are 
likely to be placed in a chiral environment, thus giving rise to spectra that can provide a 
fingerprint of the tertiaiy structure of the protein.
In this section, CD was used to determine the secondary structures o f His-CdclOp and 
His-Replp. In addition, the stability and unfolding characteristics o f both proteins were 
investigated, by monitoring changes in their CD spectra following dénaturation in increasing 
concentrations of guanidinium chloride.
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6.6.1 Secondary structure determination of His-Replp and His-CdclOp
His-CdclOp and His-Replp were solubilised and purified from inclusion bodies as described in 
Section 6.4.1. Specifically for CD measurements, inclusion bodies were solubilised in 50 mM 
KH2PO4, 150 mM NaF pH 7.5, supplemented with 0.1% (v/v) N-lauroylsarcosine. The lower 
amount of 0.1% (v/v) N-lauroylsarcosine was preferred (to 0.3%) as the sample was of greater 
purity in this preparation and a minimal amount of detergent was more suitable for CD studies. 
CD specfroscopy was carried out in the Scottish Circular Dichroism Facility, University of 
Glasgow, using standard methodology (Methods 2.4.21). In all cases, the CD spectrum was 
obtained following subtraction o f the baseline (buffer only) spectrum from the sample 
spectrum.
6.6.2 CD spectra of His-Replp and His-CdclOp
Purified His-Replp (0,24 mg ml"’) and His-CdclOp (0.22 mg mf^) were prepared for CD 
analysis as described above. An initial CD scan revealed that there was a significant level of 
nucleic acid contamination in both protein preparations. Nucleic acids display distinct CD 
spectra in the near UV region and therefore interfere with any signal produced from the protein. 
Consequently, analysis o f His-Replp and His-CdclOp in the near-UV region was not possible. 
An example of the nucleic acid contamination of His-Replp is shown in Figure 6.16. 
Furthermore, analysis of these proteins in the far-UV region was only permitted down to a 
lower wavelength limit of 180 nm due to the poor signal to noise ratio. Figures 6.17 and 6.18 
show the CD spectra obtained for His-Replp and His-CdclOp, respectively. Secondary 
structure estimates were calculated using the CONTÎN procedure (Provencher and Glockner, 
1981) and are displayed in Tables 6.1 and 6.2 for His-Replp and His-CdclOp, respectively. 
These results indicate that the majority of detergent solubilised full-length His-Replp consists 
of a-helix (-78%), with -17%  p-sheet/turn and the remaining - 6 % as random coil. For 
detergent solubilised full-length His-CdclOp the majority o f the protein consists of p-sheet/tum 
(-40%), with -30%  a-helix and the remaining -30%  as random coil.
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Figure 6.16 Nucleic acid contamination of His-Replp
CD spectrum incorporating both near and far-UV regions shows nucleotide contamination of 
His-Replp. Measurements were recorded in a quartz cell of path length 0.02 cm, containing 
purified His-Replp (0.24 mg ml"') in 50 mM KH2PO4, 150 mM NaF pH 7.5, supplemented 
with 0.1% (v/v) N-lauroylsarcosine.
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Figure 6.17 Secondary structure determination of His-Replp
The far-UV scan of His-Replp. Measurements were recorded in a quartz cell of pathlength 0.02 
cm, containing purified His-Replp (0.24 mg mf^) in 50 mM KH2PO4, 150 mM NaF pH 7,5, 
supplemented with 0.1% (v/v) N-lauroylsarcosine.
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Figure 6.18 Secondary structure determination of His-CdclOp
The far-UV scan of His-CdclOp. Measurements were recorded in a quartz cell of pathlength 
0.02 cm, containing purified His-CdclOp (0.22 mg ml'^) in 50 mM KH2PO4, 150 mM NaF pH 
7.5, supplemented with 0.1%(v/v) N-lauroylsarcosine.
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Secondary 
Structure Element
Total 
Protein %
a-helix 77.4
p-sheet 2.1
p-turn 14.8
Random coil 5.8
Table 6.1 Secondary structure content estimate of His-Replp
The secondary structure content of recombinant His-Replp was estimated from analysis of the 
far-UV CD spectra using the CONTIN procedure (Provencher and Glockner, 1981).
Secondai*y 
Structure Element
Total 
Protein %
a-helix 29.6
P-sheet 20.7
p-turn 20.9
Random coil 28.8
Table 6.2 Secondary structure content estimate of His-CdclOp
The secondary structure content o f recombinant His-CdclOp was estimated from analysis o f the 
far-UV CD spectra using the CONTIN procedure (Provencher and Glockner, 1981).
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6.6.3 Assessment of His-Replp and His-CdclOp stability
The stabilities of His-Replp and His-CdclOp were also assessed, following chemical 
dénaturation with guanidinium chloride (GdmCl). Purified His-Replp (0.24 mg ml"’) and His- 
CdclOp (0.22 mg mf^) samples were prepared in increasing guanidinium chloride 
concentrations as described (Methods 2.4.22).
The unfolding of His-Replp and His-CdclOp in GdmCl was monitored by changes in 
far-UV CD and expressed in terms o f % total change o f this parameter occurring between 0 M 
and 6  M GdmCl. The unfolding o f His-Replp and His-CdclOp as monitored by CD is 
presented in graphical form in Figures 6.19 and 6.20, respectively.
From the appearance o f the graph shown in Figure 6.19, it appears that there is a 
biphasic unfolding event occurring. An initial major unfolding event takes place between 0 and 
0.5 M GdmCl, followed by an apparent stabilisation until the GdmCl concenti’ation is increased 
to approximately 2 M. From this point onwards, a second unfolding event begins that ends at 6  
M. Similarly, the unfolding o f His-CdclOp follows a biphasic pattern. The initial unfolding 
event takes place between 0-2 M GdmCl. The second event occurs sharply between 2 M and ~ 
3 M and perhaps a third event may be occurring between 3 M and 6  M (Figure 6.20).
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Figure 6.19 Unfolding profile of His-Replp during dénaturation with guanidinium 
chloride
Purified His-Replp (0.24 mg m l ’) was incubated at room temperature in increasing 
concentrations o f GdmCl: 0 M, 0.5 M, 1 M, 2 M, 3 M, 4 M and 6  M prior to measurement. The 
CD changes were expressed relative to the total change observed between 0 M and 6  M 
GdmCl. CD was measured as change in ellipticity (0) at 222 nm.
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Figure 6.20 Unfolding profile of His-CdclOp during dénaturation with guanidinium 
chloride
Purified His-CdclOp (0.22 mg ml ') was incubated at room temperature in increasing 
concentrations o f GdmCl: CM, 0.5M, IM, 2M, 3M, 4 M and 6 M prior to measurement. The 
CD changes were expressed relative to the total change observed between 0 M and 6 M 
GdmCl. CD was measured as change in ellipticity (0) at 222 nm.
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6.7 Discussion
The aim of this chapter was to purify the bacterially overexpressed recombinant fission yeast 
DSCl components. Following on horn the results discussed in Chapter 5, several unresolved 
issues required further investigation. The initial aim of purification was to obtain protein with 
which to carry out further in vitro functional assays. In addition, purification of protein of 
sufficient yield and purity would allow the initiation of structural studies.
Unfortunately, both the yield and purity o f His-Reslp and His-Rep2p were 
unsatisfactory, following purification by IMAC. This was attributed to the low level 
overexpression of these proteins in E. coli. Attempts to increase the overexpression level have 
been discussed previously (Chapter 3 Section 3.4). A scaling up o f the purification process 
neither improved yield nor purity.
In contrast, the yields of the GST-Resp proteins obtained following overexpression in E. 
coli were significantly greater, and it was anticipated that purification would provide large 
amounts of protein. Disappointingly, neither GST-Reslp nor GST-Res2p was purified in 
suffieient amounts, following affinity purification on an immobilised glutathione column. Due 
to time constraints, the optimisation o f purification of these proteins has not been fully 
investigated and as such, the results presented represent preliminary data. Reasons for poor 
recovery may include steric hindrance of the GST moiety, by intramolecular interactions with 
the attached Resp protein. It should be noted that in both cases, DNA sequeneing has confirmed 
that the GST-tag was in-frame with the cDNA. These results were particularly frustrating, 
given that several interesting and potentially informative experiments, regarding the in vitro 
DNA-binding behaviour of these proteins, relied on their purification.
The most favourable case was in purification of His~Res2p. This protein was 
reproducibly purified in large amounts following IMAC (5-10 mg f '  culture). Despite 
eonsistent co-purification with a -60,000 Da protein, subsequent mass spectrometric analysis 
identified this protein as an N-terminally truncated product of His-Res2p (Section 6.2.3). 
Unfortunately, recovery of purified His~Res2p, in buffers suitable for structural studies, 
frequently resulted in precipitation. Indeed, initial attempts to obtain CD specfra from this 
protein were unsuccessful, primarily due to precipitation. Intriguingly, the specfral studies 
displayed a high level of nucleic acid contamination in purified samples of His-Res2p. This 
was despite the fact that both DNAase and RNAase were routinely used in purification 
procedures. Given that this protein is a DNA-binding protein its association with nucleic acids 
is not surprising. Precipitation of His-tagged proteins purified by IMAC has also been noted 
elsewhere and attributed to contamination with Zn^^ ions from the chromatography column 
(Lindner et ah, 1992). However, despite addition of EDTA, precipitation continued.
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His-CdclOp and His-Replp were solubilised from inclusion bodies, using the anionic 
detergent N-lauroylsarcosine. The yield and purity of these proteins was sufficient to initiate 
structural studies. Similarly to His-Res2p, dialysis into more suitable buffers routinely resulted 
in precipitation and aggregation o f protein. Nevertheless, CD studies were initiated on His- 
CdclOp and His-Replp, as this technique was somewhat tolerant to the presence of low levels 
of detergent. Initial CD spectra o f these proteins also revealed a significant level of nucleic acid 
contamination; this precluded near-UV analysis o f these proteins and imposed restrictions on 
the far-UV studies. Far-UV CD spectra were obtained for both proteins permitting secondary 
structure content estimations and stability studies were initiated by monitoring unfolding 
following dénaturation in increasing concentrations of guanidinium chloride. The results o f the 
CD studies using these proteins should be treated with caution, as neither o f these proteins has 
been shown to be active in vitro. It is highly likely that to obtain these proteins in their fully 
native state, re-folding will be necessary. The results obtained here serve as an example o f the 
type o f initial structural information that can be rapidly obtained following successful 
purification.
Structure-function studies o f proteins need large amounts of material. The ability to 
obtain sufficient amounts requires the development of efficient and reproducible methods for 
overexpression and purification of the proteins o f interest. As exemplified in this (and previous 
chapters) development o f such protocols requires considerable investigation. The necessity to 
produce large amounts o f protein for such studies can frequently result in aggregation and 
precipitation as has been the case with His-Res2p. Assuming that the problem of precipitation 
can be overcome, structural studies may then be initiated given the yield and purity o f this 
protein obtained, following purification by IMAC.
With respect to His-Reslp, His-Rep2p and the GST-Resp proteins, optimisation of 
purification must be addressed in order to provide sufficient material for further study. Several 
experiments o f significant interest, with purified GST-Resp proteins could then be addressed. 
In summary, due to time constraints, the results presented within this chapter provide a basis 
for further study.
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Chapter 7
General discussion
7.1 Introduction
In both budding and fission yeasts, the highly related MBF/SBF and DSCl transcription factor 
complexes are responsible for controlling the Gl -S phase-specific gene expression programme 
essential for passage through START and entry into a new round of mitotic cell division. 
Similarly, in humans, a Gl-S phase-specific gene expression programme exists that is also 
essential for passage through the Restriction point and entry into mitosis. In contrast to the two 
yeast systems, the B2F transcription factor family of proteins bear no significant resemblance to 
any of the yeast proteins at the amino acid sequence level.
In budding yeast, MBF and SBF are heterodimeric transcription factors composed of the 
single sequence-specific DNA-binding protein subunits, ScMbplp and ScSwi4p, respectively, 
combined with the common regulatoiy subunit ScSwi6 p that is present in both complexes. 
Fission yeast DSCl is believed to exist as a heterotetramer, consisting of two distinct yet 
related sequence-specific DNA-binding proteins, SpReslp and SpRes2p, each of which binds 
to a single molecule o f the regulatoiy SpCdclOp protein. The budding yeast and fission yeast 
proteins constitute a family o f related transcription factors that share eonsiderable homology, 
located to three main regions. All six proteins possess the centrally located ankyrin-repeat 
motifs, whose primary function is unclear, but may be involved in both protein-protein 
interactions and in affording flexibility. The ScMbplp/ScSwi4p and SpReslp/SpRes2p proteins 
also share considerable homology witliin their N-terminal DNA-binding regions, whilst 
ScSwi6 p and SpCdclOp do so in their C-termini. To date, structural studies on this family of 
transcription factors have been limited to the budding yeast proteins; specifically the DNA- 
binding domain of ScM bplp and ankyrin repeat domain o f ScSwi6 p (Xu et al., 1997; Taylor et 
al., 1997; Foord et al., 1999). In contrast, no structural data beyond the amino acid sequence 
level is available for any o f the fission yeast members of this family. Thus, successful cloning 
and expression of the fission yeast DSCl components will provide an invaluable resource for 
detailed structural and functional studies.
181
7.2 Summary of results
7.2.1 Chapter 3: Cloning and overexpression
In Chapter 3 the cloning strategy was described, which allowed the successful and reproducible 
overexpression of the individual components of the fission yeast DSCl complex in E, coli. 
Site-directed mutagenesis was employed to remove an artifieial internal stop codon within the 
cdclO^ open reading frame.
Each of the individual components of the DSCl complex: cdclO^, resl'^, res2'", r e p t  
and rep2* was cloned into the pET-28c vector (pET-14b for cdclO^) in-ffame with an N- 
terminal 6 -histidine tag (to facilitate purification by affinity chromatography) and successfully 
expressed following induction at 37°C. High-level expression o f the Res2p, Rep Ip and CdclOp 
components of DSCl as His-tagged fusion proteins was achieved as visualised by SDS-PAGE 
and Coomassie blue staining (Figures 3.7-3.8 ). Overexpression o f His-Reslp and His-Rep2p 
was achieved at lower levels, such that they were detectable only following immunoblot 
analysis (Figures 3.7, 3.10 and 3.9, 3.11).
7.2.2 Chapter 4: Biological activity assays in vivo
Chapter 4 described the use o f fission yeast (the organism from which these proteins originate) 
as host to assay the effects o f die N-terminal His-tag upon the biological activity o f each o f the 
recombinant proteins in vivo.
To this end, the cloning strategy was described that facilitated expression of the His- 
resl^, His-res2^, His-repï" and His~rep2^ cDNAs in fission yeast from the pREP vector. Due to 
time constraints (primarily the lengthy site-directed mutagenesis protocol), His-cdclO^ was not 
cloned into the pREP vector and so the ability o f His- cdcH f to function in vivo was not 
determined.
The biological activity o f each recombinant protein was assayed following expression in 
the Aresl mutant background. The wild type resl^^ res2^\ r e p t  and rep2^ genes can each 
suppress the cold-sensitive phenotype o f this strain (Tanaka et al., 1992; Miyamoto et al,, 1994; 
Sugiyama et al., 1994; Nakashima et al., 1995). Similarly, the His-resl^, His-res2^, H is-rep t  
and His-rep2^ cDNAs each suppressed the cold-sensitive lethality of Aresl cells when 
ectopically expressed (Figures 4.8-4.11). The biological activities o f His-Reslp and His-Res2p 
were also assayed following expression in AresJ and Ai^es2 mutant backgrounds. Ectopic 
expression o f res and res2~^  in AresJ and Ares2 cells, re-constitutes the characteristic DSCl 
band-shift activity that is otherwise lost in these mutant strains (Zhu et al., 1997; Ayte et al., 
1997). A ‘DSCl-like’ band-shift activity was observed in Ares2 cells upon ectopic expression 
o f His-res2^ (Figures 4.12-4.13). Surprisingly, no ‘DSCl-like’ band-shift activity was detected
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when H is-re s t  was expressed in /St'esl cells (Figure 4.14). That each recombinant protein was 
able to rescue the cold-sensitive lethality o f the /Aresl mutant suggested that the His-tag 
imposed no impairment to function in vivo.
7.2.3 Chapter 5: Recombinant protein solubility
In Chapter 5, attempts to obtain soluble recombinant protein, following overexpression of His- 
Reslp, His-Res2p, His-Replp, His-Rep2p or His-CdclOp in E. coli, were described. Following 
this, a series of assays were outlined to determine the biological activity of these bacterially 
expressed proteins.
A range of expression and lysis buffer conditions were tested to optimise the amount and 
solubility of each recombinant protein. Both His-Reslp and His-Rep2p were retr ieved in the 
soluble fraction under most conditions tested, although yields were low (Figures 5.3-5.4). The 
ability to produce soluble His-Res2p was dependent on both induction conditions and the 
nature of the solvent. Approximately 100% of His-Res2p was retrieved in soluble form 
following expression at 15°C and importantly, release into lysis buffer containing < 100  mM 
NaCl (Figures S.5-5.6). Despite analysis under a range of conditions, both His-Replp and His- 
CdclOp were retrieved as insoluble aggregates following release from the cell (Figures 5.1-5.2) 
and so biological activity assays using either of these two proteins were precluded.
7.2.4 Chapter 5: Biological activity assays in vitro
Following production of soluble His-Reslp and His-Res2p, these recombinant proteins were 
assayed for biological activity in vitro using the EM SA technique. In this study, neither His- 
Reslp nor His-Res2p (obtained in crude soluble E. coli extracts following overexpression) 
produced a detectable MOB DNA-binding activity when incubated with a radio-labelled MOB 
probe (Figure 5.7).
Failure to detect DNA-binding with either of these proteins may have been due, at least 
in part, to the absence of CdclOp, since in vitro DNA-binding by either protein is dependent on 
CdclOp, although weak Res2p DNA-binding has been reported alone (Ayte et al., 1995; Zhu et 
al., 1997). The insoluble nature of His-CdclOp in this study prevented such analyses and so an 
alternative strategy employed co-expression studies in an attempt to circumvent this problem. 
Unfortunately, co-expression of either His-Reslp or His-Res2p with His-CdclOp proved 
unsuccessful in terms of detectable protein. In addition, co-expression of either His-Reslp or 
His-Res2p with each other and with His-Replp or His-Rep2p was tested, reasoning that 
association of these proteins might facilitate MCB-specific DNA binding o f the Resp subunits, 
in the absence of CdclOp. Although co-expression of His-Res2p/His-Rep2p was detected, and 
both of these proteins were present in the soluble fraction (as determined by immunoblotting -  
Figure 5.8), use of this protein extract did not yield detectable MCB binding in vitro. Mixing of
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either His-Reslp or His~Res2p with fission yeast protein extracts prepared from Aresl or Ares2 
cells, respectively, were similarly ineffectual. To summarise, neither bacterially produced 
soluble His-Reslp nor His-Res2p showed detectable DNA-binding activity in vitro, in the 
absence of CdclOp.
Previous studies have indicated that in the absence of CdclOp, at least in vitro. Res Ip 
requires artificially mediated homodimerisation in order to exhibit MCB-specific DNA-binding 
(Ayte et al., 1995). It had been shown previously that bacterially expressed Res Ip as a GST- 
fiision protein could bind specifically to an MCB DNA probe in in vitj'o band-shift assays 
(Ayte et al., 1995). In this study, both Res Ip and Res2p were subsequently cloned and 
expressed as N-terminal GST-fusion proteins to investigate dimerisation-dependent MCB- 
specific DNA-binding in vitro, in comparison to the His-tagged isoforms. Hence, the cloning 
strategy was described, which allowed the successful and reproducible overexpression of the 
Res Ip and Res2p components o f the fission yeast DSCl complex in E. coli as N-terminal GST- 
fusion proteins. Each protein was successfully overexpressed in soluble form following 
induction at 15“C (Figures 5.12-5.14). Furthermore, both GST-Reslp and GST-Res2p, in 
contrast to the His-tagged isoforms, bound specifically to MCB DNA in band-shift assays 
(Figures 5.16-5.17).
7.2.5 Chapter 6: Purification and analysis of the recombinant DSCl components
Following the solubility studies and in vitro activity assays carried out in Chapter 5, 
purification o f the recombinant DSCl components and initiation o f structural analyses were 
described in Chapter 6 . The solubilisation and purification o f His-Replp and His-CdclOp from 
inclusion bodies was also described. The aims of this chapter were twofold; firstly, to obtain 
pure protein of sufficient yield and purity with which to carry out further in vitro functional 
analyses and secondly, to allow the initiation o f structural studies.
Unfortunately, both yield and purity o f His-Reslp and His-Rep2p were unsatisfactory, 
following purification by IMAC (Figure 6.2). This was attributed to the low-levels o f these 
proteins produced following overexpression in E. coli. Despite attempts to increase expression 
levels and scale-up the purification, the amounts retrieved following purification were 
insufficient to pursue structural studies.
In contrast, the yields of GST-Reslp and GST-Res2p obtained following overexpression 
in E. coli were significantly greater, and it was anticipated that purifieation would provide 
sufficient amounts of material with which to instigate structure/function studies. Frustratingly, 
however, neither GST-Reslp nor GST-Res2p was retrieved in sufficient yield or purity, 
following affinity purification (Figure 6.13). Due to time constiaints, optimisation o f the 
purification procedure for these proteins has not been fully investigated and as such, the results 
presented represent preliminaiy data.
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HiS"Res2p was reproducibly expressed and purified in high yield (5-10 mg l ' culture). 
Initial observations noted the continued presence of a ‘contaminant’ protein species of Mr 
approximately 60 kDa, although this was subsequently identified as a N-terminally degraded 
product of His-Res2p, by mass spectrometric analysis (Figures 6.4-6.11). Unfortunately, 
recovery of purified His-Res2p, in buffer solutions suitable for structural studies, frequently 
resulted in precipitation. Initial attempts to obtain CD spectral data from this protein were 
unsuccessful, primarily due to precipitation. The spectral studies showed a high level of nucleic 
acid contamination in purified samples o f His-Res2p. This was despite the fact that routine 
measures (e.g. use of both DNAase and RNAase) were employed to prevent this problem.
Both His-Replp and His-CdclOp proteins were refractory to manipulation of induction 
and solvent conditions, although each protein was ultimately solubilised and purified from 
inclusion bodies, using the anionic detergent N-lauroylsarcosine in yields that were sufficient to 
initiate structural studies (Figures 6.14-6.15). Similarly to His-Res2p, however, dialysis into 
more suitable buffers routinely resulted m precipitation and aggregation of protein. Initial CD 
spectra of these proteins also revealed a significant level of nucleic acid contamination (Figure 
6.16). Nevertheless, CD studies were initiated on His-CdclOp and His-Replp, as this technique 
is tolerant to low levels o f detergent. The results of these CD studies demonstrated that each 
protein had significant secondary structure and were at least partially folded (Figures 6.17-6.20 
and Tables 6 .1-6.2). Given that both proteins required detergent solubilisation, it is highly 
likely that to obtain these proteins in their fully native state, re-folding strategies are required.
7.3 Future experimental w ork
The aim of this work was to provide a stable reproducible and active source o f recombinant 
components of the fission yeast DSCl complex in sufficient yield and purity to allow detailed 
structural and functional analyses. Whilst significant steps have been taken toward this ultimate 
goal, several key issues require further investigation.
Importantly, this study has demonstrated that bacterially expressed Res Ip and Res2p are 
biologically active, in terms of MCB-specific DNA-binding activity, when expressed as N- 
terminal GST-fusion proteins. This indicates that post-translational modification is not essential 
for the DNA-binding activity o f these proteins in vitro. This had been demonstrated previously 
for GST-Reslp (Ayte et al., 1995). Initial attempts to purify these proteins in sufficient yield 
for further analyses, specifically structural studies, proved unsuccessful. Future work would 
therefore concentrate on optimising the purification of these two proteins to provide a 
convenient source o f pure protein with which to undertake detailed biophysical analyses.
In contrast, no such DNA-binding activity was detected with either o f the His-tagged 
Resp proteins. Previous studies reported that the MCB-specific DNA-binding activity o f in
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vitro translated Res Ip and Res2p was dependent on co-expression with CdclOp, although a 
weak band-shift activity could be detected with Res2p alone (Ayte et ah, 1995; Zhu et ah, 
1997). In this thesis, the inability to obtain soluble His-CdclOp protein (or to co-express either 
His-Reslp or His-Res2p with His-CdclOp) has prevented a definitive analysis o f the 
dependency of these proteins upon CdclOp for in vitro DNA-binding activity. Even so, this 
study has demonstrated the solubilisation o f His-CdclOp from inclusion bodies, although it is 
likely that the production of active His-CdclOp protein from this source will require re-folding. 
If this can be achieved, then the issue of His-Reslp and His-Res2p DNA-binding activity may 
be more fully investigated.
O f particular interest is why the GST-Resp proteins should exhibit MCB-specific DNA- 
binding activity, yet the His-Resp proteins do not. Clearly such differences may reflect the 
different N-terminal tags. It is possible that this may be due to a tag-mediated protein folding 
effect with the His-Resp proteins, presumably, unable to fold into their native tertiary structure, 
in contrast to their GST-tagged isoforms. However, the soluble nature o f both His-Reslp and 
His-Res2p suggests this would be unlikely. It has been demonstrated in this study that His- 
tagged Res Ip and Res2p are able to function in vivo. Perhaps a more obvious explanation for 
the difference in DNA-binding activity between these fusion proteins lies in the intrinsic 
dimérisation potential o f the GST-tag. In contrast to the His-tagged proteins, GST-fusion 
proteins are expressed as homodimers.
As discussed in Chapter 5, Res Ip and Res2p are believed to bind to DNA as 
heterodimers in vivo and Res Ip and Res2p can homo-dimerise in vitro in a Cdcl Op-dependent 
manner (Ayte et al., 1997; Zhu et al., 1997; Whitehall et al., 1999). Thus, it is highly likely that 
the difference in activity displayed by the GST-Resp and His-Resp proteins reflects intrinsic 
dimérisation potential. However, this conclusion cannot be reached solely from the results 
presented in this study, and require further investigation to be proved.
The GST-Resp fusion proteins used in band-shift assays herein were obtained from 
crude soluble bacterial extracts (Figure 5.16). Whilst the majority of protein in these extracts 
was full-length GST-Reslp or GST-Res2p, they were not homogeneous and so it could not be 
determined whether DNA-binding was mediated by full-length, or C-terminally truncated GST- 
Resp molecules. Importantly, C-terminally truncated Res2p molecules show enhanced DNA- 
binding in vitro, and the highly related ScSwi4p protein displays C-terminally mediated auto­
inhibition of DNA-binding (Zhu et al., 1997; Baetz and Andrews, 1999). Thus, it is tempting to 
speculate that the inability o f the His-Resp proteins reflects an inability to homo-dimerise 
and/or C-terminally mediated inhibition, in the absence of CdclOp.
In order to further resolve these issues, pure preparations of full-length GST-Resp fusion 
proteins must be obtained for use in DNA-binding assays. Initial attempts to do this were 
described in Chapter 6 . Due to time eonstraints the conditions for purification have not been
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optimised. Thrombin cleavage of each tag could be employed in order to separate the effects of 
the respective tags upon DNA-binding activity. O f particular importance will be assay o f the 
ability of each protein to bind DNA in the absence of GST-mediated dimérisation.
In this respect, the His-Resp fusion proteins merit further analysis. Full-length His- 
Res2p has been successfully over-expressed and purified in high yield, providing a valuable 
resource for structural studies. Importantly, to date, this represents the first member o f this 
family of transcription factors to have been produced intact and in yields sufficient to permit 
detailed biophysical analyses. As discussed above (and in Chapter 5) the apparent inactivity of 
either His-Resp protein may not simply be due to mis-folded but rather due to an inability to 
homo-dimerise in vitro. So, whilst a reproducible source of pure His-Res2p in high yield has 
been produced, final optimisation of the stability o f this protein requires further investigation. 
Specifically, protein precipitation has proven to be a frequent and frustrating problem following 
attempts to study this purified recombinant protein. Assuming that the problem of precipitation 
can be overcome, structural studies may then be initiated. Similarly, following optimisation of 
the GST-Resp purifications, structural analyses should be possible. Comparative studies with 
His-Res2p, for example using CD, will be of particular interest. In addition, the purified GST- 
R eslp and GST-Res2p may also be utilised for pull-down assays with the His-tagged DSCl 
components.
In future studies it may be worthwhile to investigate the use o f alternative heterologous 
hosts for the expression of the recombinant DSC 1 component proteins. Eukaryotic hosts such 
as the methylotrophic yeast Pichia pastoris and insect cells are now more commonly in use. In 
particular, exploitation of these systems may be required to produce sufficient amounts o f His- 
R eslp and His-Rep2p, which have been unattainable in E. coli. Ultimately following 
optimisation and extension of much of the work presented in this study, the long-term goal of 
reconstituting an in vitro DSCl complex should be possible providing an invaluable resource 
for future investigation into the structure and function of these components.
187
References
Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, J. D. (1994). Molecular 
Biology o f  the Cell (3rd Edition). Gailand publishing.
Amon, A., Tyers, M., Butcher, B., and Nasmyth, K. (1993). Mechanisms That Help the Yeast 
Cell Cycle Clock Tick: G2 Cyclins Transcriptionally Activate G2 Cyclins and Repress G1 
Cyclins. C elll4 , 993-1007.
Andrews, B.J., and Herskowitz, 1. (1989a). Identification of a DNA Binding Factor Involved in 
Cell-Cycle Control of the Yeast HO  Gene. Cell 57, 21-29.
Andrews, B.J., and Herskowitz, I. (1989b). The yeast SWI4 protein contains a motif present in 
developmental regulators and is part of a complex involved in cell-cycle dependent 
transcription. Nature 342, 830-833.
Andrews, B. J., and Moore, L. A. (1992). Interaction of the yeast Swi4 and Swi6  cell cycle 
regulatory proteins in vitro. Proceedings o f  the National Academy o f  Sciences USA 89, 11852- 
11856.
Aves, S. J., Durkaez, B. W., Carr, A., and Nurse, P. (1985). Cloning, sequencing and 
transcriptional control of the Schizosaccharomyces pombe cdclO ‘start’ gene. The EMBO 
Journal 4, 457-463.
Ayte, J., Leis, J. F., and DeCaprio, J. A. (1997). The Fission Yeast Protein p73‘^“®^ Is an 
Essential Component o f the Mitotic MBF Complex and a Master Regulator of Meiosis. 
Molecular and Cellular Biology 17, 6246-6254.
Ayte, J., Leis, J. F., Herrera, A., Tang, E., Yang, H., and DeCaprio, J. A. (1995). The 
Schizosaccharomyces pombe MBF Complex Requires Heterod imerization for enhy into S 
Phase. Molecular and Cellular Biology 15, 2589-2599.
Ayte, J., Schweitzer, C., Zarzov, P., Nurse, P., and DeCaprio, J. A. (2001). Feedback regulation 
of the MBF transcription factor by cyclin Cig2. Nature Cell Biology 3, 1043-1050.
Baber-Furnari, B. A., Rhind, N., Boddy, M. N., Shanahan, P., Lopez-Girona, A., and Russell, 
P. (2000). Regulation o f Mitotic Inhibitor Mikl Helps to Enforce the DNA Damage 
Checkpoint. Molecular Biology o f  the Cell 11, 1-11.
188
Baetz, K., and Andrews, B, (1999). Regulation of Cell Cycle Transcription Factor Swi4 
through Auto-Inhibition o f DNA-Binding. Molecular and Cellular Biology 19, 6729-6741.
Bardin, A. J., and Amon, A. (2001). MEN and SIN: What’s the Difference? Nature Reviews 
Molecular Cell Biology 2, 815-826.
Breeden, L. L. (2003). Periodic Transcription: A Cycle Within a Cycle. Current Biology 13, 
R31-R38.
Bartlett. R., and Nurse, P. (1990). Yeast as a Model System for Understanding the Control of 
DNA Replication in Eukaryotes. Bioessays 12, 457-463.
Baum, B., Nishitani, H., Yanow, S., and Nurse, P. (1998). C dcl8  transcription and proteolysis 
couple S phase to passage through mitosis. The EMBO Journal 17, 5689-5698.
Baum, B., Wuarin, J., and Nurse, P. (1997). Control of S-phase periodic transcription in the 
fission yeast mitotic cycle. The EMBO Journal 16, 4676-4688.
Bell, S. P., and Stillman, B. (1992). ATP-dependent recognition of eukaiyotic origins o f DNA 
replication by a multiprotein complex. Nature 357, 128-134.
Benito, J., Martin-Castellanos, C., and Moreno, S. (1998). Regulation of the G1 phase of the 
cell cycle by periodic stabilization and degradation o f the p25""”' CDK inhibitor. The EMBO 
Journal 17, 482-497.
Birkenbihl, R. P., and Subramani, S. (1995). The ra d ii  Gene Product o f Schizosaccharomyces 
pombe Is a Nuclear, Cell Cycle-regulated Phosphoprotein. The Journal o f  Biological Chemistry 
270, 7703-7711.
Blagosklonny, M. V., and Pardee, A. B. (2002). The Restriction Point o f the Cell Cycle. Cell 
Cycle I , 103-110.
Blanco, M. A., Sanchez-Diaz, A., De Prada, J. M., and Moreno, S. (2000). promotes
degradation of mitotic cyclins in G1 and is inhibited by cdc2 phosphoiylation. The EMBO  
Journal 19, 3945-2955.
189
Boddy, M. N., and Russell, P. (2001). DNA replication checkpoint. Current Biology 11, R953- 
R956.
Booher, R. N., Alfa, C. E., Hyams, J. S., and Beach, D. H, (1989). The Fission Yeast 
cdc2/cdcl3/sucl Protein Kinase: Regulation of Catalytic Activity and nuclear Localization. 
Cell 58, 485-497.
Bork, P. (1993). Hundreds o f ankyrin-like repeats in functionally diverse proteins: mobile 
modules that cross phyla horizontally? Proteins 17, 363-374.
Bradford, M. M. (1976). A rapid and sensitive method for the quantitation o f microgram 
quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72, 
248-254.
Breeden, L., and Nasmyth, K. (1987 a). Cell Cycle Control of the Yeast HO Gene: Cis- and 
7>a«5-Acting Regulators. Cell 48, 389-397.
Breeden, L., and Nasmyth, K. (1987 b). Similarity between cell-cycle genes o f budding yeast 
and fission yeast and the Notch gene o f Drosophila. Nature 329, 651-654.
Brown, G. W., and Kelly, T. J. (1998). Purification of Hskl, a Minichromosome Maintenance 
Protein Kinase from Fission yeast. The Journal o f  Biological Chemistry 273, 22083-22090.
Brown, G. W., and Kelly, T. J. (1999). Cell cycle regulation o f Dtp 1, an activator o f the Hskl 
protein kinase. Proceedings o f  the National Academy o f  Sciences USA 96, 8443-8448.
Caligiuri, M., and Beach, D. (1993). Sctl Functions in Partnership with CdclO in a 
Transcription Complex That Activates Cell Cycle START and Inhibits Differentiation. Cell 72, 
607-619.
Carr, A. M., and Caspari, T. (2003). Checkpoint Controls Halting the Cell Cycle. In : Egel, R. 
ed. The Molecular Biology o f Schizosaccharomyces pombe: Genetics, Genomics and Beyond. 
Springer, 41-54.
Carrio, M., M., and Villaverde, A. (2002). Construction and deconstruction of bacterial 
inclusion bodies. Journal o f  Biotechnology 96, 3-12.
190
Chaung, R. -Y., Chretien, L., Dai, J., and Kelly, T. J. (2002). Purification and Characterization 
o f the Schizosaccharomyces pombe Origin Recognition Complex. The Journal o f  Biological 
277, 16920-16927.
Chaung, R. -Y., and Kelly, T. J. (1999). The fission yeast homologue o f Orc4p binds to 
replication origin DNA via multiple AT-hooks. Proceedings o f  the National Academy o f  
Sciences USA 96, 2656-2661.
Cho, R. J., Huang, M., Campbell, M. J., Dong, H., Steinmetz, L., Sapinoso, L., Hampton, G., 
Elledge, S. J., Davis, R. W., and Lockhart, D. J. (2001). Transcriptional regulation and function 
during the human eell cycle. Nature Genetics 27, 48-54.
Christensen, P. U., Bentley, N. J., Martinho, R. G., Nielsen, O., and Carr, A. (2000). Mikl 
levels accumulate in S phase and may mediate an intrinsic link between S phase and mitosis. 
Proceedings o f  the National Academy o f  Sciences USA 97, 2579-2584.
Clarke, K. L., Halay, E. D., Lai, E., and Burley, S. K. (1993). Co-crystal structure o f the HNF- 
3/fork head DNA-recognition motif resembles histone H5. Nature 364, 412-420.
Connolly, T., and Beach, D. (1994). Interaction between the Cigl and Cig2 B-Type Cyclins in 
the Fission Yeast Cell Cycle. Molecular and Cellular Biology 14, 768-776.
Correa-Bordes, J., Gulli, M. -P., and Nurse, P. (1997). p25™"*' promotes proteolysis of the 
mitotic B-cyclin p65‘^ ‘^^ '^  during G1 of the fission yeast cell cycle. The EMBO Journal 16, 
4657-4664.
Cosma, M. P., Tanaka, T., and Nasmyth, K. (1999). Ordered Recruitment o f Transcription and 
Chromatin Remodelling Factors to a Cell Cycle and Developmentally Regulated Promoter. Cell 
97, 299-311.
Costanzo, M., Schub, O., and Andrews, B. (2003). Gi Transcription Factors Are Differentially 
Regulated in Saccharomyces cerevisiae by the Swi6 -Binding protein Stbl. Molecular and 
Cellular Biology 23, 5064-5077.
Cunliffe, L., White, S., and Mclnemy, C, J. (2004). DSCl-MCB regulation o f meiotic 
transcription in Schizosaccharomyces pombe. Molecular Genetics and Genomics 271, 60-71.
191
Daga, R. R., and Jimenez, J. (1999). Translational conti'ol of the Cdc25 cell cycle phosphatase: 
a molecular mechanism coupling mitosis to cell growth. Journal o f  Cell Science 112, 3137- 
3146.
DeBruin, A., Maiti, B., Jakoi, L., Timmers, C., Buerki, R., and Leone, G. (2003). Identification 
and Characterization of E2F7, a Novel Mammalian E2F Family Member Capable o f Blocking 
Cellular Proliferation. The Journal o f  Biological Chemistry 278, 42041-42049.
De Bruin, R. A. M., McDonald, W. H., Kalashnikova, T. L, Yates III, J., and Wittenberg, C. 
(2004). Cln3 Activates G 1-Specific Transcription via Phosphorylation o f the SBF Bound 
Repressor Wlii5. Cell 117, 887-898.
Diffley, J. F. X., and Labib, K. (2002). The chromosome replication cycle. Journal o f  Cell 
Science 115, 869-872.
Ding, R., and Smith, G. R. (1998). Global control of meiotic recombination genes by 
Schizosaccharomyces pombe recl6  {repl'). Molecular Genetics and Genomics 258, 663-670.
Dirick, L,, Moll, T., Auer, H. and Nasmyth, K. (1992). A central role for SWI6 in modulating 
cell cycle Start-specific transcription in yeast. Nature 357, 508-513.
Dyson, N. (1998). The regulation o f E2F by pRB-family proteins. Genes and Development 12, 
2245-2262.
Epstein, C. B., and Cross, F. R. (1992). CLB5, a novel B cyclin from budding yeast with a role 
in S phase. Genes and Development 6 , 1695-1706.
Espinoza, F. H., Ogas, J., Herskowitz, I., and Morgan, D. O. (1994). Cell Cycle Control by a 
Complex of the Cyclin HCS26 (PCLl) and the Kinase PH085. Science 266, 1388-1391.
Fernandez-Sarabia, M. J., Mclnerny, C. J., Harris, P., Gordon, C., and Fantes, P. A. (1993). The 
cell cycle genes cdc22^ and suc22^ of the fission yeast Schizosaccharomyces pombe encode the 
large and small subunits o f ribonucleotide reductase. Molecular Genetics and Genomics 238, 
241-251.
192
Fisher, D., and Nurse, P. (1995). Cyclins of the fission yeast Schizosaccharomyces pombe. 
Seminars in Cell Biology 6 , 73-78.
Foord, R., Taylor, I. A., Sedgwick, S. G., and Smerdon, S. J. (1999). X-ray structural analysis 
of the yeast cell cycle regulator Swi6  reveals variations o f the ankyrin fold and has implications 
for Swi6  function. Nature Structural Biology 6 , 157-165.
Ford, H. L., and Pardee, A. B. (1999), Cancer and the Cell Cycle. Journal o f  Cellular 
Biochemistry Supplements 32/33, 166-172.
Forsburg, S. L. (2004). Eukaryotic MCM Proteins: Beyond Replication Initiation. 
Microbiology and Molecular Biology Reviews 6 8 , 109-131.
Forsburg, S. (1993). Comparison of Schizosaccharomyces pombe expression systems. Nucleic 
Acids Research 21, 2955-2956.
Forsburg, S. L., and Nurse, P. (1991). Cell cycle regulation in the yeasts Saccharomyces 
cerevisiae and Schizosaccharomyces pombe. Annual Reviews o f  Cell Biology 7, 227-56.
Frangioni, J., V., and Neel, B., G. (1993). Solubilization and Purification o f Enzymatically 
Active Glutathione iS-Transferase (pGEX) Fusion Proteins. Analytical Biochemistry 210, 179- 
187.
Gaymonet, M., Spanos, A., Wells, G. P., Smerdon, S. J., and Sedgwick, S. G. (2004). 
Clb6/Cdc28 and C dcl4 Regulate Phosphorylation Status and Cellular Localization of Swi6 . 
Molecular and Cellular Biology 24, 2277-2285.
Goflfeau, A., Barrell, B. G., Bussey, H., Davis, R. W., Dujon, B., Galibert, F., Hoheisel, J. D., 
Jacq, C., Johnston, M., Louis, E. J., Mewes, H. W., Murakami, Y., Philippsen, P., Tettelin, H., 
and Oliver, S. G. (1996). Life with 6000 genes. Science 274, 546-67.
Gordon, C., and Fantes, P. A. (1986). The cdc22* gene of Sehizosaccharomyces pombe 
encodes a cell cycle-regulated transcript. The EMBO Journal 5, 2981-2985.
Gouet, P., Courcelle, E., Stuart, D. 1., and Metoz, F. (1999). ESPript: multiple sequence 
alignments in PostScript. Bioinformatics 15, 305-308.
193
Gregan, J., Lindner, K., Brimage, L., Franklin, R., Namdar, M., Hart, E. H., Aves, S., and 
Kearsey, S. (2003). Fission Yeast Cdc23/Mcml0 Functions After Pre-replicative Complex 
Formation to Promote Cdc45 Chromatin Binding. Molecular Biology o f  the Cell 14, 3876- 
3887.
Guan, K. -L ., and Dixon, J. E. (1991). Eukaryotic Proteins Expressed in Escherichia coli: An 
Improved Thrombin Cleavage and Purification procedure of Fusion Proteins with Glutathione 
^'-Transferase. Analytical Biochemistry 192, 262-267.
Hagstrom, K. A., and Meyer, B. J. (2003). Condensin and Cohesin; More than Chromosome 
Compactor and Glue. Nature Reviews Genetics 4, 520-534.
Hartwell, L. H. (1974). Saccharomyces cerevisiae Cell Cycle. Bacteriological Reviews 38, 164- 
198.
Hartwell, L. FI., Culotti, J., Pringle, J. R., and Reid, B. J. (1974). Genetic control o f the cell 
division cycle in yeast. Science 183, 46-51.
Hartwell, L. H. (1991). Twenty-Five Years of Cell Cycle Geneties. Genetics 129, 975-980.
Harper, J. W., Burton, J. L., and Solomon, M. J. (2002). The anaphase-promoting complex: it’s 
not just for mitosis any more. Genes and Development 16, 2179-2206.
Harrington, L. A., and Andrews, B. J. (1996). Binding to the yeast Swi4,6-dependent cell cycle 
box, CACGAAA, is cell cycle regulated in vivo. Nucleic Acids Research 24, 558-565.
Harris, P., Kersey, P. J,, Mclnerny, C. J., and Fantes, P. A. (1996). Cell cycle, DNA damage 
and heat shock regulate suc2 2 + expression in fission yeast. Molecular Genetics and Genomics 
252, 284-291.
Hartwell, L. H., and Weinert, T. A. (1989). Checkpoints: Controls That Ensure the Order of 
Cell Cycle Events. Science 246, 629-634.
Hofmami, J. F. X., and Beach, D. (1994). cdtl is an essential target o f the CdclO/Sctl 
transcription factor: requirement for DNA replication and inhibition o f mitosis. The EMBO 
Journal 13, 425-434.
194
Humphrey, T. (2000). DNA damage and cell cycle control in Schizosaccharomyces pombe. 
Mutation Research 451, 211-226.
Iyer, V. R., Horak, C. E., Scafe, C. S., Botstein, D., Snyder, M., and Brown, P. O. (2001). 
Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF. Nature 409, 
533-538.
Jallepalli, P. V., Brown, G. W., Muzi-Falconi, M., Tien, D., and Kelly, T. J. (1997). Regulation 
of the replication initiator protein p65‘^ '^^ ^^  ^ by CDK phosphorylation. Genes and Development 
11, 2767-2779.
Johnston, L. H., and Lowndes, N. F. (1992). Cell cycle control o f DNA synthesis in budding 
yeast. Nucleic AcidsResearch 20, 2403-2410.
Kellogg, D. R. (2003). Wee 1-dependent mechanisms required for coordination of cell growth 
and cell division. Journal o f  Cell Science 116, 4883-4890.
Kelly, S. M., and Price, N. C. (2000). The Use o f Circular Dichroism in the Investigation of 
Protein Structure and Function. Current Protein and Peptide Science 1, 349-384.
Kelly, T. J., and Brown, G. W. (2000). Regulation o f Chromosome Replication. Annual 
Reviews o f  Biochemistry 69, 829-880.
Kelly, T. J., Martin, G. S., Forsburg, S. L., Stephen, R. J., Russo, A., and Nurse, P. (1993). The 
Fission Yeast cdcl8^ Gene Product Couples S Phase to START and Mitosis. Cell 74, 1-20.
Koeh, C., Moll, T., Neuberg, M., Ahorn, H. and Nasmyth, K. (1993). A Role for the 
Transcription Factors Mbpl and Swi4 in Progression from Gl to S Phase. Science 261, 1551- 
1557.
Koch, C., and Nasmyth, K. (1994). Cell cycle regulated transcription in yeast. Current Opinion 
in Cell Biology 6, 451-459.
Koch, C., Schleiffer, A., Ammerer, G., and Nasmyth, K. (1996). Switching transcription on and 
off during the yeast cell cycle: Cln/Cdc28 kinases activate bound transcription factor SBF 
(Swi4/Swi6) at Start, whereas Clb/Cdc28 kinases displace it from the promoter in G2. Genes 
and Development 10, 129-141.
195
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature 277, 680-685.
Lee, B., and Amon, A. (2001). Meiosis: how to create a specialized cell cycle. Current Opinion 
in Cell Biology 13, 770-777.
Lee, J. -K., and Hurwitz, J. (2001). Processive DNA helicase activity of the minichromosome 
maintenance proteins 4, 6 and 7 complex requires forked DNA structures. Proceedings o f  the 
National Academy o f  Sciences USA 98, 54-59.
Lee, J. -K., Seo, Y. -S., and Hurwitz, J. (2003). The Cdc23 (Mem 10) protein is required for the 
phosphorylation of minichromosome maintenance complex by the D lpl-H skl kinase. 
Proceedings o f  the National Academy o f  Sciences USA 100, 2334-2339.
Lei, M., and Tye, B. K. (2001). Initiating DNA synthesis: from recruiting to activating the 
MCM complex. Journal o f  Cell Science 114, 1447-1454.
Levine, M., and Tjian, R. (2003). Transcription regulation and animal diversity. Nature 424, 
147-151.
Lew, D. J., Weinert, T., and Pringle, J. R. (1997). Cell Cycle Conti’ol in Saccharomyces 
cerevisiae. In The Molecular and Cellular Biology of the Yeast Saccharomyces-. Cell Cycle and 
Cell Biology, Pringle, J. R., Broach, J. R. and Jones, E. W., eds. : Cold Spring Harbor 
Laboratory Press, 607-695.
Lilie, H., Schwarz, E., and Rudolph, R. (1998). Advances in refolding o f proteins produced in 
E. coli. Current Opinion in Biotechnology 9, 497-501.
Lindner, P., Guth, B., Wülfîng, C., Krebber, C., Steipe, B., Müller, F., and Pliickthum, A. 
(1992). Purification of Native Proteins from the Cytoplasm and Periplasm of Escherichia cloi 
Using IMAC and Histidine Tails: A Comparison of Proteins and Protocols. METHODS: A 
Companion to Methods in Enzymology 4, 41-56.
Lodish, H., Baltimore, D., Berk, A., Zipursky, S. L., Matsudaira, P., and Darnell, J. (1995). 
Molecular Cell Biology (3rd edition). Scientific American Books.
196
Logan , N., Delavaine, L., Graham, A,, Reilly, C., Wilson, J., Brummelkamp, T. R., Hymans, 
E. M., Bernards, R., and LaThangue, N. B. (2004). E2F-7: a distinctive E2F family member 
with an unusual organization o f DNA-binding domains. Oncogene 23, 5138-5150.
Lopez-Girona, A., Mondesert, O., Leatheiwood, J., and Russell, P. (1998). Negative Regulation 
o f Cdcl8 DNA Replication Protein by Cdc2. Molecular Biology o f  the Cell 9, 63-73.
Lowndes, N. F., Johnston, A. L. and Johnston, L.H. (1991). Coordination o f expression of 
DNA synthesis genes in budding yeast by a cell-cycle regulated trans factor. Nature 350, 247- 
250.
Lowndes, N., Mclnerny, C. J., Johnston, A. L., Fautes, P. A., and Johnston, L.H. (1992a), 
Conti'ol of DNA synthesis genes in fission yeast by the cell-cycle gene cdclO^. Nature 355, 
449-453.
Lowndes, N., Johnston, A. L., Breeden, L., and Johnston, L.H. (1992b). SWI6 protein is 
required for transcription of the periodically expressed DNA synthesis genes in budding yeast. 
Nature 357, 505-508.
Lu, Q., Bauer, J, C., and Greener, A. et al. (1997). Using Schizosaccharomyces pombe as a host 
for expression and purification of enkaiyotic proteins. Gene 200, 135-144.
Lygerou, Z., and Nurse, P. (1999). The fission yeast origin recognition complex is 
constitutively associated with cliromatin and is differentially modified through the cell cycle. 
Journal o f  Cell Science 112, 3703-3712.
Lygerou, Z., and Nurse, P. (2000). Controlling S-phase Onset in Fission Yeast. Cold Spring 
Harbor Symposia on Quantitative Biology 65, 332-332.
MacKay, V. L., Mai, B., Waters, L., and Breeden, L. L. (2001). Early Cell Cycle Box- 
Mediated Transcription of CLN3 and SWI4 Contributes to the Proper Timing of the Gi-to-S 
Transition in Budding Yeast. Molecular and Cellular Biology 21, 4140-4148.
MacNeill, S., and Nurse, P. (1997). Cell Cycle Control in Fission Yeast. In : Pringle, J. R., 
Broach, J. R. and Jones, E. W., eds. The Molecular and Cellular Biology o f the Yeast 
Saccharomyces: Cell Cycle and Cell Biology. Cold Spring Harbor Laboratoiy Press, 697-763.
197
Maqbool, Z., Kersey, P. J., Fautes, P. A., and Mclnerny, C. J. (2003). MCB-mediated 
regulation of cell cycle-specific cdc22^ transcription in fission yeast. Molecular Genetics and 
Genomics 269, 765-775.
Marabens, Y., and Stillman, B. (1992). A Yeast Chromosomal Origin o f DNA Replication 
Defined by Multiple Functional Elements. Science 255, 817-823.
Marks, J., Fankhauser, C., Reymond, A., and Simanis, V. (1992). Cytoskeletai and DNA 
structure abnormalities result from bypass of requirement for the cdclO start gene in the fission 
Schizosaccharomyces pombe. Journal o f  Cell Science 101, 517-528.
Maitin-Castellanos, C., Blanco, M. A., De Prada, J. M., and Moreno, S. (2000). The p u d  
Cyclin Regulates the G1 Phase o f the Fission Yeast Cell Cycle in Response to Cell Size. 
Molecular Biology o f  the Cell 11, 543-544.
Martin-Castellanos, C., Labib, K., and Moreno, S. (1996). B-type cyclins regulate G1 
progression in fission yeast in opposition to the p25"™  ^ cdk inhibitor. The EMBO Journal 15, 
839-849.
Masukata, H., Huberman, J. A., Frattini, M. G., and Kelly, T. J. (2003). DNA Replication in S. 
pombe. In ; Egel, R. ed. The Molecular Biology of Schizosaccharomyces pombe: Genetics, 
Genomics and Beyond. Springer, 73-94.
Mata, J., Lyne, R., Burns, G., and Bahler, J. (2002). The tianscriptional program of meiosis 
and sporulation in fission yeast. Nature Genetics 32, 143-147.
Maundrell, K. (1993). Thiamine-repressible expression vectors pREP and pRIP for fission 
yeast. Gene 123, 127-130.
McCollum, D., and Gould, K. L. (2001). Timing is everything: regulation o f mitotic exit and 
cytokinesis by the MEN and SIN. Trends in Cell Biology 11, 89-95.
Mclnerny, C. J. (2004). Cell cycle-regulated transcription in fission yeast. Biochemical Society 
Transactions. In Press.
198
Mclnerny, C. J., Kersey, P. J., Creanor, J., and Fantes, P. A. (1995). Positive and negative roles 
for cdclO in cell cycle gene expression. Nucleic Acids Research 23, 4761-4768.
Mclnerny, C. J., Partridge, J. F., Mikesell, G. E., Creemer, D, P., and Breeden, L. L. (1997). A 
novel Mem 1-dependent element in the SWI4, CLN3, CDC6, and CDC47 promoters activates 
M/G]-specific transcription. Genes and Development 11, 1277-1288.
McIntosh, E. M., Atkinson, T., Storms, R. K. and Smith, M. (1991). Characterisation o f a short 
ci5-acting DNA sequence which conveys cell-cycle stage dependent transcription in 
Saccharomyces cerevisiae. Molecular and Cellular Biology 11, 329-337.
McIntosh, P. B., Taylor, I. A., Frenkiel, T. A., Smerdon, S. J., and Lane, A. (2000). The 
influence of DNA binding on the backbone dynamics of the yeast cell-cycle protein M bpl. 
Journal o f  Biomolecular NMR 16, 183-196.
Measday, V., Moore, L., Ogas, J., Tyers, M., and Andrews, B. (1994). The PCL2 (ORFD)- 
PH085 cyclin-dependent kinase complex: a cell cycle regulator in yeast. Science 266, 1391- 
1391.
Merrill, G. F., Morgan, B. A., Lowndes, N. F., and Johnson, L. H. (1992). DNA Synthesis 
Control in Yeast: An Evolutionarily Conserved Mechanism for Regulating DNA Synthesis 
Genes? BioEssays 14, 823-830.
Miyamoto, M., Tanaka, K., and Okayama, H. (1994). res2^, a new member o f the cdclO*lSWI4 
family, controls the ‘start’ of mitotic and raeiotic cycles in fission yeast. The EMBO Journal 
13, 1873-1880.
Moll, T., Dirick, L., Auer, H., Bonkovsky, J. and Nasmyth, K. (1992). SWI6 is a regulatory 
subunit of two different cell cyele START -dependent transcription factors in Saccharomyces 
cerevisiae. Journal o f  Cell Science 16, 87-96.
Mondesert, O., McGowan, C. H., and Russell, P. (1996). Cig2, a B-Type Cyclin, Promotes the 
Onset of S Phase in Schizosaccharomyces pombe. Molecular and Cellular Biology 16, 1527- 
1533.
199
Moon, K. -Y., Kong, D., Lee, J. -K., Raychaudhuri, S., and Hurwitz, J. (1999). Identification 
and reconstitution of the origin recognition complex from Schizosaccharomyces pombe. 
Proceedings o f  the National Academy o f  Sciences USA 96, 12367-12372.
Moreno, S., Klar, A., Nurse, P. (1991). Molecular genetic analysis of the fission yeast 
Schizossacharomyces pombe. Methods in Enzymology 194, 795-823.
Moreno, S., Nurse, P., and Russell, P. (1989). Regulation of mitosis by cyclic accumulation of 
p80 mitotic inducer in fission yeast. Nature 344, 549-552.
Morgan, D. O. (1999). Regulation o f the APC and the exit from mitosis. Nature Cell Biology 1, 
E47-E53.
Moser, B. A., and Russell, P. (2000). Cell cycle regulation in Schizosaccharomyces pombe. 
Current Opinion in Microbiology 631-636.
Nair, M., McIntosh. P. B., Frenkiel, T. A., Kelly, G., Taylor, I. A., Smerdon, S. J., and Lane, A. 
N. (2003). NMR Structure of the DNA-Binding Domain of the Cell Cycle Protein Mbpl from 
Saccharomyces cerevisiae. Biochemistry 42, 1266-1273.
Nakashima, N., Tanaka, K., Sturm, S., and Okayama, H. (1995). Fission yeast Rep2 is a 
putative transcriptional activator subunit for the cell cycle ‘start’ frmction o f Res2-Cdcl0. The 
EMBO Journal 14, 4794-4802.
Nasmyth, K. (1983). Molecular analysis o f a cell lineage. Nature 302, 670-676.
Nasmyth, K. (1996). At the heart of the budding yeast cell cycle. Trends in Genetics 12, 405- 
412.
Nasmyth, K., Peters, J. -M., and Uhlmann, F. (2000). Splitting the Chromosome: Cutting the 
Ties That Bind Sister Chromatids. Science 288, 1379-1384.
Ng, S. S., Anderson, M., Wliite, S., and Mclnerny, C. J. (2001). m i k f  Gl-S transcription
regulates mitotic entry in fission yeast. FEBS Letters 503, 131-134.
Nigg, E. A. (2001). Mitotic Kinases as regulators of Cell Division and its Checkpoints. Nature
Reviews Molecular Cell Biology 2, 21-32.
2 0 0
Nishitani, H., Lygerou, Z., Nishimoto, T., and Nurse, P. (2000). The Cdtï protein is required to 
license DNA for replication in fission yeast. Nature 404, 625-628.
Nurse, P. (1975). Genetic conti’ol o f cell size at cell division in yeast. Nature 256, 547-551.
Nurse, P. (1990). Universal control mechanism regulating onset o f M-phase. Nature 344, 503- 
508.
Nurse, P. (2000). A Long Twentieth Centuiy o f the Cell Cycle and Beyond. Cell 100, 71-78.
Nurse, P., and Bissett, Y. (1981). Gene required in G1 for commitment to cell cycle and in G2 
for control of mitosis in fission yeast. Nature 292, 558-560.
Nurse, P., Masui, Y., and Hartwell, L. (1998). Understanding the cell cycle. Nature Medicine 4, 
1103-1106.
Nurse, P., Thuriaux, P., and Nasmyth, K. (1976). Genetic Control of the Cell Division Cycle in 
the Fission Y QdiSt Schizosaccharomyces pombe. Molecular and General Genetics 146, 167-178.
Obara-Ishihara, T., and Okayama, H. (1994). A B-type cyclin negatively regulates conjugation 
via interacting with cell cycle ‘start’ genes in fission yeast. The EMBO Journal 13, 1863-1872.
Ogas, J., Andrews, B. J., and Herskowitz, I. (1991). Transcriptional Activation of CLNl, CLN2, 
and a Putative New G1 Cyclin (HCS26) by SWI4, a Positive Regulator of G 1-Specific 
Transcription. Cell 66, 1015-1026.
Okuno, Y., Satoh, H., Sekiguchi, M., and Masukata, H. (1999). Clustered Adenine/Thymine 
Stretches Are Essential for Function of a Fission Yeast Replication Origin. Molecular and 
Cellular Biology 19, 6699-6709.
Pardee, A. B. (1974). A Restriction Point for Control of Normal Animal Cell Proliferation. 
Proceedings o f  the National Academy o f  Sciences USA 71, 1286-1290.
Parker, A. E., Clyne, R., Carr, A., and Kelly, T. (1997), The Schizosaccharomyces pombe 
radl 1^  Gene Encodes the Large Subunit o f Replication Protein A. Molecular Cell Biology 17,
2 0 1
2381-2390.
Partridge, J. F., Mikesell, G. E., and Breeden, L. L. (1997). Cell Cycle-dependent Transcription 
o f CLNl In volves Swi4 Binding to MCB-like Elements. The Journal o f  Biological Chemistry 
272, 9071-9077.
Pitt, A. R. (1996). Mass Specti'ometric Methods. In : Price, N. ed. Proteins labfax, 174-186. 
BIOS Scientific Publishers.
Poratli, J., Carlsson, J., Olsson, I., and Beltfage, G. (1975). Metal chelate affinity 
chromatography, a new approach to protein fractionation. Nature 258, 598-599.
Primig, M., Sockanathan, S., Auer, H. and Nasmyth, K. (1992). Anatomy of a transcription 
factor important for the Start of the cell cycle in Saccharomyces cerevisiae. Nature 358, 593- 
597.
Provencher, S. W., and Glockner, J. (1981). Estimation of globular protein secondaiy structure 
from circular dichroism. Biochemistry 20, 33-37.
Queralt, E., and Igual, J. C. (2003). Cell Cycle Activation of the Swi6p Transcription Factor Is 
Linked to Nucleocytoplasmic Shuttling. Molecular and Cellular Biology 23, 3126-3140.
Ren, B., Cam, H., Takahashi, Y., Volkert, T., Teiragni, J., Young, R. A., and Dynlacht, B. D. 
(2002). E2F integrates cell cycle progression and with DNA repair, replication, and G2/M 
checkpoints. Genes and Development 16, 245-256.
Reymond, A., Schmidt, S., and Simanis, V. (1992). Mutations in the cdclO start gene of 
Schizosaccharomyces pombe implicate the region o f homology between cdcIO and SWI6 as 
important for p85‘^‘^‘^ ^^  function. Molecular Genetics and Genomics 234, 449-456.
Reymond, A., and Simanis, V. (1993). Domains of p85“^^ ^^  required for function of the fission 
yeast DSC-1 factor. Nucleic Acids Research 21, 3615-3621.
Rhind, N., Baber-Furnari, B. A., Lopez-Girona, A., Boddy, M. N., Brondello, J. -M., Moser, 
B., Shanahan, P., Blasina, A., McGowan, C., and Russell, P. (2000). DNA Damage Checkpoint
2 0 2
Control of Mitosis in Fission Yeast. Cold Spring Harbor Symposia on Quantitative Biology 65, 
353-359.
Rhind, N., and Russell, P. (2000). Chkl and Cdsl: linchpins of the DNA damage and 
replication checkpoint pathways. Journal o f  Cell Science 113, 3889-3896.
Rhind, N., and Russell, P. (2001). Roles of the Mitotic Inhibitors Weel and Mikl in the G2 
DNA Damage and Replication Checkpoints. Molecular and Cellular Biology 21, 1499-1508.
Rustici, G., Mata, J., Kivinen, K., Lio, P., Penkett, C. J., Burns, G., Hayles, J., Brazma, A., 
Nurse, P., and Bahler, J. (2004). Periodic gene expression program of the fission yeast cell 
cycle. Nature Genetics 36, 809-17.
Sambrook, J., and Russell, D. W. (2001) Molecular cloning: a laboratoiy manual (3rd edition). 
Cold Spring Harbor Laboratoiy Press, Cold Spring Harbor, New York.
Schultz, S. C., Shields, G. C., and Steitz, T. A. (1991). Crystal Structure of a CAP-DNA 
Complex: The DNA Is Bent by 90°. Science 253, 1001-1007.
Schien, C. H., and Notebom, M. H. M. (1988). Formation o f soluble recombinant proteins in 
Escherichia coli is favoured by lower growth temperature. Biol Technology 6, 291-294.
Schwob, E. and Nasmyth, K. (1993). CLB5 and CLB6, a new pair o f B cyclins involved in S 
phase and mitotic spindle formation in S. cerevisiae. Genes and Development 7, 1160-1175.
Sedgwick, S. G., and Smerdon, S. J. (1999). The ankyrin repeat: a diversity o f interactions on a 
common sti uctural framework. Trends in Biochemical Sciences 24, 311-316.
Sedgwick, S. G., Taylor, I. A., Adam, A. C., Spanos, A., Howell, S., Morgan, B. A., Treiber, 
M. K., Kanuga, N., Banks, G. R., Foord, R., and Smerdon, S. J. (1998). Structural and 
Functional Architecture of the Yeast Cell-cycle Transcription Factor Swi6. Journal o f  
Molecular Biology 281, 763-775.
Sheehan, D. (2000). Physical Biochemistry : Principles and Applications. Wiley.
Sherr, C. J. (1996). Cancer Cell Cycles. Science 274, 1672-1677.
203
Sidorova, J., and Breeden, L. L. (1993). Analysis of the SWI4/SWI6 protein Complex, Which 
Directs Gi/S-Specific Transcription in Saccharomyces cerevisiae. Molecular and Cellular 
Biology n ,  1069-1077.
Sidorova, J. M., Mikesell, G. E., and Breeden, L. L. (1995). Cell Cycle-regulated 
Phosplioryaltion of Swi6 Controls its Nuclear Localization. Molecular Biology o f  the Cell 6, 
1641-1658.
Siegmund, R. F., and Nasmyth, K. (1996). The Saccharomyces cerevisiae Start-Specific 
Transcription Factor Swi4 Interacts through the Ankyrin Repeats with the Mitotic Clb2/Cdc28 
Kinase and through Its Conserved Carboxy Terminus with Swi6. Molecular and Cellular 
Biology 16, 2647-2655.
Sipiczki, M. (2000). Where does fission yeast sit on the tree of life? Genome Biology 1, 1011.1- 
1011.4.
Smith, M. C., Furman, T. C., Ingolia, T. D., and Pidgeon, C. (1988). Chelating Peptide- 
immobilized Metal Ion Affinity Chromatography: A new concept in affinity chromatography 
for recombinant proteins. The Journal o f  Biochemistry 263, 7211-7215.
Smith, D. B., and Johnson, K. S. (1988). Single-step purification o f polypeptides expressed in 
Escherichia coli as fusions with glutathione *S'-transferase. Gene 67, 31-40.
Spellman, P. T., Sherlock, G., Zhang, M. Q., Iyer, V. R., Anders, K., Eisen, M B., Brown, P. 
O., Botstein, D., and Futcher, B. (1998). Comprehensive Identification o f Cell Cycle-regulated 
Genes of the Yeast Saccharomyces cerevisiae by Microarray Hybridization. Molecular Biology 
o f  the Cell 9, 3273-3297.
Stevens, C., and LaThangue, N. B. (2003). E2F and cell cycle control: a double-edged sword. 
Archives o f  Biochemistry and Biophysics 412, 157-169.
Stone, M., and Gordon, C. (2003). Ubiquitin-Dependent Proteolysis by the Proteasome. In : 
Egel, R. ed. The Molecular Biology of Schizosaccharomyces pombe: Genetics, Genomics and 
Beyond. Springer, 381-392.
204
Sturm, S., and Okayama, H. (1996). Domains determining the Functional Distinction o f the 
Fission yeast Cell Cycle “Start” Molecules Resl and Res2. Molecular Biology o f  the Cell 7, 
1967-1976.
Su, S. S. Y., and Yanagida, M. (1997). Mitosis and Cytokinesis in the Fission Yeast, 
Schizosaccharomyces pombe. In : Pringle, J. R., Broach, J. R. and Jones, E. W., eds. The 
Molecular and Cellular Biology of the Yeast Saccharomyces: Cell Cycle and Cell Biology. 
Cold Spring Harbor Laboratory Press, 765-825.
Sudbery, P. E, (1996). The expression of recombinant proteins in yeasts. Current Opinion in 
Biotechnology 7, 517-524.
Sugiyama, A., Tanaka, K., Okazaki, K., Nojima, H., and Okayama, H. (1994). A zinc finger 
protein controls the onset of premeiotic DNA synthesis of fission yeast in a Mei2-independent 
cascade. The EMBO Journal 13, 1881-1887.
Sreerama, N., and Woody, R. W. (1993). A self-consistent method for the analysis o f protein 
secondary structure from circular dichroism. Analytical Biochemistry 209, 32-44.
Taba, M. R. M., Muroff. I., Lydall, D., Tebb, G., and Nasmyth, K. (1991). Changes in a 
SWI4,6-DNA-binding complex occur at the time of HO  gene activation in yeast. Genes and 
Development 5, 2000-2013.
Tahara, S., Tanaka, K., Yuasa, Y., and Okayama, H. (1998). Functional Domains o f Rep2, a 
transcriptional Activator Subunit for Res2-Cdcl0, ConEolliiig the Cell Cycle ‘Start’. Molecular 
Biology o f  the Cell 9, 1577-1588.
Tanaka, K., and Okayama, H. (2000). A Pcl-like Cyclin Activates the Res2p-Cdcl0p Cell 
Cycle “Start” Transcriptional Factor Complex in Fission Yeast. Molecular Biology o f  the Cell 
11, 2845-2862.
Tanaka, K., Okazaki, K., Okazaki, N., Ueda, T., Sugiyama, A., Nojima, H., and Okayama, H. 
(1992). A new cdc gene required for S phase entiy o f Schizosaccharomyces pombe encodes a 
protein similar to the cdc 10^ and SWI4 gene products. The EMBO Journal 11, 4923-4932.
Tanaka, S., and Diffley, J. F. X. (2002). Interdependent nuclear accumulation of budding yeast 
Cdtl and Mcm2-7 during G1 phase. Nature Cell Biology 4, 198-207.
205
Taylor, I. A., Treiber, M. K., Olivi, L., and Smerdon, S. J. (1997). The X-ray Structure o f the 
DNA-binding Domain from the Saccharomyces cerevisiae Cell-cycle Transcription Factor 
Mbpl at 2.1 KKQSoluûon. Journal o f  Molecular B io lo ^  112, 1-8.
Taylor, I., McIntosh, P. B., Pala, P., Treiber, M. K., Howell, S., Lane, A. N., and Smerdon, S. J. 
(2000). Characterization o f the DNA-Binding Domains from the Yeast Cell-Cycle 
Transcription Factors Mbpl and Swi4. Biochemistiy 39, 3943-3954.
Tournier, S., and Millar, J. B. A. (2000). A Role for the START Gene-specific Transcription 
Factor Complex in the Inaetivation o f Cyclin B and Cut2 Destruction. Molecular Biology o f  the 
Cell 11, 3411-3424.
Trimarchi, J. M., and Lees, J. A. (2002). Sibling Rivalry in the E2F Family. Nature Reviews 
Molecular Cell Biology 31, 11-20.
Tye, B. K. (1999). Minichromosome maintenance as a genetic assay for defects in DNA 
replication. Methods 18, 329-334.
Uchiyama, M., Griffiths, D., Arai, K. -I., and Masai, H. (2001). Essential Role of Sna41/Cdc45 
in Loading of DNA Polymerase a  onto Minichromosome Maintenance Proteins in Fission 
Yeast. The Journal o f  Biological Chemistry 276, 26189-26196.
Weinberg, R. A. (1995). The Retinoblastoma Protein and Cell Cycle Control. Cell 81, 323-330.
Whitehall, S., Stacey, P., Dawson, K., and Jones, N. (1999). Cell Cycle-regulated Transcription 
in Fission Yeast: Cdc 10-Res Protein Interactions during the Cell Cycle and Domains Required 
for Regulated Transcription. Molecular Biology o f  the Cell 10, 3705-3714.
Wijnen, H., Landmann, A., and Futcher, B. (2002). The Gj Cyclin Cln3 Promotes Cell Cycle 
Entry via the Transcription Factor Swi6. Molecular and Cellular Biology 22, 4402-4418.
Wood, V., Gwilliam, R., Rajandream, M. -A., Lyne, M., Lyne, R., Stewart, A., Sgouros, J., 
Peat, N., Hayles, J., Baker, S., Basham, D. et al. (2002). The genome sequence of 
Schizossacharomyces pombe. Nature 415, 871-880.
206
Wuarin, J., Buck, V., Nurse, P., and Millar, J. B. A. (2002). Stable Association of Mitotic 
Cyclin B/Cdc2 to Replication Origins Prevents Endoreduplication. Cell 111, 419-431.
Xu, R. M., Koch, C., Liu, Y., Horton, J., Knapp, D., Nasmyth, K., and Cheng, X. (1997). 
Crystal structure of the DNA-binding domain of M bpl, a transcription factor important in cell- 
cycle control of DNA synthesis. Structure 5, 349-358.
Yanagida, M. (2000). Cell cycle mechanisms of sister chromatid separation; Roles of 
Cutl/separin and Cut2/securin. Genes to Cells 5, 1-8.
Yoshida, S., Al-Amodi, H., Nakamura, T., Melnerny, C. J., and Shimoda, C. (2003). The 
Schizosaccharomyces pombe cdtl* Gene, a Target o f G l-S Phase-Specific Transcription Factor 
Complex DSCl, Is Required for Mitotic and Premeiotic DNA Replication. Genetics 164, 881- 
893.
Zheng, N., Fraenkel, E., Pabo, C. O., and Pavlevitch, N. P. (1999), Structural basis o f DNA 
recognition by the heterodimeric cell cycle transcription factor E2F-DP. Genes and 
Development 13, 666-674.
Zhu, Y., Takeda, T., Nasmyth, K., and Jones, N. (1994). p c t t ,  which encodes a new DNA- 
binding partner o f is required for meiosis in the fission yeast Schizosaccharomyces
pombe. Genes and Development 8, 885-898.
Zhu, Y., Takeda, T., Whitehall, S., Peat, N., and Jones, N. (1997). Functional characterisation 
of the fission yeast Start-specific transcription factor Res2. The EMBO Journal 16, 1023-1034.
207
Appendices
x g l.s
CQ
6X fl
4-*X tl
0»
a.2
cmIS
f l
C5
*c
%cspq
s
A
<
III
50.sII
Aw
o
§§ 9î oocN CN C4 § o g S 8 8 3 ?? S fN {= 8 s cn 9(N (N M <Npq pq pq pq PQ m PQ PQ pq pq pq PQ pq pq pq pq pq pq PQ pq pq pqÜ Ü O o O o O O C3 Ü Ü o O O Ü Ü CD O CD CD CD CD
a a s aa 3 g' 2
3 3 1 3
'&'0 B  3 0 5 3 3 5
C/5 CO VÎ V)
l i l t
.D
o 3  3  3
.3 H H H H
% ^ H Ca s o  I
s  6
> yII
ïj e a> (u s
1 1 1 .
II.§ §.
.2 < k PL, H
W tc to
Û o5 ^  G £P e
ÜÛ  ^ M&I3#=3 3 s:#:âo 5 aa m (TH a m
f i l lliilC C! Ü M
III
. . I  fill
H ii l l  I
[Is pq pu 5  m
ii|.iI I  me l l l iÜH CQ CÛ Mh
fIm i l l III ' S . l l l u l Wf8 5 8 8 8Qs Qs a , cu a , Ll # X<yj <N nlU H P-H%%%%
"g -p "q fNi c\j rsj rvic-o e<, ^CQCo « o c r j Co « Xi  , --W ^ ^  ^  ^  ^ ^  ^  ^ tü %) ^  ^ ^ ^ ^ ^ (S'5. S, Bs Rs
oooCN
%fl1I
I
o\
R
s
3
s
pf lobD
■I
sa.
O
O
S \  5 \  r~ 1"o  lO o  a1 r-l • o  ir> (X r n T f Tl-
O  O  Q g  o o  o g  o O  O
O  Ü  O o  a a  o ©  Ü o  o
o  o
il
I #I I
8 S S 8E—^ CD E—'
U U
U o
-g O
c3 T3 3
u u u CJs  H ü
t~- .ttIfi
a i
ilVî
® l .Ilil:
l ! | g .J i
«  ,-a în  fn ’g
i s g > i 11
5  a -g .2aro4-1 a  a  a  a  (H ü  53i - iO  o  o  O  O  O
8 8 8a  a  a 888a  a  a S'S’ 11
Ilf IIIbO Û0 BO
s s i i l
ÎÎ
28 .1bp Ù0
. 3  . 3
S 3
ii
r
11
BO BO
IOO oo
S 2 11
11 CO CO
, ü
11 3 SI I
g )  8
II
3 op
•S
O
CN
s ’i l 11
H  H
Appendix III: Vector maps
pET-14b so()ucnco tarKtmarks
T7 prooioiC) C'lO-CnZ
T7 ti’aiisciipUon start (145
Hls'Tag coding sw|i)c)icc 554-571
Multiple cloning sites
(AWd-1 -BatiiH 1) 510-52G
T7 icnninalor 404-450
pBR.12Z origin 2845
b/ii coding 5c(|ucncc 3000-4403
EcoR !(4669) 
Apo I(-1GB9) eta  1(24) Hind 111(29)
Pst 1(3921)
Ëam1105 1(3675)
HglE 11(3369)
AlwN 1(3199)
Bpul 102 1(458) 
BamH l(Sin) Xho 1(515) Ndo 1(522) 
Nco 1(580) Xba 1(610) 
Bgl 11(677) 
SgrA 1(710)
Aal 11(4593) Ssp 1(4460) NIIB 1(229)
Sea 1(4156)
Pvu 1(4046)
pET-14b(4671 bp)
Bom 1(1667)
M s g  1(1754)
BpulO 1(1889) 
Bsg 1(1943)
Spll 1(874) 
ECON 1(934) ' Sal 1(959) 
PshA 1(1024)
Eag 1(1247) 
NfU 1(1282) 
[-ApaB 1(1360) 
' BspM 1(1302)
BspLUH 1(2783)Aft 111(2783)
Sap 1(2667)Bsti 107 1(2554)BsaA 1(2535)Tlh111 1(2520)BsniB ((2424) Pvu (1(2374)
B g lII TT prompter ^
a g a t c t c q a t c c c g c g a a a t t a a t a c(î a c i c a c t a t a g g g a g a c c a c a/icgotttcccT c t a g a a a t a a t t t t g t t t a a c t t t/i a o m «gaq a
N c o  I Hlit-TaB Wrfo I X h o  I B m irH  I
TATACCATGGCCAGCACCCATCATCATCATCATCACAECAOCQOCCTOGTaCCCCGCCSCACCCATATCCTCfiAGOATCCGOCTGCTAACAAAGCCCGA ha-tB(y3»r3«rH)«H)BH)gH(«H[EHIsSBrSBr(ilyL«uVa[ProÂr^)v3<irH)«H»tU»uQluA«pPrpA[oA[oAAnLvi»A(QArg
Spun02 ( ' thmmbin* T7 terminator___
AAGGAAGCTGAGTTGECTGCTGCCACCq(:TGABCAATAA'cTAQCÂfAACCCCnGGGECCtCTAAACttfi'GTCTTGAGGGGTTTTTin LygO ) uA I oO I uLeuA 1 nA I «AI aTh^  I qO ) uGÏnÉnd
T7 torm!na(qr primer 009337-3
pET-14b clonmg/expression region
Appendix Ilia: Plasmid map of the pET-14b cloning and expression vector
The pET-14b vector carries an N-terminal His-tag sequence followed by a thrombin cleavage 
site and unique restriction sites are shown on the circle map. The cloning/expression region of 
the coding strand transcribed by T7 RNA polymerase is shown in more detail in the box 
(Adapted horn www.novagen.com).
2 1 1
pETZe#(t) MqWMK# landHMfks
T7 proinoler 370-380
T7 transcrli)tloii start 369
niS'Tag coding sequence 270-287
T7*Tag coding sequence 207-239
Multiple cloning sites 
(/7,ih ))11-A7ioI) 158-203
Hls'Tag coding sequence 140-157
T7 terminator 26-72
t a d  coding sequence 773-1852
pBR322 origin 3286
Kan coding sequence 3995-4807
n  origin 4903 5358
Tlie maps for pET-28b{-r) and pET-28c(-r) 
are the same as pET-28a(+) (showm) with 
the foliowing exceptions: pET-2Bb(+) is a 
53G8bp plasmid; subtract Ibp from each site 
beyond BimAi I at 198. pET-28c(+) Is a 
5307bp plasmid; subtract 2bp from each site 
beyond BuirM I at 198.
D ra 111(5127)
X h o  1(15») Not 1(165) 
E#g 1(1*6) 
Hind ltkl73) Sat 1(179)
S ac  1(160)EOOR 1(192)BamH 1(198) Nh* 1(231) 
Nda 1(238) Nco 1(2*6)
X b a 1(335)
W  ll('ioi)SgrA 1(442) 
Sph 1(593)
Mitl i(!123) 
Bci 1(1137)
B p u 1 1 0 2  i(80)
Pvu 1(4425)
sgf 1(4425) -
S m a  i(4300)
Cia 1(4117)
B stE  ii(1304) 
^A pa 1(1334)
N ru 1(4003)
pET-28a(+)(5369bp)
BsSlt li(1534)
EC0RV (1373)
H p a  i(1029)
E co 5 7  i(3772) 
AlwN 1(3040)
B s s S  1(3397)
B sp L U II 1(3224)
S a p  1(3100) 
B s t1 1 0 7  l(2DB5) 
T t h i n  1(2000)
PsIlA  1(19®))
Bgt 1(2107) 
F s p  1(2205) 
P sp S  11(2230)
T7 promoter prîrrK^  #G934W
pET upstream primar #69214-3-„S9ÜL . TOW..AGATCTCGArCCCeCOMATTAATACSACTCACTATAGGG5AATTGTGASCCGATAACAATTCCCCTCTAGAAATAATTT7BTTTAACTTTAASAAGGA0A 
N c o \ HI««T.g JVjfeL j M L .  T7-T*B
TATACCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCQGCCÎGQTecCGCSCGeCAGCCATATGGCTAGCAÎGACÎSGTGSACAGCAA HBtB)v3«r0erHl«HHil1HiHlsHi8lH B3ar3TGlY l-»uV olProArgaiy3»rH l«t1»tA io3arR«tTt^rB lvQ [¥SiaG ln 
E a g  I thromWa
  aamHieooRi Sac I Sail HWIII N o l l  X h o  I___________________
ATCCGTCGCGOATCCBAATTCGAGCKCGTCGACAAOCTTGCOGCCGCACTCQAGCAeCACCACCACCACCACTQASATCCSGCTGCTAACAAAOCCC pET-a8o(*) 
MstG i yArgG 1 yS arG  I uPheG I ut-euA rgA rgG  InA loC ysG lyA rgT lirA rgA  to P ro P ro F ro P ro P ro L * u A rg S « rG  I yCyaOncl
...CGrCSGGATCCGAATTCGAGCTCCCTCGACAAGCTTeCBGCCGCACTCCAGCACCACCACCACCACCACTGAGATCCGGCTeETAACAAAGCCC 
.. .GiyArgA»pProAinS*r8«i'3«rVQlA«pLy*L*uAI<JAIaA)oLBu0iuHlaHI*HlaHliH1»l1l»En(1
...GGTCOQATCCOAATTCOAGCTCCQTCOACAAQCTTGCGSCCGCACTCBAGCACCACCACCACCACCACTGAQATCCGeCTGCTAACAAAGCCC .. .GivArql leArqt ieArqAtoProS«rThrSBrLBuArqPrQH)A3wrSBrThrTt)rThrTt)rT0rThPGIul leAroLBwLeuThrLvaPro..
flpul102t _________________ T7lTmtn«tPf_________
GAAAGGAAGCTGAGTTGGCTGCTOCCACC0CTOAGCAATAACTAGCAÎAACCCCItCCGGCCTCTAAACCGGtCT1OAGGGGTTTTTTG
pET-28k>(*
T7 lemlnalof primer #50337-3
pET-28a-c{+) cloning/expression region
Appendix Illb: Plasmid map of the pET-28a~c(+) cloning and expression vector
The pET-28a-c (+) vectors carry an N-terminal Hls-Tag®/thrombin/T7-Tag® configuration 
plus an optional C-terminal His-Tag sequence. Unique restriction sites are shown on the circle 
map. The cloning/expression region of the coding strand transcribed by T7 RNA polymerase is 
shown in more detail in the box (Adapted from www.novagen.com).
2 1 2
M •<
o o
OIü 5
co
CD
p <  a
£f
:
IoIAI
%IT3
MS
•I§I
m
<N
Ndel/Sall/BamHI/Smal
Hindlll
Sûcl
•EcoRIPst I 
Hindlll-
p R E P l
induced; EMM 
repreoacd: EMM + S u g /m l 
th ia m in e
EcoRI
Hindi
Appendix Illd: Plasmid map of the pREPl cloning and expression vector
The pR E P l vector is derived from  the original pREP series by addition o f  a N del site 
adjacent to the Sail site (A dapted from  M aundrell, 1993).
214
Xhoi/Sal I/BamH I/Sma I
Hindi 
P s tu
H indlll
EcoRI
Hindi
Sad
EcoRI
pREP3X
induced: EMM 
r e p r e sse d : EMM + 5 u g /m l  
th ia m i ne
EcoRI
Appendix Hie: Plasmid map of the pREP3X cloning and expression vector
The pREP3X vector is derived from the original pREP3 series by addition o f a Xhol polylinker 
between the Ball and Sail sites; this deletes the ATG within the polylinker, destroys Ball and 
recreates Sail (Adapted from www-rcf.usc.edu/~forsburg).
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